https://bostonlifesciencestimes.com/2021/09/poxel-completes-enrollment-in-phase-2-nash-trial-for-pxl065-destiny-1-in-biopsy-proven-patients/ 2021-09-21T13:29:42+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Poxel.png https://bostonlifesciencestimes.com/2021/09/alvotech-provides-update-on-fda-action-regarding-avt02-proposed-high-concentration-biosimilar-to-humira/ 2021-09-21T13:32:32+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Alvotech.jpg https://bostonlifesciencestimes.com/2021/09/virpax-to-develop-intranasal-cannabidiol-product-for-the-management-of-epilepsy-in-adults-and-children/ 2021-09-21T13:35:38+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Virpax.jpg https://bostonlifesciencestimes.com/2021/09/kiyatec-announces-addition-of-chief-commercial-officer-stacy-chick-to-executive-team/ 2021-09-21T13:40:13+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Stacy-Chick.jpg https://bostonlifesciencestimes.com/2021/09/immuneid-appoints-veteran-biotech-executive-james-s-scibetta-as-ceo/ 2021-09-21T13:43:23+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/James-S.-Scibetta.jpg https://bostonlifesciencestimes.com/2021/09/blackstones-biomed-realty-announces-plans-to-double-the-size-of-its-uk-life-sciences-portfolio/ 2021-09-21T13:57:42+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/BioMed-Realty.jpg https://bostonlifesciencestimes.com/2021/09/genmab-and-seagen-announce-fda-accelerated-approval-for-tivdak/ 2021-09-21T14:02:26+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/TIVDAK.jpg https://bostonlifesciencestimes.com/2021/09/abec-sets-another-industry-benchmark-in-single-use-bioprocessing/ 2021-09-21T14:06:22+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/ABEC.png https://bostonlifesciencestimes.com/2021/09/be-bio-appoints-mitchell-chan-as-chief-financial-officer-head-of-corporate-strategy/ 2021-09-21T14:08:36+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Mitchell-Chan.webp https://bostonlifesciencestimes.com/2021/09/well-iq-joins-the-pointclickcare-marketplace-to-provide-real-time-patient-feedback-for-the-senior-care-market/ 2021-09-21T14:23:10+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/PointClickCare.jpg https://bostonlifesciencestimes.com/2021/09/nomi-health-pays-off-medical-debt-valued-at-more-than-225-million-for-americans-burdened-by-surprise-billing-and-high-healthcare-costs/ 2021-09-21T14:25:11+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Nomi-Health.jpg https://bostonlifesciencestimes.com/2021/09/p360-boosts-its-zing-sms-communication-module-with-multimodal-enterprise-grade-features-for-compliant-communication-with-hcps/ 2021-09-22T13:14:18+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/P360s-ZING-Communication-Module.jpg https://bostonlifesciencestimes.com/2021/09/frequency-therapeutics-announces-new-fx-322-results-showing-that-additional-study-participants-gain-hearing-improvements-at-later-time-points/ 2021-09-22T13:16:28+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Frequency-Therapeutics-Inc.png https://bostonlifesciencestimes.com/2021/09/credence-medsystems-secures-39-9-million-financing-to-enable-scaling-of-innovative-drug-delivery-and-connected-health-systems/ 2021-09-22T13:18:06+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Credence-MedSystems.jpg https://bostonlifesciencestimes.com/2021/09/pfizer-and-biontech-expand-collaboration-with-u-s-to-provide-500-million-additional-covid-19-vaccine-doses-at-not-for-profit-price-for-donation-to-poorest-countries/ 2021-09-22T13:19:06+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/01/Covid-pfizer.jpg https://bostonlifesciencestimes.com/2021/09/hatchspaces-expands-to-orange-county-delivering-37000-sf-of-purpose-built-wet-lab-space-in-partnership-with-denver-based-nexcore-group/ 2021-09-22T13:23:29+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/HATCHspaces-new-37000.jpg https://bostonlifesciencestimes.com/2021/09/veklury-remdesivir-significantly-reduced-risk-of-hospitalization-in-high-risk-patients-with-covid-19/ 2021-09-22T13:25:50+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Veklury%C2%AE-Remdesivir.jpg https://bostonlifesciencestimes.com/2021/09/life-sciences-stakeholders-launch-collaboration-to-advance-inclusion-diversity-equity-and-accessibility/ 2021-09-22T13:27:40+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/IDEA.jpg https://bostonlifesciencestimes.com/2021/09/adding-multimedia-phononic-transforms-cold-chain-fulfillment-ecosystem/ 2021-09-22T13:38:47+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Phononic.jpg https://bostonlifesciencestimes.com/2021/09/immunicom-introduces-2nd-product-of-immunopheresis-therapy-platform-designed-to-suppress-cancer-progression-and-overcome-therapeutic-resistance/ 2021-09-22T13:56:28+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Immunopheresis%C2%AE-therapy.jpg https://bostonlifesciencestimes.com/2021/09/nocd-raises-33-million-to-address-global-ocd-crisis-series-b-financing-to-support-people-struggling-with-ocd-fuel-growth/ 2021-09-22T14:02:29+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Stephen-Smith.webp https://bostonlifesciencestimes.com/2021/09/goodrx-launches-goodrx-health-a-next-generation-online-health-resource/ 2021-09-23T13:25:55+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/GoodRx.jpg https://bostonlifesciencestimes.com/2021/09/blue-white-robotics-announces-37m-series-b-funding-led-by-insight-partners-to-revolutionize-autonomous-farming/ 2021-09-23T13:32:48+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Blue-White-Robotics.jpg https://bostonlifesciencestimes.com/2021/09/opentrons-announces-200-million-series-c-round-led-by-softbank-vision-fund-2/ 2021-09-23T13:37:58+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Jon-Brennan-Badal.png https://bostonlifesciencestimes.com/2021/09/pfizer-and-biontech-receive-first-u-s-fda-emergency-use-authorization-of-a-covid-19-vaccine-booster/ 2021-09-23T13:39:32+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/Pfizer.jpg https://bostonlifesciencestimes.com/2021/09/jscrambler-raises-15-million-in-series-a-funding-to-rewrite-the-rules-of-website-security/ 2021-09-23T13:44:09+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Jscrambler.jpg https://bostonlifesciencestimes.com/2021/09/neurolief-announces-first-patient-enrolled-in-clinical-study-evaluating-its-brain-neuromodulation-system-in-treating-major-depressive-disorder/ 2021-09-23T14:08:57+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Relivion-DP.jpg https://bostonlifesciencestimes.com/2021/09/evoendo-and-micro-tech-endoscopy-announce-partnership-for-single-use-unsedated-endoscopy-system/ 2021-09-23T14:10:44+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/EvoEndo.png https://bostonlifesciencestimes.com/2021/09/orthofix-announces-appointment-of-wayne-burris-to-board-of-directors/ 2021-09-23T15:19:20+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Wayne-Burris.jpg https://bostonlifesciencestimes.com/2021/09/2j-antennas-launches-the-worlds-smallest-5gnr-wifi-6e-and-gnss-combination-9-in-1-antennas/ 2021-09-23T15:42:55+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/5GNR.jpg https://bostonlifesciencestimes.com/2021/09/h-i-g-capital-acquires-aspire-pharma/ 2021-09-24T13:10:45+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/H.I.G.-Capital.jpg https://bostonlifesciencestimes.com/2021/09/astex-pharmaceuticals-presents-overall-survival-data-from-ascertain-phase-3-study-of-oral-hypomethylating-agent-inqovi/ 2021-09-24T13:12:54+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Astex-Pharmaceuticals.jpg https://bostonlifesciencestimes.com/2021/09/long-term-crysvita-%e2%96%bc-burosumab-treatment-reduces-the-burden-of-disease-in-adults-with-x-linked-hypophosphataemia/ 2021-09-24T13:15:58+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/CRYSVITA%C2%AE.jpg https://bostonlifesciencestimes.com/2021/09/carevive-introduces-carevive-smart-data-to-highlight-the-real-world-oncology-patient-experience/ 2021-09-24T13:18:54+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Carevive-Systems.png https://bostonlifesciencestimes.com/2021/09/ovarian-cancerx-new-innovative-clinical-research-effort-seeks-to-accelerate-the-development-of-new-treatments-for-deadliest-gynecological-cancer/ 2021-09-24T13:21:48+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Audra-Moran.jpg https://bostonlifesciencestimes.com/2021/09/cryosa-closes-21-5-million-series-b-funding-round-to-advance-minimally-invasive-obstructive-sleep-apnea-treatment/ 2021-09-24T13:35:55+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Dr.-Donald-Gonzales.png https://bostonlifesciencestimes.com/2021/09/nextvein-announces-affordable-high-performance-handheld-vein-visualization-system/ 2021-09-24T13:49:06+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Vein-Visualization-System.jpg https://bostonlifesciencestimes.com/2021/09/sab-biotherapeutics-announces-sab-185-receives-positive-dsmb-review-and-advances-to-phase-3-in-nih-sponsored-activ-2-trial-for-treatment-of-covid-19/ 2021-09-24T13:51:46+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/SAB-Biotherapeutics.jpg https://bostonlifesciencestimes.com/2021/09/r-zero-arc-lands-bronze-in-2021-international-design-excellence-awards/ 2021-09-24T13:54:22+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/R-Zero-Arc.jpg https://bostonlifesciencestimes.com/2021/09/rudolph-and-sletten-awarded-high-rise-replacement-hospital-in-los-angeles-county/ 2021-09-24T14:08:07+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Rudolph-and-Sletten.jpg https://bostonlifesciencestimes.com/2021/09/cyclo-therapeutics-appoints-lise-lund-kjems-md-phd-as-chief-medical-officer/ 2021-09-27T13:36:59+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/cyclo.png https://bostonlifesciencestimes.com/2021/09/ksl-biomedical-inc-announces-expansion-to-canada-with-acquisition-of-pulse-scientific/ 2021-09-27T14:17:20+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Kevin-Lawson.webp https://bostonlifesciencestimes.com/2021/09/precision-biosciences-appoints-michael-amoroso-chief-executive-officer/ 2021-09-27T14:27:28+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Michael-Amoroso.jpg https://bostonlifesciencestimes.com/2021/09/vfmcrp-announces-approval-for-tavneos-avacopan-for-the-treatment-of-anca-associated-vasculitis-in-japan/ 2021-09-27T14:37:33+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Vifor-Fresenius-Medical-Care-Renal-Pharma.jpg https://bostonlifesciencestimes.com/2021/09/life-science-industry-in-california-generates-131-billion-annually-providing-1-38m-jobs/ 2021-09-27T14:43:34+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Joseph-Panetta.jpg https://bostonlifesciencestimes.com/2021/09/astrazeneca-covid-19-and-rsv-presentations-at-idweek-2021-will-showcase-scientific-progress-in-infectious-diseases/ 2021-09-27T14:52:10+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/02/AstraZeneca-Building.jpg https://bostonlifesciencestimes.com/2021/09/tae-life-sciences-announces-installation-of-first-accelerator-based-neutron-beam-system-for-biologically-targeted-radiation-therapy/ 2021-09-27T14:59:52+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Bruce-Bauer.jpg https://bostonlifesciencestimes.com/2021/09/boehringer-ingelheim-and-invetx-announce-strategic-collaboration-to-advance-monoclonal-antibody-biotherapeutics-in-animal-health/ 2021-09-27T15:11:18+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Invetx.jpg https://bostonlifesciencestimes.com/2021/09/altasciences-continues-building-expansion-with-additional-location-in-philadelphia/ 2021-09-27T15:14:01+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Altasciences.png https://bostonlifesciencestimes.com/2021/09/orthofix-announces-milestone-%e2%88%92-more-than-60000-m6-c-artificial-cervical-discs-implanted-worldwide/ 2021-09-27T15:22:09+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Orthofix.jpg https://bostonlifesciencestimes.com/2021/09/new-study-evaluates-the-feasibility-of-using-masimo-emma-capnography-on-mechanically-ventilated-neonates/ 2021-09-27T15:33:58+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Masimo-EMMA.jpg https://bostonlifesciencestimes.com/2021/09/pfizer-and-biontech-submit-initial-data-to-u-s-fda-from-pivotal-trial-of-covid-19-vaccine-in-children-5-to/ 2021-09-28T13:25:03+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/02/Vaccine-double.jpg https://bostonlifesciencestimes.com/2021/09/anji-pharma-secures-70-million-to-deploy-dynamic-equity-and-further-build-a-global-medicines-company/ 2021-09-28T13:34:19+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Anji-Pharma.jpg https://bostonlifesciencestimes.com/2021/09/medidata-veterans-rama-kondru-and-sastry-chilukuri-named-co-ceos/ 2021-09-28T13:38:11+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Rama-Kondru.jpg https://bostonlifesciencestimes.com/2021/09/expanding-diagnostics-business-schott-signs-agreement-to-acquire-applied-microarrays-inc/ 2021-09-28T13:45:14+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/SCHOTT.jpg https://bostonlifesciencestimes.com/2021/09/kytopen-raises-30m-in-series-a-funding-led-by-northpond-ventures-to-transform-non-viral-delivery-via-the-flowfect-platform/ 2021-09-28T13:54:01+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Kytopen.jpg https://bostonlifesciencestimes.com/2021/09/genprex-strengthens-management-team-with-appointments-of-industry-leaders-mark-s-berger-m-d-as-chief-medical-officer-and-hemant-kumar-ph-d-as-chief-manufacturing-and-technology-officer/ 2021-09-28T13:56:05+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Mark-S.-Berger-MD-new-Chief-Medical-Officer-of-Genprex.jpg https://bostonlifesciencestimes.com/2021/09/care-access-and-eli-lilly-and-company-partner-to-increase-diversity-within-oncology-clinical-trials/ 2021-09-28T14:02:23+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Care-Access.png https://bostonlifesciencestimes.com/2021/09/sab-biotherapeutics-appoints-russell-beyer-chief-financial-officer/ 2021-09-28T14:05:32+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Russell-Beyer.jpg https://bostonlifesciencestimes.com/2021/09/vensana-capital-raises-325-million-and-expands-team-to-back-transformative-medical-technology-innovations/ 2021-09-28T14:19:20+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Kirk-Nielsen.webp https://bostonlifesciencestimes.com/2021/09/fda-clears-caretaker-medicals-wireless-platform-for-continuous-noninvasive-blood-pressure-and-hemodynamic-monitoring/ 2021-09-29T13:39:36+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/VitalStream.jpg https://bostonlifesciencestimes.com/2021/09/appili-therapeutics-and-aipharma-announce-strategic-alliance-and-equity-transaction/ 2021-09-29T13:56:48+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Appili-Therapeutics.jpg https://bostonlifesciencestimes.com/2021/09/ananda-scientific-and-david-geffen-school-of-medicine-ucla-announce-clinical-trial-utilizing-liquid-structuretm-cannabidiol-for-the-treatment-of-opioid-use-disorder/ 2021-09-29T13:59:32+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Sohail-R.-Zaidi.jpg https://bostonlifesciencestimes.com/2021/09/amring-pharmaceuticals-inc-licenses-lysteda-to-pierre-fabre-for-mexican-market/ 2021-09-29T14:11:27+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Amring-Pharmaceuticals-Inc.jpg https://bostonlifesciencestimes.com/2021/09/sporos-bioventures-appoints-amit-rakhit-m-d-as-chief-executive-officer/ 2021-09-29T14:14:53+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Amit-Rakhit-M.D.-M.B.A..jpg https://bostonlifesciencestimes.com/2021/09/ajax-therapeutics-expands-management-team-to-support-advancement-of-novel-therapies-for-hematologic-malignancies/ 2021-09-29T14:34:54+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Ajax-Therapeutics.jpg https://bostonlifesciencestimes.com/2021/09/sommetrics-launches-pivotal-clinical-study-of-its-aersleep-ii-product-to-treat-sleep-apnea/ 2021-09-29T14:47:37+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Sommetrics.jpg https://bostonlifesciencestimes.com/2021/09/surmodics-announces-successful-first-patient-uses-of-sublime-radial-access-018-rx-pta-dilatation-catheter/ 2021-09-29T14:56:27+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Surmodics.png https://bostonlifesciencestimes.com/2021/09/topline-results-from-shionogi-phase-2-study-in-japan-show-akilis-digital-treatment-was-well-received-and-improved-inattention-symptoms-in-children-with-adhd/ 2021-09-29T14:59:38+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Shionogi.jpg https://bostonlifesciencestimes.com/2021/09/isarna-therapeutics-appoints-claus-schalper-as-ceo/ 2021-09-30T13:30:45+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Isarna-Therapeutics.jpg https://bostonlifesciencestimes.com/2021/09/leo-pharma-presents-new-adtralza-tralokinumab-data-following-long-term-continuous-treatment/ 2021-09-30T13:33:20+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/LEO.jpg https://bostonlifesciencestimes.com/2021/09/deep-6-ai-launches-deep-6-for-life-sciences-to-accelerate-clinical-trials-for-sponsors-cros/ 2021-09-30T13:52:36+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Deep-6-AI.png https://bostonlifesciencestimes.com/2021/09/dermavant-showcases-new-long-term-data-from-phase-3-psoaring-3-trial-of-tapinarof-in-patients-with-plaque-psoriasis-at-the-30th-eadv-virtual-congress/ 2021-09-30T13:56:11+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Bruce-Strober-MD-PhD-scaled-e1633010153905.jpg https://bostonlifesciencestimes.com/2021/09/onduo-and-fitbit-collaborate-to-provide-onduo-members-with-fitbit-devices-and-services-to-help-manage-their-holistic-health/ 2021-09-30T14:00:19+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/fitbit.png https://bostonlifesciencestimes.com/2021/09/moderna-to-invest-in-new-science-center-in-cambridge-ma/ 2021-09-30T14:04:59+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Stephane-Bancel.jpg https://bostonlifesciencestimes.com/2021/09/greenhill-insurance-services-appoints-industry-veteran-chris-dunlavy-as-president/ 2021-09-30T14:14:48+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Chris-Dunlavy.jpg https://bostonlifesciencestimes.com/2021/09/alzamend-neuro-receives-positive-pre-ind-response-from-fda-for-al002-a-cell-based-therapeutic-vaccine/ 2021-09-30T14:19:04+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Alzamend-Neuro.jpg https://bostonlifesciencestimes.com/2021/09/laurent-pharmaceuticals-announces-topline-results-from-its-phase-2-resolution-clinical-trial-of-lau-7b-for-the-treatment-of-covid-19/ 2021-09-30T14:24:25+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Radu-Pislariu.jpg https://bostonlifesciencestimes.com/2021/09/hologic-expands-its-omni-hysteroscopy-offering-in-europe/ 2021-09-30T14:29:35+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Hologic.png https://bostonlifesciencestimes.com/2021/10/u-s-fda-approves-kites-tecartus-as-the-first-and-only-car-t-for-adults-with-relapsed-or-refractory-b-cell-acute-lymphoblastic-leukemia/ 2021-10-04T15:42:10+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Kite.jpg https://bostonlifesciencestimes.com/2021/10/stevanato-group-initiates-construction-on-new-u-s-facility/ 2021-10-04T15:44:14+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Stevanato.jpg https://bostonlifesciencestimes.com/2021/10/updated-vitrakvi-sub-analysis-at-ata-2021-supports-efficacy-and-safety-in-adult-and-pediatric-trk-fusion-thyroid-cancer-patients/ 2021-10-04T15:45:55+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/06/Bayer.jpg https://bostonlifesciencestimes.com/2021/10/suffolk-bolsters-invest-innovate-build-strategy-with-key-leadership-hires/ 2021-10-04T15:49:52+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Charley-Leatherbee.jpg https://bostonlifesciencestimes.com/2021/10/crestoptics-introduces-deepsim-super-resolution-confocal-microscope-module/ 2021-10-04T15:57:01+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/CrestOptics.jpg https://bostonlifesciencestimes.com/2021/10/enhertu-granted-breakthrough-therapy-designation-in-us/ 2021-10-04T16:28:05+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/02/AstraZeneca-Building.jpg https://bostonlifesciencestimes.com/2021/10/sab-biotherapeutics-announces-first-patient-dosed-in-phase-3-nih-activ-2-trial-evaluating-sab-185-for-treatment-of-covid-19/ 2021-10-04T16:30:53+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/SAB-Biotherapeutics.jpg https://bostonlifesciencestimes.com/2021/10/novos-closes-3-15m-aims-to-extend-healthy-human-lifespan-with-science-based-supplements/ 2021-10-04T16:32:54+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/NOVOS.jpg https://bostonlifesciencestimes.com/2021/10/marche-health-launches-digital-health-marketplace-and-community-with-350-vetted-solutions-to-start/ 2021-10-05T14:20:48+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Marche-Health.jpg https://bostonlifesciencestimes.com/2021/10/the-journal-of-urology-publishes-results-of-urogen-pharmas-phase-2b-study-of-ugn-102/ 2021-10-05T14:45:53+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Dr.-Mark-Schoenberg.jpg https://bostonlifesciencestimes.com/2021/10/nikons-first-european-nikon-bioimaging-lab-now-open-in-leiden/ 2021-10-05T15:43:58+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Ida-Haisma-and-Bo-Kajiwara.jpg https://bostonlifesciencestimes.com/2021/10/the-jackson-laboratory-appoints-dr-lon-cardon-as-its-next-president-and-chief-executive-officer/ 2021-10-05T15:46:09+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Dr.-Lon-Cardon.jpg https://bostonlifesciencestimes.com/2021/10/accenture-acquires-advoco-scaling-capabilities-for-intelligent-asset-management-solutions/ 2021-10-05T15:52:37+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Advoco.jpg https://bostonlifesciencestimes.com/2021/10/rho-selects-medidatas-industry-leading-decentralized-clinical-trial-dct-capabilities-for-patient-focused-approach-to-new-drug-development/ 2021-10-05T15:55:50+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Medidata.jpg https://bostonlifesciencestimes.com/2021/10/harrison-street-reaches-hard-cap-and-raises-2-5-billion-in-equity-for-eighth-u-s-opportunistic-real-estate-fund-firms-largest-closed-end-fund-ever/ 2021-10-05T15:59:22+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Christopher-Merril.jpg https://bostonlifesciencestimes.com/2021/10/azd7442-request-for-emergency-use-authorization-for-covid-19-prophylaxis-filed-in-us/ 2021-10-05T16:02:33+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/02/AstraZeneca-Building.jpg https://bostonlifesciencestimes.com/2021/10/flora-growth-forms-flora-pharma-division-launches-global-clinical-trials/ 2021-10-06T13:32:06+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Luis-Merchan.jpg https://bostonlifesciencestimes.com/2021/10/eqrx-and-absci-announce-partnership-to-discover-and-develop-next-generation-protein-based-drugs/ 2021-10-06T13:35:47+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Carlos-Garcia-Echeverria-Ph.D..png https://bostonlifesciencestimes.com/2021/10/steve-kurzeja-named-chief-revenue-officer-of-life-sciences-tech-innovator-p360/ 2021-10-06T13:38:26+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Steve-Kurzeja.jpg https://bostonlifesciencestimes.com/2021/10/redshift-bioanalytics-celebrates-opening-of-structir-scientific-services-lab-with-the-launch-of-the-structir-lab-grant-program/ 2021-10-06T13:41:48+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/RedShift-BioAnalytics.jpg https://bostonlifesciencestimes.com/2021/10/medidata-launches-groundbreaking-sensor-cloud-network-to-connect-digital-health-innovators/ 2021-10-06T13:45:46+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Anthony-Costello.png https://bostonlifesciencestimes.com/2021/10/medexecwomen-invites-women-in-life-sciences-to-join-the-2021-annual-conference-in-boston-in-october/ 2021-10-06T13:53:59+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/MedExecWomen.jpg https://bostonlifesciencestimes.com/2021/10/onemednet-partners-with-arterys-to-accelerate-access-to-world-class-clinical-ai-products-and-solutions/ 2021-10-06T14:07:37+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Mike-LaChance.jpg https://bostonlifesciencestimes.com/2021/10/orum-therapeutics-appoints-olaf-christensen-m-d-as-chief-medical-officer/ 2021-10-06T14:15:46+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Olaf-Christensen-M.D.jpg https://bostonlifesciencestimes.com/2021/10/animal-milk-oligosaccharides-can-protect-pets-microbiome-during-antibiotic-treatment/ 2021-10-06T14:23:07+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/GNUBIOTICS.jpg https://bostonlifesciencestimes.com/2021/10/abionyx-pharma-announces-positive-preclinical-results-in-a-model-of-uveitis/ 2021-10-07T12:59:13+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/ABIONYX-Pharma.jpg https://bostonlifesciencestimes.com/2021/10/perkinelmer-receives-fda-emergency-use-authorization-for-respiratory-sars-cov-2-panel/ 2021-10-07T13:02:20+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/01/1200px-PerkinElmer_logo.svg_.png https://bostonlifesciencestimes.com/2021/10/intest-enters-medical-cold-chain-market-through-acquisition-of-assets-of-z-sciences-corp/ 2021-10-07T13:06:06+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/intest.png https://bostonlifesciencestimes.com/2021/10/neumora-therapeutics-launches-to-pioneer-a-new-era-of-precision-medicines-for-brain-diseases/ 2021-10-07T13:09:21+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Neumora_Logo.jpg https://bostonlifesciencestimes.com/2021/10/aro-biotherapeutics-appoints-mittie-doyle-md-facr-as-chief-medical-officer/ 2021-10-07T13:20:02+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Mittie-Doyle-MD.webp https://bostonlifesciencestimes.com/2021/10/ambu-launches-endoscopy-insights-podcast/ 2021-10-07T13:23:43+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/%E2%80%98Endoscopy-Insights.jpg https://bostonlifesciencestimes.com/2021/10/the-midwests-leading-medical-device-and-advanced-manufacturing-event-returns-to-minneapolis-in-person-this-fall/ 2021-10-07T13:40:58+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Minneapolis-Convention-Center.png https://bostonlifesciencestimes.com/2021/10/catalyst-orthoscience-announces-12-3-million-oversubscribed-financing-round-to-fuel-company-momentum-in-shoulder-arthroplasty/ 2021-10-07T14:07:34+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Catalyst-OrthoScience.png https://bostonlifesciencestimes.com/2021/10/beigene-announces-first-regulatory-approval-in-australia-for-brukinsa-for-treatment-of-patients-with-waldenstroms-macroglobulinemia/ 2021-10-08T13:22:07+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/BRUKINSA.jpg https://bostonlifesciencestimes.com/2021/10/alvotech-beats-back-abbvies-trade-secrets-lawsuit/ 2021-10-08T13:28:03+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Robert-Wessman.webp https://bostonlifesciencestimes.com/2021/10/white-oak-healthcare-finance-provides-financing-to-highfive-healthcare-to-support-growth-strategy/ 2021-10-08T13:32:31+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/Screenshot_2021-05-10-https-whiteoaksf-com.png https://bostonlifesciencestimes.com/2021/10/cibus-appoints-co-founder-rory-riggs-as-chief-executive-officer/ 2021-10-08T13:34:55+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Rory-Riggs.jpg https://bostonlifesciencestimes.com/2021/10/gretel-ai-closes-50-million-series-b-round-for-privacy-engineering-as-a-service/ 2021-10-08T13:39:55+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Sridhar-Ramaswamy.jpg https://bostonlifesciencestimes.com/2021/10/immunicom-hires-former-fda-clinician-and-medical-device-reviewer-to-rapidly-progress-launch-of-novel-cancer-immunotherapy/ 2021-10-08T13:43:41+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Dr.-Christian-Shenouda.png https://bostonlifesciencestimes.com/2021/10/aquant-announces-70-million-series-c-funding-round-to-revolutionize-the-service-industry-using-artificial-intelligence/ 2021-10-08T13:49:12+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Aquant-Co-founders.jpg https://bostonlifesciencestimes.com/2021/10/rxcell-inc-astars-imcb-nus-and-seri-collaborate-to-develop-cellular-therapeutics-for-age-related-diseases/ 2021-10-11T16:56:44+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/RxCell-Inc.png https://bostonlifesciencestimes.com/2021/10/koya-medical-presents-positive-interim-data-from-randomized-trial-comparing-its-dayspring-lymphedema-treatment-to-pneumatic-compression/ 2021-10-11T16:58:42+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/The-Dayspring.jpg https://bostonlifesciencestimes.com/2021/10/aceto-expands-gmp-product-lines-for-biopharmaceutical-and-vaccine-manufacturing-with-acquisition-of-ac-bio-buffer/ 2021-10-12T13:01:10+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/AC-Bio-Buffe.jpg https://bostonlifesciencestimes.com/2021/10/hunterian-medicine-licenses-inscriptas-mad7-nuclease-to-advance-gene-editing-research-and-development/ 2021-10-12T13:06:00+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Inscripta.jpg https://bostonlifesciencestimes.com/2021/10/seagen-and-astellas-complete-enrollment-in-ev-103-trial-cohort-k-combining-padcev-with-pembrolizumab-as-first-line-treatment-for-advanced-urothelial-cancer/ 2021-10-12T13:15:50+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Seagen-Inc.png https://bostonlifesciencestimes.com/2021/10/pluto-biosciences-closes-1m-seed-round-for-industry-first-collaborative-life-sciences-platform/ 2021-10-12T13:21:34+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Pluto-Biosciences.jpg https://bostonlifesciencestimes.com/2021/10/merck-begins-tender-offer-to-acquire-acceleron-pharma-inc/ 2021-10-12T13:36:12+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Acceleron-Pharma.jpg https://bostonlifesciencestimes.com/2021/10/clarify-health-introduces-atlas-the-healthcare-and-life-sciences-insights-platform-that-maps-and-connects-all-patient-journeys/ 2021-10-12T13:46:00+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Clarify-Health.jpg https://bostonlifesciencestimes.com/2021/10/syros-pharmaceuticals-announces-appointment-of-jason-haas-as-chief-financial-officer/ 2021-10-12T13:50:08+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Jason-Haas.jpg https://bostonlifesciencestimes.com/2021/10/nanostring-launches-ncounter-antibody-drug-conjugate-panel-to-accelerate-the-development-of-oncology-treatments/ 2021-10-12T13:52:19+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/NanoString.jpg https://bostonlifesciencestimes.com/2021/10/covid-19-cytokine-storm-and-coagulopathy-markers-controlled-with-nichi-glucan-variants-the-first-of-its-kind-report-in-a-clinical-study/ 2021-10-12T13:54:58+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Nichi-Glucan.jpg https://bostonlifesciencestimes.com/2021/10/delphinus-receives-fda-approval-for-its-softvue-3d-whole-breast-ultrasound-tomography-system/ 2021-10-12T14:27:44+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Delphinus-Medical-Technologies.jpg https://bostonlifesciencestimes.com/2021/10/quantori-appoints-dr-steve-labkoff-as-global-head-of-clinical-and-healthcare-informatics/ 2021-10-13T13:36:01+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Dr.-Steve-Labkoff.jpg https://bostonlifesciencestimes.com/2021/10/cibc-launches-450-million-fund-focused-on-venture-capital-and-growth-equity-funds/ 2021-10-13T13:47:24+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Mark-McQueen.png https://bostonlifesciencestimes.com/2021/10/immusoft-and-takeda-collaborate-to-discover-and-develop-cell-therapies-for-rare-neurometabolic-disorders/ 2021-10-13T13:56:25+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Sean-Ainsworth.png https://bostonlifesciencestimes.com/2021/10/alnylam-announces-launch-of-alnylam-challengers-a-signature-community-impact-program-to-improve-health-access-to-underserved-communities/ 2021-10-13T14:00:12+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Dr.-Pushkal-Garg.jpg https://bostonlifesciencestimes.com/2021/10/everbridge-wins-2021-stratus-award-for-its-industry-leading-healthcare-solution-enabling-hospitals-and-health-systems-to-improve-secure-clinical-collaboration/ 2021-10-13T14:12:02+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Stratus-Award.jpg https://bostonlifesciencestimes.com/2021/10/ge-healthcare-partners-with-apprise-health-insights-to-launch-nations-first-automated-statewide-hospital-bed-management-solution-in-oregon/ 2021-10-13T14:25:28+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/GE-e1634135113775.png https://bostonlifesciencestimes.com/2021/10/inogen-appoints-stanislav-glezer-as-chief-technology-officer/ 2021-10-13T14:42:05+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Inogen.png https://bostonlifesciencestimes.com/2021/10/vbi-vaccines-announces-publication-of-results-from-pivotal-phase-3-study-constant-of-vbis-prophylactic-3-antigen-hepatitis-b-vaccine-candidate/ 2021-10-13T14:50:28+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/VBI-Vaccines.jpg https://bostonlifesciencestimes.com/2021/10/reform-biologics-inc-announces-appointments-of-kevin-kavanaugh-cpa-to-chief-financial-officer-and-robert-mahoney-phd-to-chief-scientific-officer/ 2021-10-13T14:53:29+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/ReForm-Biologics-Inc.png https://bostonlifesciencestimes.com/2021/10/exelixis-in-licenses-second-anti-cancer-compound-from-aurigene-following-fda-acceptance-of-investigational-new-drug/ 2021-10-14T13:41:36+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Peter-Lamb-Ph.D.jpg https://bostonlifesciencestimes.com/2021/10/rectify-pharmaceuticals-launches-with-100-million-series-a-financing-from-atlas-venture-omega-funds-forbion-and-longwood-fund/ 2021-10-14T13:52:43+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Rajesh-Devraj-Ph.D..jpg https://bostonlifesciencestimes.com/2021/10/rhizen-pharmaceuticals-ag-announces-first-patient-dosing-in-a-phase-ii-study-of-tenalisib-rp6530-in-locally-advanced-or-metastatic-breast-cancer-patients/ 2021-10-14T13:57:33+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Swaroop-Vakkalanka.jpg https://bostonlifesciencestimes.com/2021/10/verily-accelerates-technology-and-commercial-growth-with-new-operations-hub-in-dallas/ 2021-10-14T14:00:59+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Cypress-Waters.jpg https://bostonlifesciencestimes.com/2021/10/lunaphore-webinar-to-highlight-real-world-implementation-of-comet-at-scilifelab/ 2021-10-14T14:02:57+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/The-TMA.jpg https://bostonlifesciencestimes.com/2021/10/kriya-therapeutics-appoints-theresa-heah-m-d-mba-as-chief-medical-officer-and-president-of-kriya-ophthalmology/ 2021-10-14T14:09:23+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Theresa-Heah-M.D.-MBA.jpg https://bostonlifesciencestimes.com/2021/10/kojin-therapeutics-announces-luba-greenwood-as-chief-executive-officer/ 2021-10-14T14:18:28+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Luba-Greenwood.jpg https://bostonlifesciencestimes.com/2021/10/abalos-therapeutics-completes-series-a-extension-bringing-total-raised-to-eur-43-million/ 2021-10-14T14:42:07+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Abalos-Therapeutics.png https://bostonlifesciencestimes.com/2021/10/sacituzumab-govitecan-receives-positive-chmp-opinion-as-2l-treatment-for-adult-patients-with-metastatic-triple-negative-breast-cancer/ 2021-10-15T13:21:28+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/06/Gilead-Sciences.png https://bostonlifesciencestimes.com/2021/10/culture-biosciences-raises-80m-series-b-to-tackle-demand-for-large-scale-biomanufacturing/ 2021-10-15T13:25:53+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Culture-Biosciences.jpg https://bostonlifesciencestimes.com/2021/10/resilience-and-harvard-university-announce-five-year-rd-alliance-to-incubate-new-technologies-launch-companies-to-advance-the-manufacture-of-complex-medicines/ 2021-10-15T13:29:45+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Lee-L.-Rubin-Ph.D..jpg https://bostonlifesciencestimes.com/2021/10/organon-launches-new-fertility-journey-website-as-part-of-ongoing-commitment-to-help-address-the-needs-of-women/ 2021-10-15T13:34:30+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Women.jpg https://bostonlifesciencestimes.com/2021/10/henry-schein-ceo-stanley-m-bergman-issues-statement-supporting-primary-care-physician-access-to-covid-19-vaccines/ 2021-10-15T13:43:38+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Stanley-M.-Bergman.jpg https://bostonlifesciencestimes.com/2021/10/sanaby-health-acquisition-corp-i-announces-pricing-of-150-million-initial-public-offering/ 2021-10-15T13:50:45+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Sanaby-Health-Acquisition-Corp.jpg https://bostonlifesciencestimes.com/2021/10/moderna-announces-fda-advisory-committee-unanimously-votes-in-support-of-emergency-use-for-a-booster-dose-of-modernas-covid-19-vaccine-in-the-u-s/ 2021-10-15T14:05:24+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Moderna.jpg https://bostonlifesciencestimes.com/2021/10/biotools-innovator-names-machine-bio-as-inaugural-grand-prize-winner/ 2021-10-15T14:20:46+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/David-Marash.webp https://bostonlifesciencestimes.com/2021/10/boston-lab-market-red-hot-as-vacancy-drops-and-rents-rise/ 2021-10-15T14:24:52+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Eric-Smith.webp https://bostonlifesciencestimes.com/2021/10/definitive-healthcare-launches-latitude-reporting-for-custom-patient-cohort-creation-and-analytics/ 2021-10-18T13:54:05+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Screenshot-2021-10-18-at-09-53-20-Our-People.png https://bostonlifesciencestimes.com/2021/10/perkinelmer-and-honeycomb-biotechnologies-launch-the-hive-scrnaseq-solution-for-single-cell-analysis/ 2021-10-18T13:56:04+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/HIVE-scRNAseq-Solution.jpg https://bostonlifesciencestimes.com/2021/10/takara-bio-usa-inc-launches-automated-full-length-single-cell-rna-seq-solution-for-enhanced-biomarker-discovery/ 2021-10-18T13:59:19+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Takara-Bio-USA.jpg https://bostonlifesciencestimes.com/2021/10/u-s-food-and-drug-administration-approves-expanded-indication-of-gileads-biktarvy-for-treatment-of-hiv-1-in-pediatric-populations/ 2021-10-18T14:07:27+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Merdad-Parsey-MD-PhD.jpg https://bostonlifesciencestimes.com/2021/10/nanostring-unveils-spatial-organ-atlas-during-the-american-society-of-human-genetics-ashg-conference/ 2021-10-18T14:11:34+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/NanoString-1.jpg https://bostonlifesciencestimes.com/2021/10/gp-write-partners-with-dna-script-to-accelerate-dna-writing-technology-and-accessibility/ 2021-10-18T14:17:47+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Screenshot-2021-10-18-at-10-17-21-About-Us-DNA-Script.png https://bostonlifesciencestimes.com/2021/10/nflection-therapeutics-appoints-william-hodder-as-ceo-and-expands-leadership-team-to-accelerate-development-of-targeted-treatments-for-rare-diseases/ 2021-10-18T14:39:01+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/NFlection-Therapeutics.jpg https://bostonlifesciencestimes.com/2021/10/aditxt-announces-pricing-of-4-25-million-public-offering/ 2021-10-18T14:40:27+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Aditxt-Inc..jpg https://bostonlifesciencestimes.com/2021/10/altoida-launches-5-year-multi-center-alzheimers-study-with-eisai-and-ionian-university/ 2021-10-18T14:56:26+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Altoida.png https://bostonlifesciencestimes.com/2021/10/globus-resorts-to-lawsuit-to-fight-back-against-life-spines-top-performing-prolift-product-life-spine-will-vigorously-fight-the-allegations-it-announces/ 2021-10-18T15:02:03+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Life-Spine.png https://bostonlifesciencestimes.com/2021/10/jama-study-of-over-28000-participants-finds-84-of-hello-heart-users-reduced-blood-pressure-over-three-years/ 2021-10-18T15:13:40+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Hello-Heart.png https://bostonlifesciencestimes.com/2021/10/fsd-pharma-signs-agreement-with-covar-pharmaceuticals-to-support-the-development-of-lucid-psych/ 2021-10-19T13:41:12+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Anthony-Durkacz.jpg https://bostonlifesciencestimes.com/2021/10/boehringer-ingelheim-and-partners-to-accelerate-development-of-first-in-class-gene-therapy-for-patients-with-cystic-fibrosis/ 2021-10-19T13:43:56+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Boehringer-Ingelheim.png https://bostonlifesciencestimes.com/2021/10/promega-launches-sanger-sequencing-chemistry-compatible-with-all-capillary-electrophoresis-platforms/ 2021-10-19T13:46:14+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Promega.jpg https://bostonlifesciencestimes.com/2021/10/sofinnova-partners-raises-e472-548-million-to-form-largest-early-stage-healthcare-vc-fund-in-europe/ 2021-10-19T13:59:40+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Antoine-Papiernik.webp https://bostonlifesciencestimes.com/2021/10/molecular-targeting-technologies-inc-announces-spray-technology-that-lights-up-tumors/ 2021-10-19T14:10:38+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Molecular-Targeting-Technologies.jpg https://bostonlifesciencestimes.com/2021/10/clovis-oncology-and-itm-announce-lutetium-177-clinical-supply-agreement/ 2021-10-19T14:16:54+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Patrick-Mahaffy.jpg https://bostonlifesciencestimes.com/2021/10/dd-pharmatech-raises-51m-in-series-c-financing-to-advance-potential-disease-modifying-treatments-for-neurodegenerative-fibrotic-and-metabolic-diseases/ 2021-10-19T14:27:19+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Yoo-Seok-Hong.jpg https://bostonlifesciencestimes.com/2021/10/omnivision-announces-uniquely-small-diameter-cable-modules-with-mini-led-illumination-for-single-use-endoscopes/ 2021-10-19T14:40:54+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/OmniVision.jpg https://bostonlifesciencestimes.com/2021/10/carlyle-and-leading-healthcare-focused-venture-funds-announce-strategic-growth-investment-of-up-to-430-million-in-saama/ 2021-10-20T13:37:45+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Suresh-Katta.jpeg https://bostonlifesciencestimes.com/2021/10/beigene-and-nanolek-announce-approval-in-russia-for-brukinsa-zanubrutinib-for-treatment-of-patients-with-relapsed-or-refractory-mantle-cell-lymphoma/ 2021-10-20T13:39:08+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/BRUKINSA.jpg https://bostonlifesciencestimes.com/2021/10/marc-schneebaum-joins-avalyn-pharma-as-chief-financial-officer/ 2021-10-20T13:42:21+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Avalyn-Pharma.jpg https://bostonlifesciencestimes.com/2021/10/phononic-announces-full-customer-and-manufacturing-qualification-in-apac-expanding-global-production-of-high-performance-thermoelectrics/ 2021-10-20T13:45:42+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/thermoelectric-chips.jpg https://bostonlifesciencestimes.com/2021/10/quantum-si-announces-expansion-of-early-access-program-for-the-platinum-single-molecule-protein-sequencing-platform/ 2021-10-20T13:50:23+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Quantum-Si.jpg https://bostonlifesciencestimes.com/2021/10/rsip-vision-introduces-bladder-panorama-generator-and-sparse-reconstruction-tool/ 2021-10-20T14:11:53+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/RSIP-Vision.jpg https://bostonlifesciencestimes.com/2021/10/freudenberg-medical-launches-breakthrough-speakfree-hme-valve-for-laryngectomy-care/ 2021-10-20T14:13:59+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/SpeakFree%E2%84%A2.jpg https://bostonlifesciencestimes.com/2021/10/allisonpartners-bolsters-health-practice-with-several-hires-and-client-wins/ 2021-10-20T14:19:34+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Michelle-Webb.jpg https://bostonlifesciencestimes.com/2021/10/shouti-secures-100-million-series-b-financing-to-accelerate-development-of-life-changing-medicines/ 2021-10-20T14:21:46+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/ShouTi.jpg https://bostonlifesciencestimes.com/2021/10/prilenia-and-huntington-study-group-announce-completion-of-patient-enrollment-ahead-of-schedule-in-global-phase-3-proof-hd-huntingtons-disease-clinical-trial/ 2021-10-20T14:25:41+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Prilenia-Therapeutics-B.V..jpg https://bostonlifesciencestimes.com/2021/10/pfizer-and-biontech-announce-phase-3-trial-data-showing-high-efficacy-of-a-booster-dose-of-their-covid-19-vaccine/ 2021-10-21T13:43:54+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Covid-vaccine.jpg https://bostonlifesciencestimes.com/2021/10/croma-pharma-expands-successful-mask-range-with-face-masks-for-different-areas-of-application/ 2021-10-21T13:47:04+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Croma-Pharma.jpg https://bostonlifesciencestimes.com/2021/10/mablink-bioscience-and-emergence-therapeutics-enter-into-a-licensing-agreement-to-develop-antibody-drug-conjugate-as-a-potential-cancer-therapy/ 2021-10-21T13:49:45+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Jack-Elands.png https://bostonlifesciencestimes.com/2021/10/steven-n-austad-ph-d-appointed-as-inaugural-protective-life-endowed-chair-in-healthy-aging-research-at-uab/ 2021-10-21T13:56:11+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Steven-N.-Austad.jpg https://bostonlifesciencestimes.com/2021/10/agilent-pd-l1-ihc-28-8-pharmdx-receives-ce-ivd-mark-as-a-companion-diagnostic-test-in-advanced-or-metastatic-gastric-gastroesophageal-junction-or-esophageal-adenocarcinoma/ 2021-10-21T13:59:04+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Sam-Raha.jpg https://bostonlifesciencestimes.com/2021/10/recode-therapeutics-raises-oversubscribed-series-b-financing-round-of-80-million/ 2021-10-21T14:03:25+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/David-Lockhart-Ph.D..png https://bostonlifesciencestimes.com/2021/10/longbow-immunotherapy-launches-react-a-novel-car-t-platform-targeting-solid-tumors/ 2021-10-21T14:19:21+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Dr.-Weiguo-Cui.jpg https://bostonlifesciencestimes.com/2021/10/oncodesign-and-tiumbio-sign-collaboration-agreement-for-rd-of-fibrosis-drug-candidates/ 2021-10-21T14:37:20+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Philippe-Genne.webp https://bostonlifesciencestimes.com/2021/10/adtralza-tralokinumab-achieves-primary-and-secondary-endpoints-in-phase-3-trial-of-adolescents-with-moderate-to-severe-atopic-dermatitis/ 2021-10-22T13:40:15+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/LEO-Pharma.jpg https://bostonlifesciencestimes.com/2021/10/egle-therapeutics-raises-40-million-e-series-a-to-develop-first-in-class-t-regulatory-cells-therapies-based-on-treg-starvers/ 2021-10-22T13:45:14+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Luc-Boblet.jpeg https://bostonlifesciencestimes.com/2021/10/research-reveals-trivalent-protacs-more-potent-in-targeted-protein-degradation/ 2021-10-22T13:50:54+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/three-headed-hydra.jpg https://bostonlifesciencestimes.com/2021/10/adding-multimedia-lucid-diagnostics-appoints-suman-verma-md-phd-as-chief-scientific-officer/ 2021-10-22T13:58:41+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Suman-Verma-MD-PhD.jpg https://bostonlifesciencestimes.com/2021/10/walgreens-now-offering-moderna-and-johnson-johnson-covid-19-vaccine-booster-shots-nationwide/ 2021-10-22T14:00:50+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Moderna.jpg https://bostonlifesciencestimes.com/2021/10/first-nasally-administered-pharmaceutical-treatment-for-dry-eye-disease-approved-by-us-fda-with-aptars-nasal-pump-system/ 2021-10-25T13:55:55+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/TYRVAYA%E2%84%A2-Nasal-Spray.jpg https://bostonlifesciencestimes.com/2021/10/caprisa-and-evotec-launch-new-project-to-fast-track-new-technology-for-hiv-prevention/ 2021-10-25T13:59:36+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/CAPRISA.png https://bostonlifesciencestimes.com/2021/10/xeris-pharmaceuticals-enters-collaboration-agreement-with-merck/ 2021-10-25T14:01:02+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Xeris-Pharmaceuticals.png https://bostonlifesciencestimes.com/2021/10/epiendo-pharmaceuticals-wins-the-swedish-american-life-sciences-summit-salss-rising-star-award-2021/ 2021-10-25T14:02:44+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Maria-Bech-CEO-and-Dr-Fridrik-Gardarsson.jpg https://bostonlifesciencestimes.com/2021/10/study-finds-overwhelming-evidence-that-color-blindness-hinders-learning-in-school-reports-enchroma/ 2021-10-25T14:09:40+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Color-Blindness.jpg https://bostonlifesciencestimes.com/2021/10/flare-therapeutics-appoints-daphne-karydas-as-coo-and-cfo-and-michaela-bowden-phd-as-svp-of-biology-and-translation/ 2021-10-25T14:15:15+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Michaela-Bowden.jpg https://bostonlifesciencestimes.com/2021/10/pavmed-digital-health-subsidiary-veris-health-appoints-sunny-webb-as-chief-technology-officer/ 2021-10-25T14:31:17+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Sunny-Webb.jpg https://bostonlifesciencestimes.com/2021/10/onchilles-pharma-appoints-christopher-twitty-ph-d-chief-scientific-officer/ 2021-10-26T13:47:45+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Christopher-Twitty-Ph.D..webp https://bostonlifesciencestimes.com/2021/10/stallergenes-greer-and-aptar-pharma-announce-partnership-to-develop-novel-connected-device-for-allergen-immunotherapy-treatment-delivery/ 2021-10-26T13:49:58+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Stallergenes-Greer.png https://bostonlifesciencestimes.com/2021/10/medable-secures-304-million-in-funding-at-2-1-billion-valuation-new-round-co-led-by-blackstone-growth-gsr-ventures-and-tiger-global/ 2021-10-26T13:53:58+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Dr.-Michelle-Longmire.jpg https://bostonlifesciencestimes.com/2021/10/solasia-and-nippon-kayaku-announce-license-agreement-in-japan-for-new-drug-candidate-darinaparsin-sp-02/ 2021-10-26T14:00:43+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Yoshihiro-Arai.jpg https://bostonlifesciencestimes.com/2021/10/vaxess-technologies-announces-grand-opening-of-gmp-manufacturing-facility/ 2021-10-26T14:12:39+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Screenshot-2021-10-26-at-10-12-08-Michael-Schrader-Vaxess.png https://bostonlifesciencestimes.com/2021/10/simbiosys-raises-15-million-series-a-to-develop-the-future-of-precision-cancer-care/ 2021-10-26T14:19:48+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/SimBioSys-2.jpg https://bostonlifesciencestimes.com/2021/10/sofinnova-partners-congratulates-portfolio-company-dna-script-for-the-success-of-its-e142m-165m-oversubscribed-series-c-fundraise/ 2021-10-26T14:24:01+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Sofinnova.jpg https://bostonlifesciencestimes.com/2021/10/citiustech-names-bhaskar-sambasivan-as-ceo-succeeding-co-founder-rizwan-koita/ 2021-10-26T14:32:24+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/CitiusTech.png https://bostonlifesciencestimes.com/2021/10/scineuro-pharmaceuticals-and-mabylon-ag-to-collaborate-on-development-of-novel-therapeutics-for-neurological-diseases/ 2021-10-26T14:43:14+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/SciNeuro-Pharmaceuticals.jpg https://bostonlifesciencestimes.com/2021/10/vaccine-mandates-survey-reveals-discordant-views-may-fuel-challenges-in-tight-labor-market/ 2021-10-26T14:44:31+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/BioSpace.png https://bostonlifesciencestimes.com/2021/10/dna-script-raises-165m-in-oversubscribed-series-c-financing-to-accelerate-commercialization-of-enzymatic-dna-printing-platform/ 2021-10-26T14:46:38+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Screenshot-2021-10-26-at-10-46-04-Team-DNA-Script.png https://bostonlifesciencestimes.com/2021/10/frequency-therapeutics-virtual-rd-event-to-detail-fx-322-clinical-advances-a-new-program-for-hearing-restoration-and-in-vivo-data-from-its-ms-remyelination-program/ 2021-10-27T13:17:27+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Frequency-Therapeutics.png https://bostonlifesciencestimes.com/2021/10/takeda-to-acquire-gammadelta-therapeutics-to-accelerate-development-of-allogeneic-%ce%b3%ce%b4t-cell-therapies-addressing-solid-tumors/ 2021-10-27T13:22:46+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Dr.-Paolo-Paoletti.jpg https://bostonlifesciencestimes.com/2021/10/agilent-commits-to-net-zero-greenhouse-gas-emissions-by-2050/ 2021-10-27T13:29:36+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Mike-McMullen.jpg https://bostonlifesciencestimes.com/2021/10/fractyl-health-announces-publication-of-pioneering-new-model-of-intestines-role-in-metabolism/ 2021-10-27T13:31:26+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Harith-Rajagopalan-M.D.-Ph.D..webp https://bostonlifesciencestimes.com/2021/10/incloudcounsel-announces-200-million-series-b-funding-from-blackstone-growth-bxg-rebrands-as-ontra/ 2021-10-27T13:34:14+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/InCloudCounsel.jpg https://bostonlifesciencestimes.com/2021/10/kezar-announces-first-patient-dosed-in-phase-1-trial-of-kzr-261-in-advanced-solid-tumor-malignancies/ 2021-10-27T13:37:22+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/John-Fowler.jpg https://bostonlifesciencestimes.com/2021/10/over-150-million-americans-can-now-access-their-covid-19-vaccination-records-in-verifiable-digital-format/ 2021-10-27T13:58:38+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/VCI.jpg https://bostonlifesciencestimes.com/2021/10/bayer-to-present-new-analyses-adding-to-the-depth-of-knowledge-on-the-cardiovascular-and-renal-outcomes-of-kerendia/ 2021-10-27T14:02:00+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/06/Bayer.jpg https://bostonlifesciencestimes.com/2021/10/symphony-retailai-acquires-shelf-intelligence-saas-technology-leader-retech-labs/ 2021-10-27T14:04:48+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Chris-Koziol.png https://bostonlifesciencestimes.com/2021/10/in-substantial-growth-move-hemogenyx-pharmaceuticals-moves-to-mink-building-in-new-york-city/ 2021-10-27T14:41:53+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Scott-Metzner.webp https://bostonlifesciencestimes.com/2021/10/triumvira-appoints-oncology-industry-veteran-deyaa-adib-m-d-as-chief-medical-officer/ 2021-10-28T13:23:29+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Deyaa-Adib-M.D..jpg https://bostonlifesciencestimes.com/2021/10/inscopix-names-pharma-leader-dr-david-gray-as-chief-scientific-officer-in-new-position-to-oversee-drug-development-for-brain-disorders/ 2021-10-28T13:25:01+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Dr.-David-Gray.jpg https://bostonlifesciencestimes.com/2021/10/pfizer-and-biontech-to-provide-u-s-government-an-additional-50-million-pediatric-doses-of-covid-19-vaccine-to-support-further-preparedness-for-future-needs/ 2021-10-28T13:30:15+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/01/Covid-pfizer.jpg https://bostonlifesciencestimes.com/2021/10/j-r-simplot-company-and-plant-sciences-inc-forge-strategic-alliance-on-gene-editing-of-strawberries/ 2021-10-28T13:35:34+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Simplots-and-PSIs-gene-edited-strawberry-plants.jpg https://bostonlifesciencestimes.com/2021/10/biolabs-appoints-dr-nina-dudnik-chief-business-officer/ 2021-10-28T13:38:06+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Dr.-Nina-Dudnik.jpg https://bostonlifesciencestimes.com/2021/10/embleema-and-george-washington-university-led-consortium-wins-fda-contract-to-advance-the-fight-against-infectious-disease-outbreaks/ 2021-10-28T13:42:47+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Robert-Chu.webp https://bostonlifesciencestimes.com/2021/10/alnylam-announces-planned-ceo-leadership-transition/ 2021-10-28T13:58:11+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/John-Maraganore-Ph.D.jpg https://bostonlifesciencestimes.com/2021/10/meissa-announces-positive-preliminary-clinical-data-on-safety-and-immunogenicity-of-intranasal-covid-19-vaccine/ 2021-10-28T14:02:41+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Meissa-Vaccines.jpg https://bostonlifesciencestimes.com/2021/10/sphere-fluidics-closes-a-40-million-funding-round-led-by-sofinnova-partners-and-redmile-group/ 2021-10-28T14:07:32+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Sphere-Fluidics.jpg https://bostonlifesciencestimes.com/2021/10/magnus-medical-launches-with-breakthrough-device-designation-for-rapid-individualized-treatment-of-major-depression-and-25m-in-series-a-financing/ 2021-10-29T12:55:39+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Magnus-Medical.jpg https://bostonlifesciencestimes.com/2021/10/intersystems-iris-for-health-and-first-line-software-to-streamline-clinical-research-workflows-on-i2b2/ 2021-10-29T13:07:07+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/InterSystems.jpg https://bostonlifesciencestimes.com/2021/10/despite-recent-fda-hold-us-cancer-specialists-are-enthusiastic-about-car-t-cell-therapies-says-incrowd-instant-insights-data/ 2021-10-29T13:09:20+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/InCrowd.jpg https://bostonlifesciencestimes.com/2021/10/clinical-and-patient-reported-outcomes-in-people-living-with-hiv-on-biktarvy-in-observational-bicstar-study-demonstrate-consistent-efficacy-profile-in-real-world-setting/ 2021-10-29T13:10:48+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/06/Gilead-Sciences.png https://bostonlifesciencestimes.com/2021/10/intest-expands-process-technology-offerings-with-acquisition-of-videology-imaging-solutions/ 2021-10-29T13:16:29+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/intest.png https://bostonlifesciencestimes.com/2021/10/dr-reddys-laboratories-announces-the-launch-of-ephedrine-sulfate-injection-usp-50-mg-ml-single-dose-vial-in-the-u-s-market/ 2021-10-29T13:19:36+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Dr.-Reddy.webp https://bostonlifesciencestimes.com/2021/10/better-therapeutics-closes-business-combination-and-debuts-on-nasdaq/ 2021-10-29T13:27:01+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Better-Therapeutics-scaled.jpg https://bostonlifesciencestimes.com/2021/10/empowering-targeted-cancer-drug-discovery-with-ai-and-novel-disease-models-signet-therapeutics-raises-10-million-in-seed-2-round/ 2021-10-29T13:37:49+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/04/doctor.jpg https://bostonlifesciencestimes.com/2021/11/canbridge-pharmaceuticals-enters-into-duchenne-muscular-dystrophy-gene-therapy-research-agreement-with-university-of-washington-school-of-medicine/ 2021-11-01T13:39:28+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/Jeffrey-Chamberlain-Ph.D..jpg https://bostonlifesciencestimes.com/2021/11/perspectum-and-hepquant-announce-partnership-to-bring-a-more-complete-picture-of-liver-health/ 2021-11-01T13:42:08+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/Dr.-Rajarshi-Banerjee.jpg https://bostonlifesciencestimes.com/2021/11/rhizen-pharmaceuticals-ag-announces-first-patient-dosing-in-a-phase-i-ib-study-of-its-novel-parp-inhibitor-rp12146-in-patients-with-advanced-solid-tumors/ 2021-11-01T13:52:00+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Swaroop-Vakkalanka.jpg https://bostonlifesciencestimes.com/2021/11/agrology-introduces-the-first-effective-affordable-and-easy-to-use-predictive-agriculture-system-for-the-wine-industry-specialty-crops/ 2021-11-01T14:02:20+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/Agrology.jpg https://bostonlifesciencestimes.com/2021/11/dr-marcia-eisenberg-labcorp-diagnostics-chief-scientific-officer-named-to-fierce-healthcares-2021-women-of-influence/ 2021-11-01T14:09:23+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/Dr.-Marcia-Eisenberg.jpg https://bostonlifesciencestimes.com/2021/11/dalrada-corporation-investors-convert-6-million-into-equity/ 2021-11-01T14:40:16+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/Dalrada.jpg https://bostonlifesciencestimes.com/2021/11/rheos-medicines-presents-data-demonstrating-potential-of-malt1-inhibition-as-novel-approach-for-the-treatment-of-autoimmune-and-inflammatory-diseases/ 2021-11-01T15:06:27+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/Barbara-Fox-Ph.D..jpg https://bostonlifesciencestimes.com/2021/11/careplus-introduces-medicare-advantage-plan-to-benefit-floridians-with-chronic-lung-conditions-including-copd/ 2021-11-01T15:09:56+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/CarePlus.jpg https://bostonlifesciencestimes.com/2021/11/corporate-action-on-toxic-chemicals-in-clothing-target-leads-amazon-lags-according-to-new-company-scorecard/ 2021-11-01T15:24:34+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/Toxic-Chemicals-in-Clothing.jpg https://bostonlifesciencestimes.com/2021/11/beigene-to-present-clinical-data-on-brukinsa-in-chronic-lymphocytic-leukemia-at-the-63rd-ash-annual-meeting/ 2021-11-04T14:15:40+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/BeiGene.png https://bostonlifesciencestimes.com/2021/11/qstream-appoints-dan-whelan-as-chief-executive-officer/ 2021-11-04T14:24:02+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/Dan-Whelan.jpg https://bostonlifesciencestimes.com/2021/11/cybin-granted-dea-schedule-i-manufacturing-license/ 2021-11-04T14:44:34+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/Doug-Drysdale.png https://bostonlifesciencestimes.com/2021/11/dp-brightful-joins-qualtrics-as-president-worldwide-field-operations/ 2021-11-04T14:50:08+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/DP-Brightful.jpg https://bostonlifesciencestimes.com/2021/11/premia-spines-tops-spinal-arthroplasty-system-yields-positive-patient-outcomes-at-6-weeks-through-12-months/ 2021-11-04T14:59:40+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/Premia-Spines-TOPS-System.jpg https://bostonlifesciencestimes.com/2021/11/plateletbio-completes-75-5m-series-b-financing/ 2021-11-04T15:03:06+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/PlateletBio.jpg https://bostonlifesciencestimes.com/2021/11/takeda-recommends-common-sense-policy-reforms-designed-to-reduce-time-to-diagnosis-improve-access-to-care-for-patients-with-rare-disease/ 2021-11-04T15:08:37+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/Takeda.jpg https://bostonlifesciencestimes.com/2021/11/the-vascular-care-group-launches-worcester-center-for-patient-care-in-central-massachusetts/ 2021-11-04T15:10:51+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/Dr.-Hector-Simosa.jpg https://bostonlifesciencestimes.com/2021/11/graftech-announces-150-million-share-repurchase-authorization/ 2021-11-04T15:16:22+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/David-J.-Rintoul.jpg https://bostonlifesciencestimes.com/2021/11/genbodys-anterior-nasal-swab-covid-19-antigen-test-granted-fda-emergency-use-authorization-as-part-of-an-effort-to-meet-increased-national-demand-amid-rapid-test-shortage/ 2021-11-04T15:18:49+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/GenBody.jpg https://bostonlifesciencestimes.com/2021/11/astrazeneca-advances-ambition-to-redefine-care-for-blood-cancer-at-ash-2021/ 2021-11-05T14:01:48+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/02/AstraZeneca-Building.jpg https://bostonlifesciencestimes.com/2021/11/thoma-bravo-completes-acquisition-of-qad/ 2021-11-05T14:07:41+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/Thoma-Bravo.jpg https://bostonlifesciencestimes.com/2021/11/new-publication-in-cell-implicates-a-rare-form-of-dna-driving-antimicrobial-resistance-in-bacterial-biofilms/ 2021-11-05T14:13:03+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/Clarametyx-Biosciences-Inc.jpg https://bostonlifesciencestimes.com/2021/11/glycoera-ag-raises-chf-45-million-us-49-million-series-a-financing-to-develop-novel-biologics-based-on-innovative-glycoengineering-platform/ 2021-11-05T14:19:46+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/GlycoEra-AG.jpg https://bostonlifesciencestimes.com/2021/11/care-access-drives-decentralized-trial-discussions-and-on-site-covid-19-testing-at-four-key-industry-events/ 2021-11-05T14:22:22+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Care-Access.png https://bostonlifesciencestimes.com/2021/11/bit-bio-raises-in-excess-of-100-million-in-first-close-of-series-b-financing/ 2021-11-05T14:26:28+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/bit.bio-team-at-Cambridge-Headquarters-on-the-Babraham-Campus.jpg https://bostonlifesciencestimes.com/2021/11/bluebird-bio-and-federal-realty-to-establish-biotech-footprint-at-assembly-row/ 2021-11-05T14:28:34+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/bluebird-bio.jpg https://bostonlifesciencestimes.com/2021/11/ethos-asset-management-inc-usa-announces-deal-in-rwanda-with-baho-international-hospital-ltd-to-build-brand-new-hospital-facilities-and-equip-them-in-kigali/ 2021-11-05T14:34:39+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Carlos-Santos.jpeg https://bostonlifesciencestimes.com/2021/11/the-hartford-announces-pilot-to-train-connecticut-medical-providers-on-addiction-pain-management-and-stigma/ 2021-11-05T14:38:48+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/Christopher-Swift.jpg https://bostonlifesciencestimes.com/2021/11/avrobio-announces-inducement-grant-under-nasdaq-listing-rule-5635c4/ 2021-11-05T14:41:34+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/AVROBIO.jpg https://bostonlifesciencestimes.com/2021/11/cerebras-systems-raises-250m-in-funding-for-over-4b-valuation-to-advance-the-future-of-artificial-intelligence-compute/ 2021-11-10T14:11:38+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/Andrew-Feldman.jpg https://bostonlifesciencestimes.com/2021/11/mei-pharma-and-kyowa-kirin-receive-orphan-drug-designation-for-zandelisib-for-the-treatment-of-follicular-lymphoma/ 2021-11-10T14:14:04+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/MEI-Pharma.jpg https://bostonlifesciencestimes.com/2021/11/virpax-advances-envelta-development-with-ncats-under-crada-agreement/ 2021-11-10T14:20:12+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/Anthony-P.-Mack.jpg https://bostonlifesciencestimes.com/2021/11/intima-bioscience-appoints-alessandro-riva-m-d-as-chief-executive-officer/ 2021-11-10T14:23:54+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/Intima-Bioscience.jpg https://bostonlifesciencestimes.com/2021/11/dovetail-genomics-launches-boston-epigenetics-society-to-accelerate-vital-epigenetics-and-epitranscriptomics-research/ 2021-11-10T14:28:16+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/Todd-Dickinson.png https://bostonlifesciencestimes.com/2021/11/general-atlantic-closes-sixth-flagship-growth-equity-fund-at-7-8-billion-bringing-total-committed-capital-to-23-8-billion/ 2021-11-10T14:38:56+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/General-Atlantic.jpg https://bostonlifesciencestimes.com/2021/11/flywheel-announces-final-series-c-investment/ 2021-11-10T14:45:17+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/Flywheel.jpg https://bostonlifesciencestimes.com/2021/11/imbed-biosciences-wins-a-2m-award-from-the-u-s-army-to-prevent-combat-wound-infections/ 2021-11-10T14:47:48+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/Imbed-Biosciences.jpg https://bostonlifesciencestimes.com/2021/11/easypost-and-precisemdx-partner-to-streamline-shipping-of-medical-testing-kits/ 2021-11-10T14:56:57+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/EasyPost.jpg https://bostonlifesciencestimes.com/2021/11/endologix-names-dr-matthew-thompson-president-and-ceo/ 2021-11-10T15:03:09+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/Dr.-Matthew-Thompson.png https://bostonlifesciencestimes.com/2021/11/new-clinical-study-hinge-health-enso-wearable-demonstrates-significant-improvements-in-both-mobility-and-pain-reduction/ 2021-11-10T15:04:26+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/Hinge-Healths-Enso.jpg https://bostonlifesciencestimes.com/2021/11/organon-to-acquire-forendo-pharma/ 2021-11-11T14:58:09+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/Kevin-Ali.webp https://bostonlifesciencestimes.com/2021/11/inflammatix-awarded-1-7-million-grant-from-national-institutes-of-health-nih/ 2021-11-11T15:02:20+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/Tim-Sweeney-MD-PhD.webp https://bostonlifesciencestimes.com/2021/11/crestoptics-acquired-by-apposite-capital-llp-to-enable-rapid-commercial-growth-and-innovation-in-bioimaging/ 2021-11-11T15:05:52+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/Renato-Giacobbo-Scavo.jpg https://bostonlifesciencestimes.com/2021/11/baxter-announces-100-million-investment-in-biopharma-solutions-halle-westfalen-germany-sterile-fill-finish-manufacturing-facility/ 2021-11-11T15:12:18+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/Baxter-International-Inc..jpg https://bostonlifesciencestimes.com/2021/11/nuritas-raises-45-million-to-scale-its-peptide-discovery-platform-and-expand-globally/ 2021-11-11T15:22:18+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/Dr.-Nora-Khald-e1636644128186.jpg https://bostonlifesciencestimes.com/2021/11/activ-surgical-appoints-richard-stamm-as-vice-president-general-counsel-and-mark-johnson-as-vice-president-global-sales/ 2021-11-11T15:28:00+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/Richard-Stamm.jpg https://bostonlifesciencestimes.com/2021/11/horizon-therapeutics-plc-receives-chmp-positive-opinion-for-uplizna-inebilizumab-as-a-monotherapy-for-the-treatment-of-adult-patients-with-neuromyelitis-optica-spectrum-disorder/ 2021-11-12T15:32:25+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/Horizon-Therapeutics.png https://bostonlifesciencestimes.com/2021/11/innate-pharma-highlights-new-nk-cell-engager-data-with-partner-sanofi-at-sitc-annual-meeting/ 2021-11-12T15:38:08+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/Innate-Pharma.png https://bostonlifesciencestimes.com/2021/11/pharmacyte-biotech-announces-cell-encapsulation-technology-material-does-not-cause-skin-irritation/ 2021-11-12T16:16:08+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/PharmaCyte-Biotech.png https://bostonlifesciencestimes.com/2021/11/oncomyx-presents-new-data-at-sitc-2021-demonstrating-the-potential-of-a-multi-armed-myxoma-virus-as-a-novel-oncolytic-immunotherapy-for-solid-tumors-and-heme-malignancies/ 2021-11-12T16:18:22+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/OncoMyx.jpg https://bostonlifesciencestimes.com/2021/11/ursa-health-successfully-completes-soc-2-type-ii-assessment/ 2021-11-12T16:30:43+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/Ursa-Health.jpg https://bostonlifesciencestimes.com/2021/11/emulate-introduces-the-second-generation-zoe-culture-module-for-replicating-complex-human-biology-and-drug-effect/ 2021-11-15T14:16:22+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/Emulate-Inc..jpg https://bostonlifesciencestimes.com/2021/11/rocket-pharmaceuticals-announces-positive-updates-from-phase-1-clinical-trial-of-rp-a501-in-danon-disease/ 2021-11-15T14:17:50+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Rocket-Pharma.webp https://bostonlifesciencestimes.com/2021/11/bayshore-pharmaceuticals-announces-commercial-launch-of-anda-approved-products/ 2021-11-15T14:20:34+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/Mark-Moshier.jpg https://bostonlifesciencestimes.com/2021/11/hcl-technologies-brings-new-jobs-to-the-northeast-with-hartford-center-opening/ 2021-11-15T14:24:40+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/HCL-Technologies-Hartford-Center.jpg https://bostonlifesciencestimes.com/2021/11/alchemab-therapeutics-appoints-young-t-kwon-phd-as-chief-financial-and-operating-officer/ 2021-11-15T14:29:14+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/Young-T.-Kwon-PhD.jpg https://bostonlifesciencestimes.com/2021/11/theramex-enters-otc-market-with-femarelle-a-non-hormonal-option-to-treat-menopause-symptoms/ 2021-11-15T14:34:23+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/Theramex.jpg https://bostonlifesciencestimes.com/2021/11/fda-grants-the-hemolung-de-novo-clearance/ 2021-11-15T14:44:39+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/ALung-Technologies.jpg https://bostonlifesciencestimes.com/2021/11/sky-labs-cart-i-a-wearable-heart-monitoring-medical-device-advances-into-the-british-medical-device-market/ 2021-11-15T14:47:53+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/Sky-Labs.jpg https://bostonlifesciencestimes.com/2021/11/sos-raises-3-4-million-in-funding-to-expand-smart-vending-and-digital-marketing-platform/ 2021-11-15T14:50:46+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/SOS.jpg https://bostonlifesciencestimes.com/2021/11/casper-sleep-inc-to-be-acquired-by-durational-capital-management/ 2021-11-15T14:53:49+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/Casper-Sleep-Inc.jpg https://bostonlifesciencestimes.com/2021/11/late-breaking-phase-2-data-for-investigational-oral-factor-xia-inhibitor-milvexian-suggest-favorable-antithrombotic-profile-across-a-wide-range-of-doses/ 2021-11-15T18:51:36+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/Jeffrey-Weitz-M.D.-Professor-of-Medicine-Biochemistry-and-Biomedical-Sciences-at-McMaster-University.jpg https://bostonlifesciencestimes.com/2021/11/former-us-chief-technology-officer-aneesh-chopra-joins-board-of-onyx-technology/ 2021-11-16T16:47:52+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/Onyx-Technology.jpg https://bostonlifesciencestimes.com/2021/11/synthace-raises-35m-to-expand-access-to-its-revolutionary-rd-technology-for-life-changing-research/ 2021-11-16T16:51:46+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/Synthace.jpg https://bostonlifesciencestimes.com/2021/11/bruker-announces-collaborative-advances-in-ccs-enabled-4d-proteomics-workflows-at-hupo/ 2021-11-16T16:56:09+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/cellenONE.jpg https://bostonlifesciencestimes.com/2021/11/effrx-obtains-swiss-marketing-authorization-for-alkindi-for-paediatric-adrenocortical-insufficiency/ 2021-11-16T16:59:07+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/EffRx.jpg https://bostonlifesciencestimes.com/2021/11/ip-group-inc-partners-with-comotion-at-the-university-of-washington-to-launch-nanotechnology-innovator-somalytics/ 2021-11-16T17:04:08+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/Barbara-Barclay.jpg https://bostonlifesciencestimes.com/2021/11/alira-health-further-expands-its-digital-healthcare-platform-with-the-acquisition-of-patchai/ 2021-11-16T17:07:50+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/Gabriele-Brambilla.jpg https://bostonlifesciencestimes.com/2021/11/aavantibio-further-enhances-leadership-team-with-appointment-of-jenny-marlowe-ph-d-as-chief-scientific-officer/ 2021-11-16T17:13:18+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/AavantiBio.jpg https://bostonlifesciencestimes.com/2021/11/desktop-health-appoints-industry-veteran-lou-azzara-as-president-of-the-dental-and-biofabrication-parts-platform/ 2021-11-16T17:22:12+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/Lou-Azzara.jpg https://bostonlifesciencestimes.com/2021/11/amn-healthcare-honored-in-the-top-3-of-public-corporate-boards-for-gender-parity/ 2021-11-16T17:28:46+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/AMN-Healthcare-Board-of-Directors.jpg https://bostonlifesciencestimes.com/2021/11/pfizer-and-the-medicines-patent-pool-mpp-sign-licensing-agreement-for-covid-19-oral-antiviral-treatment-candidate-to-expand-access-in-low-and-middle-income-countries/ 2021-11-16T17:34:48+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/01/Covid-pfizer.jpg https://bostonlifesciencestimes.com/2021/11/life-science-technology-visionary-steve-rosenberg-joins-anju-softwares-board-of-directors/ 2021-11-17T16:10:59+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/Steve-Rosenberg.jpg https://bostonlifesciencestimes.com/2021/11/lynx-biosciences-appoints-sylvaine-cases-ph-d-as-chief-business-officer/ 2021-11-17T16:13:45+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/Lynx-Biosciences.png https://bostonlifesciencestimes.com/2021/11/cardialen-receives-fda-approval-to-conduct-clinical-trial-of-low-energy-atrial-fibrillation-treatment/ 2021-11-17T16:18:48+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/Cardialen.jpg https://bostonlifesciencestimes.com/2021/11/memgen-appoints-kevin-m-coveney-as-chief-financial-officer/ 2021-11-17T16:26:27+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/Kevin-M.-Coveney.jpg https://bostonlifesciencestimes.com/2021/11/pfizer-announces-retirement-of-chief-financial-officer-frank-damelio/ 2021-11-17T16:27:26+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/Pfizer.jpg https://bostonlifesciencestimes.com/2021/11/emulate-recognized-in-the-deloitte-technology-fast-500/ 2021-11-17T17:11:08+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/Emulate.jpg https://bostonlifesciencestimes.com/2021/11/bayer-microsoft-enter-into-strategic-partnership-to-optimize-and-advance-digital-capabilities-for-food-feed-fuel-fiber-value-chain/ 2021-11-17T17:16:34+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/06/Bayer.jpg https://bostonlifesciencestimes.com/2021/11/waters-2021-sustainability-report-highlights-progress-on-esg-initiatives-and-response-to-covid-19/ 2021-11-17T17:19:14+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/Waters-2021-Sustainability-Report.jpg https://bostonlifesciencestimes.com/2021/11/wellair-launches-new-air-cleaning-device-that-is-99-9-effective-against-indoor-airborne-pathogens/ 2021-11-17T17:24:00+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/well-air-1.jpg https://bostonlifesciencestimes.com/2021/11/bit-bio-appoints-accomplished-biotechnology-executive-and-drug-developer-kathryn-corzo-as-chief-operating-officer/ 2021-11-17T19:32:27+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/Kathryn-Corzo.jpg https://bostonlifesciencestimes.com/2021/11/mjh-life-sciences-announces-multi-franchise-partnership-with-vanderbilt-university-medical-center/ 2021-11-17T19:50:30+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/Mike-Hennessy-Jr.jpg https://bostonlifesciencestimes.com/2021/11/university-of-pittsburgh-gets-a-100-million-grant-to-transform-the-region-into-a-life-sciences-powerhouse/ 2021-11-17T19:58:59+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/Patrick-Gallagher.jpg https://bostonlifesciencestimes.com/2021/11/bakx-raises-25-million-to-develop-therapeutics-targeting-pro-apoptotic-proteins-and-mitochondrial-apoptosis-pathway/ 2021-11-18T15:05:10+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/BAKX-Therapeutics.jpg https://bostonlifesciencestimes.com/2021/11/new-executive-appointments-position-physiq-for-further-strategic-growth-and-market-expansion/ 2021-11-18T15:09:41+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/Chris-Economos.jpg https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/Michael-Petrarca.jpg https://bostonlifesciencestimes.com/2021/11/lassen-therapeutics-appoints-puneet-s-arora-m-d-as-chief-medical-officer/ 2021-11-18T15:13:28+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/Lassen-Therapeutics.png https://bostonlifesciencestimes.com/2021/11/eqrx-and-evotec-announce-integrated-drug-discovery-and-development-partnership/ 2021-11-18T15:17:06+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/EQRx.jpg https://bostonlifesciencestimes.com/2021/11/biomind-labs-completes-development-of-a-thermosensitive-nasal-gel-pharmaceutical-dosage-form/ 2021-11-18T15:23:36+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/Alejandro-Antalich.png https://bostonlifesciencestimes.com/2021/11/labcorp-to-acquire-toxikon-expanding-nonclinical-development-testing-capabilities-for-pharmaceutical-biotech-and-medical-device-clients/ 2021-11-18T15:25:57+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/Labcorp.jpg https://bostonlifesciencestimes.com/2021/11/everbridge-public-warning-wins-2021-gold-globee-for-product-excellence/ 2021-11-18T15:33:19+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/everbridge-1.jpg https://bostonlifesciencestimes.com/2021/11/biocepts-cnside-cerebrospinal-fluid-assay-aids-in-monitoring-treatment-response-and-detects-actionable-biomarkers-in-patients-with-metastatic-breast-cancer/ 2021-11-18T15:36:18+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/Biocept.jpg https://bostonlifesciencestimes.com/2021/11/gelesis-receives-30-million-plenity-order-from-ro/ 2021-11-18T15:40:11+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/Gelesis.jpg https://bostonlifesciencestimes.com/2021/11/immunology-biotech-firm-to-relocate-from-cambridge-to-woburn/ 2021-11-18T16:30:14+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/SeromYx-Systems.webp https://bostonlifesciencestimes.com/2021/11/1910-genetics-opens-new-headquarters-boston/ 2021-11-18T23:12:15+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/1910-Genetics.webp https://bostonlifesciencestimes.com/2021/11/pfizer-and-biontech-receive-expanded-u-s-fda-emergency-use-authorization-of-covid-19-vaccine-booster-to-include-individuals-18-and-older/ 2021-11-19T14:49:40+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/01/Covid-pfizer.jpg https://bostonlifesciencestimes.com/2021/11/bruker-announces-acquisition-of-molecubes-nv/ 2021-11-19T14:51:04+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/Modular-benchtop-CUBES.jpg https://bostonlifesciencestimes.com/2021/11/gilead-submits-biologics-license-application-to-u-s-food-and-drug-administration-for-bulevirtide-an-investigational-treatment-for-people-living-with-chronic-hepatitis-delta/ 2021-11-19T14:53:42+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/06/Gilead-Sciences.png https://bostonlifesciencestimes.com/2021/11/biovectra-mrna-vaccine-and-bio-manufacturing-facility-announced/ 2021-11-19T14:57:31+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/BIOVECTRA.png https://bostonlifesciencestimes.com/2021/11/dr-otis-brawley-named-to-agilent-board-of-directors/ 2021-11-19T15:00:26+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/Dr.-Otis-Brawley.jpg https://bostonlifesciencestimes.com/2021/11/avodah-closes-7-million-seed-round-to-scale-digital-healthcare-platform-with-ai-capabilities/ 2021-11-19T15:03:22+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/AvodahMed.jpg https://bostonlifesciencestimes.com/2021/11/appili-therapeutics-announces-positive-one-year-challenge-results-from-preclinical-study-evaluating-biodefense-vaccine-candidate-ati-1701-and-change-to-board-of-directors/ 2021-11-19T15:07:35+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/Appili-Therapeutics.jpg https://bostonlifesciencestimes.com/2021/11/flywheel-partners-with-roche-and-genentech-to-accelerate-development-of-personalized-healthcare-solutions/ 2021-11-22T14:18:31+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/Flywheel-1.jpg https://bostonlifesciencestimes.com/2021/11/follow-up-data-from-phase-3-trial-of-pfizer-biontech-covid-19-vaccine-support-safety-and-high-efficacy-in-adolescents-12-through-15-years-of-age/ 2021-11-22T14:19:57+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/01/Covid-pfizer.jpg https://bostonlifesciencestimes.com/2021/11/merck-completes-acquisition-of-acceleron-pharma-inc/ 2021-11-22T14:22:05+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/Merck-e1637590913813.png https://bostonlifesciencestimes.com/2021/11/vifor-pharma-to-spearhead-development-of-vascular-calcification-field-through-acquisition-of-sanifit-therapeutics-and-inositec-ag/ 2021-11-22T14:24:46+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/Vifor-Pharma.jpg https://bostonlifesciencestimes.com/2021/11/dalrada-corporation-appoints-harvey-hershkowitz-as-president-of-dalrada-health/ 2021-11-22T14:27:55+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/Dalrada-Health.jpg https://bostonlifesciencestimes.com/2021/11/scorpion-therapeutics-announces-appointment-of-brian-piper-as-chief-financial-officer/ 2021-11-22T14:30:13+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/Scorpion-Therapeutics.png https://bostonlifesciencestimes.com/2021/11/knowles-partners-with-lucid-hearing-to-enable-hearing-aid-premium-audio-performance/ 2021-11-22T14:33:10+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/Knowles-Corporation.jpg https://bostonlifesciencestimes.com/2021/11/render-raises-20m-series-a-to-meet-accelerating-demand-for-big-3-cloud-alternatives/ 2021-11-22T14:36:54+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/render.jpg https://bostonlifesciencestimes.com/2021/11/athenahealth-healthcare-technology-leader-to-be-acquired-by-hellman-friedman-and-bain-capital-for-17-billion/ 2021-11-22T14:39:41+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/Bob-Segert.jpg https://bostonlifesciencestimes.com/2021/11/biocept-launches-combined-covid-19-and-influenza-test-to-provide-answers-during-peak-flu-season/ 2021-11-22T14:42:24+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/Biocept-1.jpg https://bostonlifesciencestimes.com/2021/11/mirati-therapeutics-and-verastem-oncology-partner-to-evaluate-adagrasib-in-combination-with-vs-6766-in-krasg12c-mutant-non-small-cell-lung-cancer/ 2021-11-22T14:44:45+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/Mirati-Therapeutics.jpg https://bostonlifesciencestimes.com/2021/11/enpro-names-eric-vaillancourt-president-and-chief-executive-officer/ 2021-11-29T16:25:15+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/Enpro-scaled-e1638203095458.webp https://bostonlifesciencestimes.com/2021/11/gilead-and-aws-collaborate-on-development-and-delivery-of-new-medicines-for-patients/ 2021-11-29T16:29:22+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/aws.jpg https://bostonlifesciencestimes.com/2021/11/avacta-announces-fda-approval-of-its-investigational-new-drug-ind-application-for-ava6000/ 2021-11-29T17:41:13+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/Avacta.webp https://bostonlifesciencestimes.com/2021/11/galderma-to-acquire-award-winning-alastin-skincare-enhancing-its-integrated-dermatology-platform-to-continue-delivering-the-best-experience-to-patients/ 2021-11-29T17:43:25+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/Galderma.jpg https://bostonlifesciencestimes.com/2021/11/tailormed-announces-acquisition-of-vivor-to-create-the-largest-provider-and-pharmacy-network-tackling-financial-barriers-to-care/ 2021-11-29T17:45:41+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/TailorMed.jpg https://bostonlifesciencestimes.com/2021/11/ranok-therapeutics-announces-agreement-with-pfizer-on-targeted-protein-degradation/ 2021-11-29T17:52:25+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/Ranok-Therapeutics.png https://bostonlifesciencestimes.com/2021/11/turnstone-biologics-announces-research-collaboration-with-moffitt-cancer-center-to-advance-novel-til-immunotherapies-for-solid-tumor-indications/ 2021-11-29T17:53:47+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/Turnstone-Biologics.png https://bostonlifesciencestimes.com/2021/11/qiagen-and-diasorin-widen-access-to-latent-tb-testing-in-the-u-s-with-fda-approval-of-quantiferon-tb-gold-plus-assay-on-liaison-xs/ 2021-11-29T17:55:36+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/QIAGEN.png https://bostonlifesciencestimes.com/2021/11/hagar-gwave-awarded-fda-breakthrough-device-designation/ 2021-11-29T17:57:16+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/HAGAR-GWave.png https://bostonlifesciencestimes.com/2021/11/samsungs-push-to-leverage-artificial-intelligence-on-display-at-rsna-2021/ 2021-11-29T17:58:27+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/samsung.jpg https://bostonlifesciencestimes.com/2021/11/walgreens-boots-alliance-acquires-remaining-stake-in-german-gehe-alliance-healthcare-joint-venture-from-mckesson/ 2021-11-30T15:45:49+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/Walgreens-Boots-Alliance.jpg https://bostonlifesciencestimes.com/2021/11/the-schall-law-firm-announces-it-is-investigating-claims-against-instadose-pharma-corp-and-encourages-investors-with-losses-of-100000-to-contact-the-firm/ 2021-11-30T15:51:11+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/Brian-Schall.jpg https://bostonlifesciencestimes.com/2021/11/inflammatix-appoints-dr-kian-beyzavi-as-new-board-member/ 2021-11-30T16:03:51+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/Dr.-Kian-Beyzavi.jpg https://bostonlifesciencestimes.com/2021/11/labcorp-now-offers-observed-collection-for-covid-19-pcr-testing-in-over-500-locations-nationwide-with-plans-to-expand-to-more-than-1000-locations/ 2021-11-30T16:18:28+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/Labcorp-1.jpg https://bostonlifesciencestimes.com/2021/11/trinity-life-sciences-recapitalizes-with-kohlberg-company/ 2021-11-30T16:26:09+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/David-Fitzhenry.jpg https://bostonlifesciencestimes.com/2021/11/forma-therapeutics-announces-appointment-of-acclaimed-global-sickle-cell-disease-leader-ifeyinwa-osunkwo-md-mph-as-senior-vice-president-chief-patient-officer/ 2021-11-30T16:34:53+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/Forma-Therapeutics.png https://bostonlifesciencestimes.com/2021/11/dna-script-obtains-ce-mark-for-syntax-dna-printing-platform/ 2021-11-30T16:59:24+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/DNA-Script.jpg https://bostonlifesciencestimes.com/2021/11/alzamend-neuro-announces-date-for-delivery-of-topline-data-for-phase-1-first-in-human-clinical-trial-for-al001-for-dementia-related-to-alzheimers/ 2021-11-30T17:03:53+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/06/Alzamend-Neuro.png https://bostonlifesciencestimes.com/2021/11/novo-integrated-sciences-acquires-majority-stake-in-terragenx-and-intellectual-property-for-fda-and-health-canada-approved-water-soluble-iodine-micro-nutrient/ 2021-11-30T17:08:01+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/Novo-Integrated-Sciences.png https://bostonlifesciencestimes.com/2021/11/labgenius-appoints-dr-gino-van-heeke-as-chief-scientific-officer/ 2021-11-30T17:10:52+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/Dr.-Gino-Van-Heeke.jpg https://bostonlifesciencestimes.com/2021/12/parthenon-therapeutics-appoints-tamas-oravecz-ph-d-as-chief-scientific-officer/ 2021-12-01T14:57:57+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Tamas-Oravecz-Ph.D..jpg https://bostonlifesciencestimes.com/2021/12/the-emulate-brain-chip-ranked-4-on-the-scientists-top-10-innovations-list-for-2021/ 2021-12-01T14:59:32+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Emulate.jpg https://bostonlifesciencestimes.com/2021/12/oskare-capital-and-sapphire-capital-partners-llp-launch-first-ever-uk-seis-eis-fund-targeting-medical-pharma-cannabis-sector/ 2021-12-01T15:03:58+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Oliver-Lamb.jpg https://bostonlifesciencestimes.com/2021/12/certis-biologicals-adds-midwestern-field-development-manager/ 2021-12-01T15:06:23+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Nick-Vandervort.jpg https://bostonlifesciencestimes.com/2021/12/back-bay-life-science-advisors-announces-expansion-into-canada-with-opening-of-toronto-office/ 2021-12-01T15:12:38+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Back-Bay-Life-Science.jpg https://bostonlifesciencestimes.com/2021/12/two-thirds-of-us-doctors-say-mobile-diabetes-apps-help-patients-stay-in-touch-with-disease-management-in-new-incrowd-instant-insights-data/ 2021-12-01T15:15:06+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/InCrowd.jpg https://bostonlifesciencestimes.com/2021/12/resolve-biosciences-appoints-oliver-dick-as-chief-operating-officer/ 2021-12-01T15:19:12+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Resolve-Biosciences.jpg https://bostonlifesciencestimes.com/2021/12/ironwood-pharmaceuticals-appoints-sravan-k-emany-as-chief-financial-officer/ 2021-12-01T15:25:24+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Ironwood-Pharmaceuticals.jpg https://bostonlifesciencestimes.com/2021/12/covid-proof-for-events-now-available-to-automate-covid-vaccination-verification/ 2021-12-01T15:32:41+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Nametag.png https://bostonlifesciencestimes.com/2021/12/vbi-vaccines-announces-fda-approval-of-prehevbrio-for-the-prevention-of-hepatitis-b-in-adults/ 2021-12-01T15:39:49+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/VBI-Vaccines.jpg https://bostonlifesciencestimes.com/2021/12/fsd-pharma-unveils-videos-demonstrating-positive-effects-of-lucid-ms-in-treating-multiple-sclerosis-in-pre-clinical-models-mouse-models/ 2021-12-02T15:01:37+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/FSD-Pharma2.jpg https://bostonlifesciencestimes.com/2021/12/venatorx-pharmaceuticals-names-scott-mcconnell-pharm-d-as-vice-president-medical-affairs/ 2021-12-02T15:03:49+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Venatorx-Pharmaceuticals.jpg https://bostonlifesciencestimes.com/2021/12/phase-1-clinical-trial-data-indicate-igcs-thc-based-investigational-new-drug-may-reduce-symptoms-of-dementia-in-alzheimers-patients/ 2021-12-02T15:07:41+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/India-Globalization-Capital-Inc.png https://bostonlifesciencestimes.com/2021/12/alpha-cognition-appoints-cedric-ogorman-m-d-mba-as-chief-medical-officer/ 2021-12-02T15:11:00+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Alpha-Cognition.jpg https://bostonlifesciencestimes.com/2021/12/aws-helps-pfizer-accelerate-drug-development-and-clinical-manufacturing/ 2021-12-02T15:13:46+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/aws.jpg https://bostonlifesciencestimes.com/2021/12/pulmotect-provides-results-from-two-randomized-placebo-controlled-phase-2-trials-of-pul-042-against-covid-19/ 2021-12-02T15:17:06+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Pulmotect.jpg https://bostonlifesciencestimes.com/2021/12/rimsys-closes-16-million-series-a-financing-led-by-bessemer-venture-partners/ 2021-12-02T15:24:45+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Rimsys.jpg https://bostonlifesciencestimes.com/2021/12/alnylam-ranks-1-in-boston-globes-top-places-to-work-list-for-2021/ 2021-12-02T15:30:31+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Alnylam-Ranks.jpg https://bostonlifesciencestimes.com/2021/12/code-biotherapeutics-appoints-erin-brubaker-as-chief-operating-officer/ 2021-12-02T15:33:05+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Erin-Brubaker.webp https://bostonlifesciencestimes.com/2021/12/interna-technologies-announces-u-s-fda-clearance-of-ind-application-for-phase-i-clinical-trial-with-lead-microrna-candidate-int-1b3-in-patients-with-advanced-solid-tumors/ 2021-12-02T15:37:41+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/InteRNA-Technologies.jpg https://bostonlifesciencestimes.com/2021/12/u-s-food-and-drug-administration-accepts-for-priority-review-supplemental-biologics-license-application-for-reblozyl/ 2021-12-03T14:44:52+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Bristol-Myers-Squibb.jpg https://bostonlifesciencestimes.com/2021/12/optomec-establishes-3d-printed-electronics-technical-advisory-board-with-top-industry-leaders/ 2021-12-03T14:49:09+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Optomec.jpg https://bostonlifesciencestimes.com/2021/12/dorsey-expands-u-s-china-practice-with-high-profile-hires/ 2021-12-03T14:50:45+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Marc-Kushner.jpg https://bostonlifesciencestimes.com/2021/12/hospital-operating-margins-down-15-as-tight-competition-for-healthcare-workers-drives-up-hourly-rates-according-to-syntellis-performance-trends-report/ 2021-12-03T14:54:26+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Syntellis.jpg https://bostonlifesciencestimes.com/2021/12/phase-iii-investigational-trial-of-nubeqa-darolutamide-in-combination-with-docetaxel-and-androgen-deprivation-therapy-adt-meets-primary-endpoint-of-significantly-increasing-overall-survival/ 2021-12-03T14:56:04+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/NUBEQA.webp https://bostonlifesciencestimes.com/2021/12/modernizing-medicine-shortens-brand-to-modmed-and-launches-timely-ad-campaign/ 2021-12-03T15:01:18+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Dan-Cane.jpg https://bostonlifesciencestimes.com/2021/12/eurofins-environment-testing-adds-omicron-variant-detection-to-its-sars-cov-2-monitoring-solution-for-wastewater-surface-air-and-worn-masks/ 2021-12-03T15:09:21+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/Eurofins.png https://bostonlifesciencestimes.com/2021/12/nabla-bio-closes-11m-seed-financing-led-by-khosla-ventures-and-zetta-venture-partners/ 2021-12-06T15:15:43+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Surge-Biswas.png https://bostonlifesciencestimes.com/2021/12/cyrus-biotechnology-announces-18m-financing-and-acquisition-of-orthogonal-biologics-to-form-an-integrated-software-driven-pre-clinical-stage-drug-discovery-firm/ 2021-12-06T15:22:38+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Cyrus-Biotechnology.jpg https://bostonlifesciencestimes.com/2021/12/new-report-indicates-prairies-face-bio-economy-talent-shortage-especially-in-agri-bio/ 2021-12-06T15:26:17+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/BioTalent.jpg https://bostonlifesciencestimes.com/2021/12/yarrow-biotechnology-appoints-dr-mark-t-keating-as-chief-scientific-officer/ 2021-12-06T15:28:04+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Yarrow-Biotechnology.jpg https://bostonlifesciencestimes.com/2021/12/arrakis-therapeutics-appoints-james-mutamba-phd-as-chief-business-officer/ 2021-12-06T15:30:01+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/James-Mutamba-PhD.jpg https://bostonlifesciencestimes.com/2021/12/escape-bio-appoints-mark-kaufmann-as-chief-financial-officer-and-chief-business-officer/ 2021-12-06T15:32:18+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Mark-Kaufmann.jpg https://bostonlifesciencestimes.com/2021/12/saranas-announces-initial-enrollment-of-clinical-trial-assessing-the-utility-of-early-bleed-detection-in-patients-undergoing-mechanical-circulatory-support/ 2021-12-06T15:49:46+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Saranas-Inc.jpg https://bostonlifesciencestimes.com/2021/12/metroplushealth-brings-behavioral-health-services-in-house-citing-need-for-integrated-care-of-body-and-mind/ 2021-12-06T15:52:01+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/MetroPlusHealth.jpg https://bostonlifesciencestimes.com/2021/12/helioliver-an-innovative-liquid-biopsy-test-for-the-early-detection-of-liver-cancer-is-now-commercially-available/ 2021-12-06T16:09:15+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/HelioLiver.jpg https://bostonlifesciencestimes.com/2021/12/xcovery-acquires-majority-controlling-stake-in-meryx-pharmaceuticals/ 2021-12-07T15:24:23+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Lieming-Ding-M.D.jpg https://bostonlifesciencestimes.com/2021/12/humana-foundation-names-tiffany-benjamin-as-chief-executive-officer/ 2021-12-07T15:40:39+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Tiffany-Benjamin.jpg https://bostonlifesciencestimes.com/2021/12/mpm-capital-announces-the-addition-of-detlev-biniszkiewicz-ph-d-to-its-investment-committee/ 2021-12-07T15:50:09+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Detlev-Biniszkiewicz-Ph.D..jpg https://bostonlifesciencestimes.com/2021/12/clinical-trials-tech-leader-to-launch-new-podcast-series-focused-on-innovation-and-trends-in-the-biotech-healthtech-and-data-sectors/ 2021-12-07T15:56:11+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/ClinCapture-scaled.jpg https://bostonlifesciencestimes.com/2021/12/greenwich-lifesciences-expands-role-of-industry-expert-dr-f-joseph-daugherty-to-include-medical-monitor-for-its-upcoming-phase-iii-clinical-trial/ 2021-12-07T16:02:15+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Greenwich-LifeSciences.jpg https://bostonlifesciencestimes.com/2021/12/foldax-receives-approval-for-clinical-trial-of-tria-biopolymer-surgical-aortic-heart-valve-in-india/ 2021-12-07T16:28:53+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Foldax.jpg https://bostonlifesciencestimes.com/2021/12/nanosonics-announces-juama-as-new-distributor-in-mexico/ 2021-12-07T16:32:12+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Nanosonics.jpg https://bostonlifesciencestimes.com/2021/12/bg-medical-surgimesh-and-cqinsights-announce-the-first-patient-treated-in-a-national-hernia-patient-centered-outcomes-initiative/ 2021-12-07T16:34:58+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Dr.-Mazen-Iskandar-MD.jpg https://bostonlifesciencestimes.com/2021/12/acuity-international-appoints-industry-veteran-russ-langford-as-chief-growth-officer/ 2021-12-07T17:14:42+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Acuity-International.jpg https://bostonlifesciencestimes.com/2021/12/virpax-reports-successful-results-of-toxicology-and-pharmacokinetic-study-for-epoladerm/ 2021-12-08T15:31:22+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Virpax.jpg https://bostonlifesciencestimes.com/2021/12/nomic-closes-17-million-series-a-to-develop-and-commercialize-the-worlds-highest-throughput-proteomic-platform/ 2021-12-08T15:40:04+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Nomic-Bio.jpg https://bostonlifesciencestimes.com/2021/12/ranpak-expands-total-solution-for-cold-chain-packaging-with-acquisition-of-recycold-cool-solutions-bv-makers-of-cool-packs/ 2021-12-08T15:45:34+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Ranpak.jpg https://bostonlifesciencestimes.com/2021/12/pfizer-and-biontech-provide-update-on-omicron-variant/ 2021-12-08T15:52:04+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/01/Pfizer-Building-logo.jpg https://bostonlifesciencestimes.com/2021/12/eric-dutang-appointed-as-cfo-at-biolog-id/ 2021-12-08T15:59:02+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Eric-Dutang.jpg https://bostonlifesciencestimes.com/2021/12/avistone-pharmaceuticals-secures-200-million-strategic-investment-from-vivo-capital-bain-capital-and-primavera-capital/ 2021-12-08T16:05:15+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Vivo-Capital.jpg https://bostonlifesciencestimes.com/2021/12/perkinelmer-launches-nextflex-variant-seq-sars-cov-2-kit-v2-to-strengthen-sars-cov-2-surveillance/ 2021-12-08T16:07:55+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/01/1200px-PerkinElmer_logo.svg_.png https://bostonlifesciencestimes.com/2021/12/rocket-pharmaceuticals-appoints-martin-l-wilson-as-general-counsel-and-chief-compliance-officer/ 2021-12-08T16:09:29+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Rocket-Pharmaceuticals.jpg https://bostonlifesciencestimes.com/2021/12/mission-biocapital-boosts-team-to-support-investments-from-new-fund/ 2021-12-08T16:21:11+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Cassidy-Blundell-Ph.D.jpg https://bostonlifesciencestimes.com/2021/12/premia-spine-appoints-three-new-board-advisors/ 2021-12-08T16:24:38+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Premia-Spine.jpg https://bostonlifesciencestimes.com/2021/12/cvent-lists-on-the-nasdaq-as-cvt-after-announcing-close-of-business-combination-with-dragoneer-growth-opportunities-corp-ii/ 2021-12-09T15:04:27+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Cvent-Holding-Corp.png https://bostonlifesciencestimes.com/2021/12/ceo-of-phononic-wins-rtcc-cleantech-entrepreneur-of-the-year/ 2021-12-09T15:10:19+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Tony-Atti-CEO-of-Phononic.jpg https://bostonlifesciencestimes.com/2021/12/ziff-davis-appoints-bret-richter-as-chief-financial-officer/ 2021-12-09T15:15:18+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Ziff-Davis.jpg https://bostonlifesciencestimes.com/2021/12/exai-bio-secures-67-5-million-series-a-financing-to-advance-next-generation-rna-based-liquid-biopsy-platform-for-early-cancer-detection/ 2021-12-09T15:16:41+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Exai-Bio.jpg https://bostonlifesciencestimes.com/2021/12/report-demonstrates-stevenage-bioscience-catalysts-key-role-in-delivering-the-economic-benefit-from-leading-edge-uk-life-sciences/ 2021-12-09T15:18:05+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Stevenage-Bioscience.jpg https://bostonlifesciencestimes.com/2021/12/evusheld-formerly-azd7442-long-acting-antibody-combination-authorized-for-emergency-use-in-the-us-for-pre-exposure-prophylaxis-prevention-of-covid-19/ 2021-12-09T15:22:52+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/EVUSHELD.jpg https://bostonlifesciencestimes.com/2021/12/whitecap-venture-partners-launches-new-140-million-early-stage-venture-capital-fund/ 2021-12-09T15:25:30+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Whitecap-Venture.jpg https://bostonlifesciencestimes.com/2021/12/deep-knowledge-group-deep-pharma-intelligence-releases-analytical-study-5-high-impact-cancer-vaccine-platforms/ 2021-12-09T15:27:57+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Deep-Pharma.jpg https://bostonlifesciencestimes.com/2021/12/orthobond-appoints-frank-cammisa-md-as-chief-medical-officer/ 2021-12-09T16:08:44+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Frank-Cammisa-MD.jpg https://bostonlifesciencestimes.com/2021/12/zerigo-health-appoints-helen-calvin-as-president-and-chief-commercial-officer/ 2021-12-09T16:09:59+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Helen-Calvin.jpg https://bostonlifesciencestimes.com/2021/12/be-the-match-biotherapies-adds-boston-based-senior-director-to-sales-and-business-development-team/ 2021-12-09T17:33:31+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Eck-Redmond-Be-The-Match-BioTherapies.jpeg https://bostonlifesciencestimes.com/2021/12/beigene-presents-results-from-phase-3-trial-of-tislelizumab-in-nasopharyngeal-cancer-at-esmo-immuno-oncology-congress-2021/ 2021-12-10T15:19:02+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/BeiGene.png https://bostonlifesciencestimes.com/2021/12/lechase-opens-new-center-to-train-workers-in-cutting-edge-systems-to-contain-noise-and-dust-during-hospital-and-laboratory-construction-projects/ 2021-12-10T15:22:11+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/David-Campbell.jpg https://bostonlifesciencestimes.com/2021/12/trodelvy-demonstrates-clinical-benefit-for-black-patients-consistent-with-full-metastatic-triple-negative-breast-cancer-population-in-ascent-study/ 2021-12-10T15:24:53+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/06/Gilead-Sciences.png https://bostonlifesciencestimes.com/2021/12/eurofins-enhances-clinical-and-covid-19-testing-offering-in-japan-through-acquisition-of-genetic-lab-co-ltd/ 2021-12-10T15:33:33+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/Eurofins.png https://bostonlifesciencestimes.com/2021/12/cross-border-impact-ventures-launches-new-impact-fund-with-commitments-of-us30-million/ 2021-12-10T15:39:58+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Cross-Border-Impact-Ventures.jpg https://bostonlifesciencestimes.com/2021/12/energous-appoints-cesar-johnston-as-chief-executive-officer/ 2021-12-10T15:49:32+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Energous.jpg https://bostonlifesciencestimes.com/2021/12/moderna-announces-positive-interim-phase-1-data-for-mrna-flu-vaccine-and-provides-program-update/ 2021-12-10T15:59:43+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/Moderna-Inc.jpg https://bostonlifesciencestimes.com/2021/12/organon-completes-acquisition-of-forendo-pharma/ 2021-12-13T14:43:37+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Organon.jpg https://bostonlifesciencestimes.com/2021/12/rocket-pharmaceuticals-presents-positive-clinical-data-from-companys-lentiviral-gene-therapies-for-treatment-of-fanconi-anemia-lad-i-and-pkd/ 2021-12-13T14:44:30+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Rocket-Pharmaceuticals.jpg https://bostonlifesciencestimes.com/2021/12/arcturus-therapeutics-appoints-jing-marantz-m-d-ph-d-m-b-a-to-its-board-of-directors/ 2021-12-13T14:46:30+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Jing-Marantz-M.D.-Ph.D.-M.B.A..jpg https://bostonlifesciencestimes.com/2021/12/4d-pharma-announces-positive-topline-results-from-part-a-of-phase-i-ii-trial-of-mrx-4dp0004-for-the-treatment-of-asthma/ 2021-12-13T14:47:57+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/4dpharma.png https://bostonlifesciencestimes.com/2021/12/lifespin-gmbh-secures-e2-5m-bridge-financing-to-further-build-its-ai-enabled-metabolomics-based-differential-diagnosis-panel-for-neurological-diseases/ 2021-12-13T15:04:46+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Lifespin-GmbH.jpg https://bostonlifesciencestimes.com/2021/12/accellix-raises-10-million-from-broadoak-capital-partners/ 2021-12-13T15:19:44+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Accellix.jpg https://bostonlifesciencestimes.com/2021/12/ascensus-expands-fine-chemicals-production-capabilities-for-life-sciences-with-acquisition-of-wychem/ 2021-12-13T15:28:54+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Ascensus-Specialties.jpg https://bostonlifesciencestimes.com/2021/12/two-year-analysis-of-cartitude-1-shows-early-durable-and-deepening-responses-of-ciltacabtagene-autoleucel-cilta-cel-in-heavily-pretreated-patients-with-multiple-myeloma/ 2021-12-13T15:54:19+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Ying-Huang-PhD.webp https://bostonlifesciencestimes.com/2021/12/baxter-completes-acquisition-of-hillrom-creating-15-billion-global-medtech-leader/ 2021-12-13T15:57:02+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/Baxter-International-Inc..jpg https://bostonlifesciencestimes.com/2021/12/hospital-iq-expands-reach-of-operational-excellence-technology-with-siemens-healthineers/ 2021-12-13T16:01:44+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Hospital-IQ.jpg https://bostonlifesciencestimes.com/2021/12/turner-imaging-systems-welcomes-its-new-vice-president-of-sales-marketing/ 2021-12-13T16:24:44+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Roberto-Scorcia.jpg https://bostonlifesciencestimes.com/2021/12/bostongene-and-nec-announce-global-partnership/ 2021-12-14T15:00:41+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/BostonGene.jpg https://bostonlifesciencestimes.com/2021/12/pci-pharma-services-announces-the-closing-of-its-acquisition-of-lsne/ 2021-12-14T15:04:27+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/PCI-Pharma.jpg https://bostonlifesciencestimes.com/2021/12/smartlabs-announces-launch-of-worlds-largest-multi-modality-and-multi-product-cgmp-center-for-cell-and-gene-therapies-in-south-san-francisco/ 2021-12-14T15:22:05+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/SmartLabs.png https://bostonlifesciencestimes.com/2021/12/ubiquigent-celebrates-milestone-anniversary-of-dubprofiler-compound-profiling-platform/ 2021-12-14T15:24:03+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Ubiquigent.jpg https://bostonlifesciencestimes.com/2021/12/whizai-raises-8m-in-series-a-financing-to-bring-the-future-of-analytics-to-the-life-sciences-industry/ 2021-12-14T15:26:46+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Rohit-Vashisht.jpg https://bostonlifesciencestimes.com/2021/12/leo-pharma-initiates-a-phase-2b-dose-ranging-clinical-trial-with-an-oral-h4r-antagonist-in-adult-patients-with-moderate-to-severe-atopic-dermatitis/ 2021-12-14T15:42:06+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/LEO-Pharma.jpg https://bostonlifesciencestimes.com/2021/12/sofinnova-partners-announces-a-new-investment-from-its-medtech-acceleration-fund/ 2021-12-14T15:44:56+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Lukas-Guenther-M.D..webp https://bostonlifesciencestimes.com/2021/12/neutron-therapeutics-appoints-elizabeth-reczek-ph-d-as-chief-executive-officer/ 2021-12-14T15:56:55+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Elizabeth-Reczek-Ph.D..jpg https://bostonlifesciencestimes.com/2021/12/anheart-therapeutics-raises-61-million-in-oversubscribed-series-b-financing-to-advance-precision-oncology-pipeline/ 2021-12-14T16:03:19+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Junyuan.webp https://bostonlifesciencestimes.com/2021/12/in-wake-of-historic-overdose-deaths-spero-health-brings-hope-with-the-opening-of-new-addiction-treatment-clinic-in-dublin-va/ 2021-12-14T16:09:56+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Spero-Health.png https://bostonlifesciencestimes.com/2021/12/former-president-of-lyft-healthcare-inc-megan-callahan-joins-happify-health-as-chief-operating-officer/ 2021-12-15T14:50:20+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Megan-Callahan.jpg https://bostonlifesciencestimes.com/2021/12/inventia-life-science-accelerates-growth-with-25m-series-b-and-launches-3d-cell-culture-platform-into-us-market/ 2021-12-15T14:53:54+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Inventia-Life-Science.jpg https://bostonlifesciencestimes.com/2021/12/life-science-consulting-companies-lack-gender-equality-with-only-28-percent-of-leadership-roles-held-by-women/ 2021-12-15T14:58:04+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Leslie-Orne.jpg https://bostonlifesciencestimes.com/2021/12/health-care-organizations-continue-to-adopt-artificial-intelligence-to-help-achieve-better-more-equitable-and-affordable-patient-outcomes/ 2021-12-15T14:59:52+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Optum-Survey.jpg https://bostonlifesciencestimes.com/2021/12/innovaccer-raises-150-million-series-e-round-at-3-2-billion-valuation-continues-rapid-growth-trajectory/ 2021-12-15T15:06:13+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Innovaccer.jpg https://bostonlifesciencestimes.com/2021/12/accenture-announces-intent-to-acquire-afd-tech-to-bolster-its-cloud-first-network-capabilities/ 2021-12-15T15:11:50+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Accenture.jpg https://bostonlifesciencestimes.com/2021/12/laurent-pharmaceuticals-extends-covid-19-phase-2-study-with-oral-antiviral-lau-7b-that-has-showed-100-reduction-in-the-risk-of-progression-onto-mechanical-ventilation-and-death/ 2021-12-15T15:21:54+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Laurent-Pharmaceuticals-Inc.jpg https://bostonlifesciencestimes.com/2021/12/first-subjects-dosed-in-first-in-human-trial-for-varmxs-anticoagulant-reversal-agent-vmx-c001/ 2021-12-15T15:27:00+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/VarmX.jpg https://bostonlifesciencestimes.com/2021/12/agomab-therapeutics-completes-acquisition-of-origo-biopharma/ 2021-12-15T15:54:34+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Agomab.png https://bostonlifesciencestimes.com/2021/12/carbon-america-closes-30-million-series-a-to-launch-carbon-capture-industrys-first-vertically-integrated-super-developer/ 2021-12-15T16:10:13+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Carbon-America.jpg https://bostonlifesciencestimes.com/2021/12/tasso-secures-100m-in-series-b-financing/ 2021-12-16T15:19:24+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Tasso.jpg https://bostonlifesciencestimes.com/2021/12/cerba-healthcare-enters-agreement-to-acquire-viroclinics-ddl-expanding-and-transforming-its-offering-in-clinical-trials/ 2021-12-16T15:24:23+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Cerba-Healthcare.jpg https://bostonlifesciencestimes.com/2021/12/aerie-pharmaceuticals-appoints-raj-kannan-as-chief-executive-officer/ 2021-12-16T15:34:21+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Raj-Kannan.jpg https://bostonlifesciencestimes.com/2021/12/verge-genomics-secures-98-million-in-new-financing/ 2021-12-16T15:37:20+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Verge-Genomics.png https://bostonlifesciencestimes.com/2021/12/argobio-and-genecode-partner-on-parkinsons-disease-in-argobios-first-announced-research-agreement/ 2021-12-16T15:41:19+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Thierry-Laugel.jpg https://bostonlifesciencestimes.com/2021/12/evusheld-long-acting-antibody-combination-retains-neutralizing-activity-against-omicron-variant-in-independent-fda-study/ 2021-12-16T15:46:44+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/AstraZeneca-India.jpg https://bostonlifesciencestimes.com/2021/12/ilc-dover-acquires-kse-scientific-a-leading-supplier-of-water-for-injection-and-related-solutions-for-biopharma-cell-gene-therapy-tissue-banking-and-medical-device-end-markets/ 2021-12-16T16:03:08+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/ILC-Dover.png https://bostonlifesciencestimes.com/2021/12/axcella-therapeutics-announces-initiation-of-axa1125-long-covid-phase-2a-clinical-trial/ 2021-12-16T16:17:38+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Axcella-Therapeutics.jpg https://bostonlifesciencestimes.com/2021/12/surgical-innovation-associates-raises-15-million-in-oversubscribed-series-b-round-appoints-veteran-medtech-ceo/ 2021-12-16T16:43:08+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Josh-Vose-MD-MBA.jpg https://bostonlifesciencestimes.com/2021/12/affinivax-appoints-vanya-sagar-as-chief-people-officer/ 2021-12-16T16:48:31+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Vanya-Sagar.jpg https://bostonlifesciencestimes.com/2021/12/bruker-introduces-fast-bioafm-for-automated-mechanobiology/ 2021-12-20T17:13:36+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/The-JPK-NanoWizard-V-BioAFM.jpg https://bostonlifesciencestimes.com/2021/12/pfizer-and-biontech-to-provide-european-union-more-than-200-million-additional-doses-of-comirnaty-to-help-meet-continued-need-for-vaccine-supply/ 2021-12-20T17:14:39+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/01/Covid-pfizer.jpg https://bostonlifesciencestimes.com/2021/12/vifor-pharma-and-american-regent-announce-settlement-of-injectafer-patent-litigation/ 2021-12-20T17:39:15+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Vifor-Pharma.jpg https://bostonlifesciencestimes.com/2021/12/urovant-sciences-announces-publication-in-advances-in-therapy-of-analyses-of-patient-perceived-meaningfulness-of-improvement-in-symptom-reduction-for-overactive-bladder-patients-treated-with-gemtesa/ 2021-12-20T18:13:34+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Screenshot-2021-12-20-at-12-23-10-GEMTESA-Google-Search.png https://bostonlifesciencestimes.com/2021/12/medical-device-company-lazurite-to-relocate-its-headquarters-to-accommodate-growth/ 2021-12-20T18:18:57+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Lazurite.jpg https://bostonlifesciencestimes.com/2021/12/kriya-therapeutics-expands-leadership-team-with-the-appointment-of-neera-ravindran-m-d-m-b-a-as-chief-financial-officer/ 2021-12-20T18:21:55+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Neera-Ravindran.png https://bostonlifesciencestimes.com/2021/12/boston-properties-announces-full-building-lease-with-leading-biotech-firm-in-south-san-francisco/ 2021-12-21T15:59:31+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/751-Gateway.png https://bostonlifesciencestimes.com/2021/12/curia-unveils-comprehensive-mrna-solution/ 2021-12-22T15:16:12+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Curia.jpg https://bostonlifesciencestimes.com/2021/12/pherecydes-pharma-obtains-ansm-approval-for-its-phagodair-program-the-worlds-first-study-in-precision-phage-therapy/ 2021-12-22T15:19:42+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Pherecydes-Pharma.png https://bostonlifesciencestimes.com/2021/12/908-devices-teams-with-world-renowned-guardian-centers-of-georgia-for-first-responder-training/ 2021-12-22T15:23:40+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/908-Devices-Inc.jpg https://bostonlifesciencestimes.com/2021/12/piper-sandler-expands-healthcare-equity-research-with-the-hiring-of-dave-westenberg/ 2021-12-22T15:26:04+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Piper-Sandler.jpg https://bostonlifesciencestimes.com/2021/12/cytonus-therapeutics-announces-publication-in-nature-biomedical-engineering-of-preclinical-results-to-support-disease-specific-drug-delivery-capabilities-of-their-novel-cargocyte-platform/ 2021-12-22T15:38:21+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Cargocyte-Transmigration.jpg https://bostonlifesciencestimes.com/2021/12/alnylam-submits-cta-application-for-aln-app-an-investigational-rnai-therapeutic-for-the-treatment-of-alzheimers-disease-and-cerebral-amyloid-angiopathy/ 2021-12-22T15:40:36+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Alnylam-Ranks.jpg https://bostonlifesciencestimes.com/2021/12/first-clinical-study-on-tria-biopolymer-heart-valve-shows-excellent-one-year-performance/ 2021-12-22T15:42:43+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Foldax.jpg https://bostonlifesciencestimes.com/2021/12/heartbeam-appoints-alan-baumel-as-chief-operating-officer/ 2021-12-22T15:45:31+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Alan-Baumel.png https://bostonlifesciencestimes.com/2021/12/hca-healthcare-appoints-frank-morgan-vice-president-of-investor-relations/ 2021-12-22T16:00:49+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Frank-Morgan.jpg https://bostonlifesciencestimes.com/2021/12/aarvik-therapeutics-and-arrivent-biopharma-announce-research-collaboration-to-advance-novel-oncology-drug-candidate-using-aarviks-proprietary-modular-antibody-platform/ 2021-12-23T15:30:29+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Aarvik-Therapeutics.jpg https://bostonlifesciencestimes.com/2021/12/labcorp-strengthens-oncology-leadership-position-with-the-addition-of-personal-genome-diagnostics/ 2021-12-23T15:35:07+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Labcorp.jpg https://bostonlifesciencestimes.com/2021/12/evusheld-long-acting-antibody-combination-retains-neutralizing-activity-against-omicron-variant-in-studies-from-oxford-and-washington-universities/ 2021-12-23T15:37:14+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/AstraZeneca-India.jpg https://bostonlifesciencestimes.com/2021/12/gilead-announces-new-england-journal-of-medicine-publication-of-data-demonstrating-veklury-remdesivir-significantly-reduced-risk-of-hospitalization-in-high-risk-patients-with-covid-19/ 2021-12-23T15:41:13+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/06/Gilead-Sciences.png https://bostonlifesciencestimes.com/2021/12/theramex-announces-an-agreement-with-enzene-biosciences-limited-for-the-development-and-commercialisation-of-tocilizumab/ 2021-12-23T15:45:17+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Theramex.jpg https://bostonlifesciencestimes.com/2021/12/bioceres-crop-solutions-subsidiary-rizobacter-completes-20-million-offering-of-series-vii-corporate-bonds/ 2021-12-23T15:49:32+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Bioceres-Crop-Solutions.jpg https://bostonlifesciencestimes.com/2021/12/quidel-corporation-signs-definitive-agreement-to-acquire-ortho-clinical-diagnostics/ 2021-12-23T15:54:42+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Quidel-Corporation.jpg https://bostonlifesciencestimes.com/2021/12/obituary-of-harvey-frederick-wachsman-m-d-j-d-f-c-l-m/ 2021-12-23T16:06:15+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Harvey-Frederick-Wachsman-M.D.-J.D.-F.C.L.M..jpg https://bostonlifesciencestimes.com/2021/12/leo-pharma-announces-fda-approval-of-adbry-tralokinumab-as-the-first-and-only-treatment-specifically-targeting-il-13-for-adults-with-moderate-to-severe-atopic-dermatitis/ 2021-12-28T18:23:27+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/LEO-Pharma.jpg https://bostonlifesciencestimes.com/2021/12/dr-kizzmekia-corbett-awarded-the-2021-green-sands-prize-for-her-contributions-to-science-and-development-of-moderna-vaccine/ 2021-12-28T18:30:42+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Dr.-Kizzmekia-Corbett.jpg https://bostonlifesciencestimes.com/2022/01/pharmajet-partner-zydus-cadila-announces-covid-19-vaccine-expansion-plan-to-multiple-countries-with-korean-firm/ 2022-01-04T14:41:39+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/PharmaJet.jpg https://bostonlifesciencestimes.com/2022/01/ananda-scientific-announces-fda-approval-of-the-ind-for-the-clinical-trial-on-the-treatment-of-opioid-use-disorder/ 2022-01-04T14:44:47+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/ANANDA-Scientific.jpg https://bostonlifesciencestimes.com/2022/01/alentis-therapeutics-starts-first-in-human-clinical-trial-for-the-treatment-of-liver-and-kidney-fibrosis/ 2022-01-04T14:54:55+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Alentis-Therapeutics-1.jpg https://bostonlifesciencestimes.com/2022/01/weka-increases-funding-to-140-million-to-accelerate-ai-data-platform-adoption-in-the-enterprise/ 2022-01-04T15:06:39+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/WEKA-the-data-platform-for-AI.jpg https://bostonlifesciencestimes.com/2022/01/quantum-si-signs-lease-for-new-headquarters-in-new-haven/ 2022-01-04T15:07:51+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Quantum-Si.jpg https://bostonlifesciencestimes.com/2022/01/intrance-medical-systems-completes-17-million-series-a-financing-and-appoints-ed-schutter-to-board-of-directors/ 2022-01-04T15:08:54+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Ed-Schutter.jpg https://bostonlifesciencestimes.com/2022/01/dna-script-closes-200-million-series-c-financing-with-completion-of-second-tranche/ 2022-01-04T15:10:05+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/DNA-Script.jpg https://bostonlifesciencestimes.com/2022/01/wheeler-bio-announces-14m-seed-round-to-expand-access-to-portable-cmc/ 2022-01-04T15:11:46+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Jesse-McCool.jpg https://bostonlifesciencestimes.com/2022/01/pharmacyte-biotech-study-proves-capsule-material-is-not-toxic-for-encapsulated-cells/ 2022-01-04T15:14:47+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/PharmaCyte-Biotech.jpg https://bostonlifesciencestimes.com/2022/01/onera-health-launches-the-onera-biomedical-lab-on-chip-at-ces-2022/ 2022-01-04T15:17:15+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Onera-Health.jpg https://bostonlifesciencestimes.com/2022/01/sound-bioventures-raises-e-110-million-for-new-biotherapeutics-venture-fund/ 2022-01-04T20:54:55+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Casper-Breum.jpg https://bostonlifesciencestimes.com/2022/01/catalent-announces-plan-for-alessandro-maselli-to-become-new-ceo-effective-july-1-2022/ 2022-01-05T15:08:57+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Alessandro-Maselli.jpg https://bostonlifesciencestimes.com/2022/01/inscripta-appoints-kristala-prather-phd-to-its-board-of-directors/ 2022-01-05T15:10:46+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Kristala-Prather-PhD.jpg https://bostonlifesciencestimes.com/2022/01/spruce-biosciences-appoints-javier-szwarcberg-m-d-mph-as-chief-executive-officer/ 2022-01-05T15:13:58+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Spruce-Biosciences.jpg https://bostonlifesciencestimes.com/2022/01/pfizer-and-biontech-sign-new-global-collaboration-agreement-to-develop-first-mrna-based-shingles-vaccine/ 2022-01-05T15:14:55+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/Pfizer-Inc.jpg https://bostonlifesciencestimes.com/2022/01/diamedica-therapeutics-appoints-dr-kirsten-gruis-as-chief-medical-officer/ 2022-01-05T15:19:16+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/DiaMedica-Therapeutics.jpg https://bostonlifesciencestimes.com/2022/01/puretech-founded-entity-gelesis-appoints-inogen-co-founder-and-former-cfo-ali-bauerlein-to-board-of-directors-and-audit-committee/ 2022-01-05T15:22:12+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Ali-Bauerlein.jpg https://bostonlifesciencestimes.com/2022/01/nikang-therapeutics-and-aveo-oncology-announce-a-clinical-trial-collaboration-and-supply-agreement-to-evaluate-the-combination-of-nkt2152-a-hif2%ce%b1-inhibitor-and-fotivda/ 2022-01-05T15:24:35+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/NiKang-Therapeutics.jpg https://bostonlifesciencestimes.com/2022/01/prilenia-announces-completion-of-patient-enrollment-ahead-of-schedule-in-the-pridopidine-arm-of-the-healey-als-platform-trial/ 2022-01-05T15:29:36+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Prilenia.jpg https://bostonlifesciencestimes.com/2022/01/new-ectr-blade-assembly-from-hand-biomechanics-lab-could-save-up-to-10000-per-surgeon-per-year/ 2022-01-05T15:35:33+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/ECTR-Blade.jpg https://bostonlifesciencestimes.com/2022/01/barrow-neurological-institute-selects-cubresas-brainpet-system-to-support-neurological-research-activities/ 2022-01-05T15:37:39+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Cubresa.jpg https://bostonlifesciencestimes.com/2022/01/the-signs-diagnosis-and-treatment-of-lyme-disease/ 2022-01-05T15:39:47+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Quidel-Corporation.jpg https://bostonlifesciencestimes.com/2022/01/strateos-appoints-biopharma-executive-tom-rush-phd-to-its-scientific-advisory-board/ 2022-01-06T15:22:39+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Tom-Rush-PhD.jpg https://bostonlifesciencestimes.com/2022/01/verisim-life-secures-15-million-series-a-funding/ 2022-01-06T15:26:44+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/VeriSIM-Life.jpg https://bostonlifesciencestimes.com/2022/01/eikon-therapeutics-announces-517-8-million-series-b-raise-and-expansion-of-executive-leadership-team/ 2022-01-06T15:28:00+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Eikon-Therapeutics.png https://bostonlifesciencestimes.com/2022/01/notable-expands-executive-leadership-team-with-appointment-of-dr-kevin-lynch-as-chief-business-officer/ 2022-01-06T15:31:36+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Kevin-Lynch-Ph.D.-MBA.jpg https://bostonlifesciencestimes.com/2022/01/oral-decitabine-and-cedazuridine-astx727-granted-orphan-drug-designation-odd-by-the-european-commission-for-the-treatment-of-acute-myeloid-leukemia/ 2022-01-06T15:35:26+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Astex-Pharmaceuticals.jpg https://bostonlifesciencestimes.com/2022/01/china-nmpa-approves-tislelizumab-as-second-or-third-line-treatment-for-patients-with-locally-advanced-or-metastatic-non-small-cell-lung-cancer/ 2022-01-06T15:36:38+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/BeiGene.png https://bostonlifesciencestimes.com/2022/01/melinta-therapeutics-president-and-ceo-christine-ann-miller-elected-to-board-of-directors-of-iveric-bio/ 2022-01-06T15:38:37+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Christine-Ann-Miller.jpg https://bostonlifesciencestimes.com/2022/01/horizon-therapeutics-plc-announces-significant-expansion-of-east-coast-research-and-development-and-technical-operations-capability/ 2022-01-06T15:41:07+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/Horizon-Therapeutics.png https://bostonlifesciencestimes.com/2022/01/zymeworks-names-biotechnology-industry-leader-kenneth-galbraith-as-chair-and-ceo-to-succeed-dr-ali-tehrani/ 2022-01-06T15:43:22+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Ken-Galbraith.jpg https://bostonlifesciencestimes.com/2022/01/n-lorem-foundation-notes-latest-in-guidance-from-fda-on-developing-aso-drug-products-for-patients-with-nano-rare-diseases/ 2022-01-06T15:45:50+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/n-Lorem.png https://bostonlifesciencestimes.com/2022/01/nervgen-pharma-announces-intent-to-conduct-groundbreaking-spinal-cord-injury-clinical-trial/ 2022-01-10T15:03:32+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Dr.-Jerry-Silver.jpg https://bostonlifesciencestimes.com/2022/01/jamp-and-alvotech-announce-canadian-approval-of-simlandi-a-high-concentration-biosimilar-to-humira/ 2022-01-10T15:06:37+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/JAMP.jpg https://bostonlifesciencestimes.com/2022/01/iksuda-therapeutics-deepens-clinical-pipeline-through-licensing-agreement-for-her2-antibody-drug-conjugate-programme-from-legochem-biosciences/ 2022-01-10T15:12:03+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Iksuda-Therapeutics.jpg https://bostonlifesciencestimes.com/2022/01/clarify-health-welcomes-niall-brennan-as-chief-analytics-and-privacy-officer/ 2022-01-10T15:16:24+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Niall-Brennan.jpg https://bostonlifesciencestimes.com/2022/01/polycarbin-comes-out-of-stealth-raising-2m-from-ringbolt-capital-and-volo-earth-ventures-to-decarbonize-the-life-science-and-healthcare-sector/ 2022-01-10T15:18:10+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Polycarbin.jpg https://bostonlifesciencestimes.com/2022/01/gilead-announces-clinical-trial-collaborations-with-merck-to-evaluate-trodelvy-in-combination-with-keytruda-in-first-line-metastatic-non-small-cell-lung-cancer/ 2022-01-10T15:19:56+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/06/Gilead-Sciences.png https://bostonlifesciencestimes.com/2022/01/bluestar-genomics-appoints-david-mullarkey-chief-executive-officer/ 2022-01-10T15:22:05+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/David-Mullarkey.jpg https://bostonlifesciencestimes.com/2022/01/recode-therapeutics-appoints-shehnaaz-suliman-m-d-mba-m-phil-as-chief-executive-officer/ 2022-01-10T15:23:57+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Shehnaaz-Suliman-M.D.-MBA-M.Phil_..png https://bostonlifesciencestimes.com/2022/01/regulators-approve-impella-5-5-with-smartassist-in-japan-and-hong-kong-us-fda-grants-impella-btr-conditional-ide-approval-for-first-in-human-early-feasibility-study/ 2022-01-10T15:26:40+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Impella-5.5.jpg https://bostonlifesciencestimes.com/2022/01/kkr-closes-4-0-billion-health-care-strategic-growth-fund-ii/ 2022-01-10T15:28:23+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/KKR.jpg https://bostonlifesciencestimes.com/2022/01/tissium-appoints-ruth-krestin-as-vice-president-of-portfolio-strategy/ 2022-01-10T15:30:00+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Ruth-Krestin.jpg https://bostonlifesciencestimes.com/2022/01/vitalconnect-announces-closure-of-39-million-round-of-growth-financing/ 2022-01-10T15:36:20+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/VitalConnect.jpg https://bostonlifesciencestimes.com/2022/01/airxom-reveals-the-1st-mask-capable-of-destroying-viruses-bacteria-and-volatile-organic-compounds/ 2022-01-10T15:38:02+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/AIRXOM.jpg https://bostonlifesciencestimes.com/2022/01/food-allergy-science-initiative-strengthens-leadership-team-appoints-john-e-walter-as-chief-operating-officer/ 2022-01-10T15:40:10+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/John-E.-Walter.jpg https://bostonlifesciencestimes.com/2022/01/panavance-therapeutics-inc-created-to-transform-cancer-treatment/ 2022-01-11T16:23:35+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Panavance-Therapeutics.jpg https://bostonlifesciencestimes.com/2022/01/gho-capital-invests-in-roslinct-a-leading-cell-therapy-cdmo/ 2022-01-11T16:26:05+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Alan-MacKay.png https://bostonlifesciencestimes.com/2022/01/scitara-corp-raises-15m-in-series-b-financing-to-disrupt-the-laboratory-data-integration-market/ 2022-01-11T16:27:26+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Scitara-Corp.jpg https://bostonlifesciencestimes.com/2022/01/new-level-1-evidence-finds-geistlich-derma-gide-closes-significantly-more-diabetic-foot-ulcers-in-appreciably-shorter-time-and-at-lower-costs/ 2022-01-11T16:29:35+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Geistlich-Pharma-AG.jpg https://bostonlifesciencestimes.com/2022/01/susquehanna-private-capital-announces-investment-in-spherix-global-insights/ 2022-01-11T16:33:35+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Susquehanna-Private-Capital.jpg https://bostonlifesciencestimes.com/2022/01/mangata-networks-announces-33-million-series-a-raise-launching-innovative-satellite-edge-computing-network/ 2022-01-11T17:21:37+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Mangata.jpg https://bostonlifesciencestimes.com/2022/01/life-science-washington-names-cummings-as-president-ceo-appoints-board-members/ 2022-01-11T17:26:40+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Marc-Cummings.jpg https://bostonlifesciencestimes.com/2022/01/new-ultimusplus-nx-fluid-dispensers-improve-operational-efficiency-by-allowing-remote-programming-directly-from-a-plc/ 2022-01-11T17:35:39+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/UltimusPlus-NX.jpg https://bostonlifesciencestimes.com/2022/01/lazurite-announces-fda-510k-submission-for-its-arthrofree-wireless-camera-system-is-recognized-by-angelmd-as-one-of-the-best-startups-of-2021/ 2022-01-11T17:49:15+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/ArthroFree.jpg https://bostonlifesciencestimes.com/2022/01/dr-stephen-j-hoenig-completes-first-of-its-kind-procedure-at-the-vascular-care-group-leominster/ 2022-01-11T17:54:58+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Dr.-Stephen-J.-Hoenig.jpg https://bostonlifesciencestimes.com/2022/01/state-of-minnesota-selects-truveris-to-help-optimize-its-pharmacy-benefits-program/ 2022-01-12T15:29:46+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Truveris.jpg https://bostonlifesciencestimes.com/2022/01/procaps-group-acquires-1st-u-s-based-softgel-production-facility-and-pharmaceutical-rd-center-to-expand-global-growth-of-its-icdmo-business-unit/ 2022-01-12T15:32:45+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Procaps-Group.jpg https://bostonlifesciencestimes.com/2022/01/immunitybio-expands-manufacturing-capacity-with-state-of-the-art-manufacturing-plant-in-new-york-for-global-pandemic-response-and-preparedness/ 2022-01-12T15:38:01+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/ImmunityBio.jpg https://bostonlifesciencestimes.com/2022/01/nirogy-therapeutics-appoints-simon-pedder-ph-d-as-chief-executive-officer/ 2022-01-12T15:40:43+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Simon-Pedder-Ph.D..jpg https://bostonlifesciencestimes.com/2022/01/deep-lens-and-hematology-oncology-associates-of-central-new-york-collaborate-to-improve-clinical-trial-matching-for-oncology-patients/ 2022-01-12T15:43:22+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Deep-Lens.png https://bostonlifesciencestimes.com/2022/01/henley-ion-announces-promising-technology-developed-to-protect-against-covid-19-and-emerging-variants/ 2022-01-12T15:45:05+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Henley-Ion-Virus-Defender.jpg https://bostonlifesciencestimes.com/2022/01/american-real-estate-partners-and-harrison-street-joint-venture-commits-1-billion-to-develop-2-1-million-square-feet-of-powered-shell-data-centers-across-northern-virginias-data-center-alley/ 2022-01-12T15:54:14+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Harrison-Street-Joint-Venture.jpg https://bostonlifesciencestimes.com/2022/01/hemogenyx-pharmaceuticals-and-selexis-sa-will-advance-hemogenyxs-acute-myeloid-leukemia-aml-cdx-bispecific-antibody-to-human-trials/ 2022-01-12T15:57:02+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Hemogenyx-Pharmaceuticals.jpg https://bostonlifesciencestimes.com/2022/01/blade-therapeutics-announces-successful-completion-of-phase-1-clinical-study-that-evaluated-co-administration-of-cudetaxestat-with-either-of-two-approved-therapies-for-idiopathic-pulmonary-fibrosis/ 2022-01-12T16:01:03+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Blade-Therapeutics.jpg https://bostonlifesciencestimes.com/2022/01/early-feasibility-study-demonstrates-successful-use-of-abiomeds-precardia-technology/ 2022-01-12T16:14:31+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/preCARDIA.jpg https://bostonlifesciencestimes.com/2022/01/paragon-28-announces-acquisition-of-disior/ 2022-01-12T16:20:23+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Paragon-28.jpg https://bostonlifesciencestimes.com/2022/01/alira-health-secures-an-additional-40m-in-funding-led-by-creadev/ 2022-01-13T15:16:04+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Alira-Health.jpeg https://bostonlifesciencestimes.com/2022/01/angelini-pharma-appoints-rafal-kaminski-as-new-chief-scientific-officer/ 2022-01-13T15:17:50+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Rafal-Kaminski.jpg https://bostonlifesciencestimes.com/2022/01/themathcompany-announces-50-million-investment-from-brighton-park-capital/ 2022-01-13T15:20:51+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/TheMathCompany.jpg https://bostonlifesciencestimes.com/2022/01/allecra-therapeutics-and-advanz-pharma-sign-exclusive-license-and-supply-agreement-for-allecras-antibiotic-cefepime-enmetazobactam-in-europe/ 2022-01-13T15:51:55+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Allecra-Therapeutics.jpg https://bostonlifesciencestimes.com/2022/01/mary-kay-continues-its-commitment-to-skin-science/ 2022-01-13T16:04:35+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Dr.-Lucy-Gilde.jpg https://bostonlifesciencestimes.com/2022/01/n-lorem-foundation-announces-new-publication-in-trends-in-molecular-medicine/ 2022-01-13T16:30:56+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/n-Lorem.jpg https://bostonlifesciencestimes.com/2022/01/we-need-help-now-how-two-ohio-partners-are-helping-to-fill-critical-health-care-roles/ 2022-01-13T16:35:04+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Ohio-Virtual-Academy.png https://bostonlifesciencestimes.com/2022/01/kinnos-wins-new-york-transit-tech-labs-covid-19-response-challenge/ 2022-01-13T16:46:04+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Kinnos.jpg https://bostonlifesciencestimes.com/2022/01/theradiag-signing-of-a-distribution-agreement-with-biosynex-of-their-ampliquick-sars-cov-2-pcr-test/ 2022-01-13T16:51:31+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Theradiag.jpg https://bostonlifesciencestimes.com/2022/01/novo-integrated-sciences-announces-the-signing-of-a-master-facility-license-agreement-with-la-fitness-in-canada/ 2022-01-14T15:30:01+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Novo-Integrated-Sciences.png https://bostonlifesciencestimes.com/2022/01/alnylam-to-present-full-18-month-results-from-the-helios-a-phase-3-study-of-vutrisiran-at-the-societe-francophone-du-nerf-peripherique-annual-meeting/ 2022-01-14T15:31:10+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/Alnylam-Pharmaceuticals.png https://bostonlifesciencestimes.com/2022/01/humana-names-dr-andrew-agwunobi-president-of-companys-home-solutions-business/ 2022-01-14T15:44:15+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Dr.-Andrew-Agwunobi.jpg https://bostonlifesciencestimes.com/2022/01/air-liquide-recognized-by-the-cdp-as-one-of-the-best-performing-companies-in-the-fight-against-climate-change/ 2022-01-14T15:50:59+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Air-Liquide.png https://bostonlifesciencestimes.com/2022/01/virpax-successfully-completes-preclinical-dermal-safety-studies-for-epoladerm/ 2022-01-18T15:37:38+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Virpax%C2%AE-Pharmaceuticals.jpg https://bostonlifesciencestimes.com/2022/01/silence-therapeutics-head-of-molecular-design-dr-marie-wikstrom-lindholm-appointed-to-oligonucleotide-therapeutics-society-board-of-directors/ 2022-01-18T15:39:40+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Dr.-Marie-Wikstrom-Lindholm.jpg https://bostonlifesciencestimes.com/2022/01/revolutionary-chronic-kidney-disease-therapeutics-company-prokidney-to-become-publicly-traded-via-business-combination-with-social-capital-suvretta-holdings-corp-iii/ 2022-01-18T15:42:07+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/ProKidney-LP.jpg https://bostonlifesciencestimes.com/2022/01/dc-therapeutics-announces-exclusive-license-with-mitsubishi-tanabe-pharma-corporation-to-develop-and-commercialize-zynlonta/ 2022-01-18T15:44:38+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/ADC-Therapeutics-SA.png https://bostonlifesciencestimes.com/2022/01/inversago-pharma-completes-phase-1-clinical-trial-on-first-in-class-peripheral-cb1-blocker-and-provides-strategy-update/ 2022-01-18T15:48:06+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Dr.-Francois-Ravenelle.jpg https://bostonlifesciencestimes.com/2022/01/vistavu-acquires-r-tech-to-boost-customer-experience-commitment/ 2022-01-18T15:52:37+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/VistaVu.jpg https://bostonlifesciencestimes.com/2022/01/ascellahealth-designates-preferred-status-to-leading-pharmacies-for-home-infusion-pharmacy-network-enhances-site-of-care-optimization/ 2022-01-18T15:55:00+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/AscellaHealth.png https://bostonlifesciencestimes.com/2022/01/schrocken-inc-raises-undisclosed-funding-from-deep-tech-funds-five-gardens-llc-thinkuvate-and-their-existing-investors/ 2022-01-18T15:58:18+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Schrocken-Inc.png https://bostonlifesciencestimes.com/2022/01/ami-bavishi-joins-rallybio-to-lead-investor-relations-and-corporate-communications/ 2022-01-18T16:04:47+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Ami-Bavishi.jpg https://bostonlifesciencestimes.com/2022/01/corvista-health-appoints-charles-r-bridges-as-chief-scientific-officer/ 2022-01-18T16:07:10+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Dr.-Charles-Bridges.jpg https://bostonlifesciencestimes.com/2022/01/restrospective-study-finds-that-masimo-set-pulse-oximetry-has-no-difference-in-accuracy-or-bias-between-black-people-and-white-people/ 2022-01-18T16:10:22+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Masimo-SET%C2%AE-Pulse-Oximetry.jpg https://bostonlifesciencestimes.com/2022/01/gro-biosciences-appoints-rakhshita-dhar-to-its-board-of-directors/ 2022-01-18T16:11:48+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Rakhshita-Dhar.jpg https://bostonlifesciencestimes.com/2022/01/panavance-announces-abstract-and-poster-at-asco-gastrointestinal-cancers-symposium-providing-an-update-on-the-status-of-gp-2250-clinical-trial/ 2022-01-19T15:23:28+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Panavance-Therapeutics-1.jpg https://bostonlifesciencestimes.com/2022/01/elevatebio-announces-andrew-sandford-joins-as-president-of-elevatebio-basecamp/ 2022-01-19T15:27:34+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Andrew-Sandford.jpg https://bostonlifesciencestimes.com/2022/01/bruker-acquires-prolab-instruments-to-augment-multiomics-solutions/ 2022-01-19T15:30:07+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Zirconium.jpg https://bostonlifesciencestimes.com/2022/01/ceptur-therapeutics-launches-with-75m-series-a-financing-to-advance-rna-therapeutics-based-on-proprietary-u1-adaptor-technology/ 2022-01-19T15:31:24+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Ceptur-Therapeutics.jpg https://bostonlifesciencestimes.com/2022/01/babson-diagnostics-grows-leadership-team-with-key-executive-hires/ 2022-01-19T15:35:07+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Jim-Jacobson-Ph.D..jpg https://bostonlifesciencestimes.com/2022/01/xcellbio-announces-27-5-million-series-b-financing/ 2022-01-19T15:39:45+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Xcellbio.png https://bostonlifesciencestimes.com/2022/01/biolabs-philadelphia-to-open-premier-graduate-lab-space-in-center-city-philadelphia/ 2022-01-19T15:43:28+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/BioLabs-Philadelphia.jpg https://bostonlifesciencestimes.com/2022/01/64x-bio-raises-55-million-series-a-financing-to-advance-cell-line-engineering-platform-for-gene-therapy-manufacturing/ 2022-01-19T15:45:14+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/64x-Bio.jpg https://bostonlifesciencestimes.com/2022/01/sensydia-receives-fda-breakthrough-device-designation-for-cpstm-non-invasive-cardiac-monitoring-device/ 2022-01-19T15:47:36+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Cardiac-Performance-System.jpg https://bostonlifesciencestimes.com/2022/01/pack-green-launches-initiative-to-decrease-plastic-waste/ 2022-01-19T15:49:54+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/James-Asali.jpg https://bostonlifesciencestimes.com/2022/01/jnana-therapeutics-announces-appointment-of-john-throup-ph-d-as-senior-vice-president-head-of-development/ 2022-01-20T15:05:42+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Jnana-Therapeutics.jpg https://bostonlifesciencestimes.com/2022/01/harris-williams-strengthens-european-presence-with-appointment-of-dr-julian-feneley-as-managing-director-healthcare-life-sciences/ 2022-01-20T15:07:34+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Harris-Williams.png https://bostonlifesciencestimes.com/2022/01/oni-closes-75-million-series-b-led-by-arch-venture-partners-and-casdin-capital/ 2022-01-20T15:12:03+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/usd.jpg https://bostonlifesciencestimes.com/2022/01/ambys-medicines-appoints-dr-corinne-foo-atkins-as-chief-strategy-officer/ 2022-01-20T15:20:27+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Ambys-Medicines.jpg https://bostonlifesciencestimes.com/2022/01/orthofix-announces-investment-and-partnership-with-nview-medical-developer-of-novel-imaging-and-guidance-systems/ 2022-01-20T15:38:27+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Orthofix.jpg https://bostonlifesciencestimes.com/2022/01/cardiovascular-systems-inc-and-orbusneich-announce-fda-pma-approval-of-scoreflex-scoring-balloon/ 2022-01-20T15:56:54+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Cardiovascular-Systems-Inc.png https://bostonlifesciencestimes.com/2022/01/eleanor-health-welcomes-seasoned-executives-ellen-harrison-and-seth-frazier-to-its-leadership-team/ 2022-01-20T15:59:38+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Ellen-Harrison.jpg https://bostonlifesciencestimes.com/2022/01/bigtime-software-receives-100-million-strategic-growth-investment-from-vista-equity-partners/ 2022-01-20T16:02:15+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/BigTime-Software.png https://bostonlifesciencestimes.com/2022/01/danimer-scientific-appoints-michael-a-hajost-as-chief-financial-officer/ 2022-01-20T16:37:32+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Danimer-Scientific.jpg https://bostonlifesciencestimes.com/2022/01/osmind-announces-appointment-of-brent-saunders-pharma-veteran-and-former-ceo-of-allergan-to-board-of-directors/ 2022-01-21T15:15:45+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Osmind.png https://bostonlifesciencestimes.com/2022/01/francisco-partners-to-acquire-ibms-healthcare-data-and-analytics-assets/ 2022-01-21T15:20:40+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Francisco-Partners.jpg https://bostonlifesciencestimes.com/2022/01/eurofins-empowerdx-launches-pfas-exposure-in-the-u-s-the-first-at-home-blood-test-to-detect-and-measure-40-pfas-compounds/ 2022-01-21T15:27:04+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/empowerDX.png https://bostonlifesciencestimes.com/2022/01/ecolab-life-sciences-announces-12-price-increase/ 2022-01-21T15:30:00+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Ecolab-Inc.webp https://bostonlifesciencestimes.com/2022/01/hercules-capital-closes-upsized-public-offering-of-350-0-million-3-375-notes-due-2027/ 2022-01-21T15:38:32+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Hercules-Capital.webp https://bostonlifesciencestimes.com/2022/01/routine-vaccination-rates-in-teens-and-adults-continue-to-lag-behind-pre-pandemic-levels-follow-up-analysis-shows/ 2022-01-21T15:45:22+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/GSK.png https://bostonlifesciencestimes.com/2022/01/biocept-reports-an-increase-in-covid-19-rt-pcr-testing-volume-with-spread-of-the-omicron-variant/ 2022-01-21T15:50:22+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Biocept.jpg https://bostonlifesciencestimes.com/2022/01/equideum-health-appoints-colonel-joseph-wood-md-phd-us-army-retired-as-executive-director-of-veterans-facing-vici-initiative-also-to-serve-as-vice-president-decentralized-trials-and-virtual-hea/ 2022-01-21T15:55:02+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Joseph-Wood-MD-PhD.jpg https://bostonlifesciencestimes.com/2022/01/carbon-health-launches-large-covid-19-testing-sites-in-south-san-francisco-california-montgomery-township-and-plainsboro-township-new-jersey/ 2022-01-21T16:10:27+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Covid-Image-Better-1.png https://bostonlifesciencestimes.com/2022/01/expansion-therapeutics-names-sudhir-rao-senior-vice-president-of-business-development/ 2022-01-24T15:14:11+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Sudhir-Rao.jpg https://bostonlifesciencestimes.com/2022/01/goldfinch-bio-announces-appointment-of-edwin-j-tucker-m-d-as-chief-medical-officer/ 2022-01-24T15:21:03+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Edwin-J.-Tucker-M.D..jpg https://bostonlifesciencestimes.com/2022/01/beigene-announces-positive-findings-from-phase-3-trial-of-tislelizumab-in-combination-with-chemotherapy-in-first-line-gastric-or-gastroesophageal-junction-cancer/ 2022-01-24T15:24:24+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/BeiGene.png https://bostonlifesciencestimes.com/2022/01/rayzebio-expands-leadership-team-with-arvind-kush-as-chief-financial-officer-and-aubrey-haddach-j-d-as-general-counsel/ 2022-01-24T15:28:57+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/RayzeBio.jpg https://bostonlifesciencestimes.com/2022/01/ceremorphic-exits-stealth-mode-unveils-technology-plans-to-deliver-a-new-architecture-specifically-designed-for-reliable-performance-computing/ 2022-01-24T15:31:58+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/supercomputing-chip.jpg https://bostonlifesciencestimes.com/2022/01/cana-technology-emerges-from-stealth-with-worlds-first-molecular-beverage-printer-serving-thousands-of-beverages-with-a-tiny-environmental-footprint/ 2022-01-24T15:39:20+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Cana-Technology.webp https://bostonlifesciencestimes.com/2022/01/aizon-launches-predictive-maintenance-solution-for-pharmaceutical-manufacturing/ 2022-01-24T15:43:36+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Aizon.jpg https://bostonlifesciencestimes.com/2022/01/peptilogics-promotes-nicholas-nystrom-ph-d-to-chief-technology-officer/ 2022-01-24T15:52:41+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Peptilogics.png https://bostonlifesciencestimes.com/2022/01/heartland-and-ravago-develop-products-to-reduce-the-carbon-footprint-of-plastic/ 2022-01-24T16:08:16+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Ravago-Americas.jpg https://bostonlifesciencestimes.com/2022/01/virica-biotech-announces-rd-partnership-with-oxford-biomedica-to-improve-the-manufacturing-of-lentiviral-vector-gene-therapies-using-viral-sensitizers/ 2022-01-24T16:09:57+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Virica-Biotech-Inc.jpg https://bostonlifesciencestimes.com/2022/01/activ-surgical-appoints-manisha-shah-bugaj-as-chief-operating-officer/ 2022-01-24T16:22:17+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Manisha-Shah-Bugaj.jpg https://bostonlifesciencestimes.com/2022/01/amid-rapid-growth-vida-health-hires-patrick-carroll-md-as-chief-medical-officer/ 2022-01-24T16:29:06+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Patrick-Carroll-MD.jpg https://bostonlifesciencestimes.com/2022/01/dnovo-emerges-from-stealth-with-its-potential-cure-for-hair-loss/ 2022-01-24T16:31:51+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/dNovo-Inc.jpg https://bostonlifesciencestimes.com/2022/01/quantori-names-pharma-it-veteran-arun-nayar-as-global-head-of-rd-informatics/ 2022-01-25T15:26:48+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Arun-Nayar.jpg https://bostonlifesciencestimes.com/2022/01/alira-health-expands-its-digital-health-portfolio-with-the-acquisition-of-self-care-catalysts/ 2022-01-25T15:30:50+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Alira-Health.jpeg https://bostonlifesciencestimes.com/2022/01/pfizer-and-biontech-initiate-study-to-evaluate-omicron-based-covid-19-vaccine-in-adults-18-to-55-years-of-age/ 2022-01-25T15:32:33+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/01/Pfizer-Building-logo.jpg https://bostonlifesciencestimes.com/2022/01/qiagen-completes-u-s-federal-contract-to-equip-local-public-health-authorities-with-qiacuity-digital-pcr-system-for-covid-19-surveillance/ 2022-01-25T15:35:56+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/QIAGEN.png https://bostonlifesciencestimes.com/2022/01/donor-gives-25-million-to-establish-unc-lineberger-center-for-triple-negative-breast-cancer/ 2022-01-25T15:42:03+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Lisa-A.-Carey-MD.jpg https://bostonlifesciencestimes.com/2022/01/eisana-corp-and-cortex-design-announce-collaboration-to-develop-medical-device-for-cancer-patients/ 2022-01-25T15:50:15+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Carole-Spangler-Vaughn-PhD-MBA.webp https://bostonlifesciencestimes.com/2022/01/oxford-finances-leveraged-lending-group-closes-more-than-1-4-bn-of-capital-commitments-in-2021/ 2022-01-25T15:57:11+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Oxford-Finance.png https://bostonlifesciencestimes.com/2022/01/metagenomi-closes-oversubscribed-175m-series-b-financing-to-advance-therapeutic-pipeline-and-expand-novel-gene-editing-platform/ 2022-01-25T16:04:25+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Metagenomi.jpg https://bostonlifesciencestimes.com/2022/01/mispro-to-open-new-preclinical-research-facility-in-long-island-city/ 2022-01-25T16:05:54+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Mispro.jpg https://bostonlifesciencestimes.com/2022/01/new-study-finds-more-than-60-of-adult-women-in-the-u-s-experience-urinary-incontinence/ 2022-01-25T16:09:49+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Axonics-Inc.jpg https://bostonlifesciencestimes.com/2022/01/crowdstreet-identifies-their-20-best-places-to-invest-in-private-equity-real-estate-in-2022/ 2022-01-25T16:14:25+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/CrowdStreet.jpg https://bostonlifesciencestimes.com/2022/01/%e2%80%8b%e2%80%8batlas-health-raises-40m-series-a-to-expand-ai-powered-patient-advocacy-solution/ 2022-01-25T16:39:45+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/%E2%80%8B%E2%80%8BAtlas-Health.jpg https://bostonlifesciencestimes.com/2022/01/atomwise-strengthens-its-management-team-adds-veteran-biopharma-leader-david-thomson-ph-d-as-chief-scientific-officer-and-two-additional-senior-appointments/ 2022-01-25T20:13:55+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Atomwise.png https://bostonlifesciencestimes.com/2022/01/massbios-2021-massachusetts-biopharma-funding-report-reveals-another-record-breaking-year-for-the-industry/ 2022-01-26T14:52:58+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Joe-Boncore.jpg https://bostonlifesciencestimes.com/2022/01/stevanato-group-extends-pen-injector-technology-licensing-agreement-with-haselmeier/ 2022-01-26T14:55:57+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Haselmeier.jpg https://bostonlifesciencestimes.com/2022/01/puretech-founded-entity-akili-interactive-a-leader-in-digital-medicine-to-become-publicly-traded-through-combination-with-social-capital-suvretta-holdings-corp/ 2022-01-26T15:00:00+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/PureTech.jpg https://bostonlifesciencestimes.com/2022/01/labcorp-to-offer-risk-scoring-test-for-people-with-advanced-liver-fibrosis-due-to-nash/ 2022-01-26T15:03:27+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Labcorp.jpg https://bostonlifesciencestimes.com/2022/01/spotsee-acquires-biosynergy-inc/ 2022-01-26T15:07:20+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/SpotSee.png https://bostonlifesciencestimes.com/2022/01/o9-solutions-raises-295-million-from-strategic-investors-to-continue-its-growth-across-industry-verticals-markets/ 2022-01-26T15:15:34+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Chakri-Gottemukkala.jpg https://bostonlifesciencestimes.com/2022/01/big-health-adds-former-fda-deputy-commissioner-anand-shah-to-its-board-of-directors/ 2022-01-26T15:22:23+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Big-Health.png https://bostonlifesciencestimes.com/2022/01/axion-biosystems-welcomes-industry-leader-david-ferrick-as-new-cso/ 2022-01-26T15:24:54+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/David-Ferrick.jpg https://bostonlifesciencestimes.com/2022/01/preclinical-study-provides-guidance-for-optimizing-safety-and-efficacy-of-endovascular-hepatic-denervation-devices-to-treat-diabetes/ 2022-01-26T15:37:04+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/CBSET-Inc.png https://bostonlifesciencestimes.com/2022/01/epa-renews-emergency-exemption-for-grignard-pure-airborne-antiviral-treatment-effective-against-sars-cov-2/ 2022-01-26T15:49:36+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/U.S.-Environmental-Protection-Agency.png https://bostonlifesciencestimes.com/2022/01/croma-pharma-completed-the-decentralized-procedure-for-its-botulinum-toxin-to-treat-glabellar-frown-lines/ 2022-01-27T15:20:42+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Croma-Pharma.jpg https://bostonlifesciencestimes.com/2022/01/lunaphore-appoints-alice-feng-as-chief-financial-officer/ 2022-01-27T15:24:02+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Alice-Feng.jpg https://bostonlifesciencestimes.com/2022/01/reform-biologics-changes-name-to-comera-life-sciences/ 2022-01-27T15:29:04+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Comera-Life-Sciences.jpg https://bostonlifesciencestimes.com/2022/01/interchecks-announces-16m-series-b-financing-co-led-by-senator-investment-group-and-standard-investments-to-accelerate-instant-payment-infrastructure/ 2022-01-27T15:34:20+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Interchecks.jpg https://bostonlifesciencestimes.com/2022/01/tensixteen-bio-launches-with-funding-from-foresite-capital-and-gv-as-the-first-company-to-use-chip-to-treat-age-related-diseases/ 2022-01-27T15:39:04+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/TenSixteen-Bio.jpg https://bostonlifesciencestimes.com/2022/01/ted-davis-to-succeed-amy-tseng-as-president-and-ceo-of-tissuetech/ 2022-01-27T15:50:44+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/TissueTech.jpg https://bostonlifesciencestimes.com/2022/01/galvani-bioelectronics-announces-worlds-first-investigational-treatment-of-rheumatoid-arthritis-using-splenic-nerve-stimulation/ 2022-01-27T15:56:47+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Galvani-Bioelectronics.jpg https://bostonlifesciencestimes.com/2022/01/nymbl-science-fall-prevention-program-addresses-multi-billion-dollar-problem-in-u-s/ 2022-01-27T16:06:57+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Nymbl-Science-Fall-Prevention-Program.jpg https://bostonlifesciencestimes.com/2022/01/broad-sky-partners-announces-investment-from-capital-constellation-and-acquisition-of-thomas-scientific/ 2022-01-27T16:09:18+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Broad-Sky-Partners.jpg https://bostonlifesciencestimes.com/2022/01/bioventrix-expands-heart-failure-treatment-portfolio-with-acquisition-of-materacor-inc/ 2022-01-27T16:25:17+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/BioVentrix-Inc.jpg https://bostonlifesciencestimes.com/2022/01/biobarica-worldwide-leaders-in-hyperbaric-treatments/ 2022-01-27T16:28:42+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Biobarica.jpg https://bostonlifesciencestimes.com/2022/01/are-pests-riding-out-the-winter-in-your-house-experts-say-keep-them-out-for-a-healthy-home/ 2022-01-27T16:34:46+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/National-Pest-Management-Association.png https://bostonlifesciencestimes.com/2022/01/procaps-group-announces-appointment-of-melissa-angelini-as-investor-relations-director/ 2022-01-28T15:24:09+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Melissa-Angelini.jpg https://bostonlifesciencestimes.com/2022/01/biocom-california-applauds-governors-legislatures-support-for-life-saving-research/ 2022-01-28T15:33:15+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Biocom-California.png https://bostonlifesciencestimes.com/2022/01/hcl-technologies-expands-reach-in-canada-with-new-engineering-and-rd-center/ 2022-01-28T15:42:07+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/HCL.jpg https://bostonlifesciencestimes.com/2022/01/first-patient-recruited-for-multi-year-collaborative-primary-sclerosing-cholangitis-psc-pediatric-study-using-perspectums-imaging-technology-to-help-predict-disease-progression-and-guide-pa/ 2022-01-28T15:45:23+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Perspectum.jpg https://bostonlifesciencestimes.com/2022/01/insulet-announces-fda-clearance-of-its-omnipod-5-automated-insulin-delivery-system-first-tubeless-system-with-smartphone-control/ 2022-01-28T15:55:24+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Omnipod.jpg https://bostonlifesciencestimes.com/2022/01/causalens-raises-45m-series-a-to-scale-human-centered-ai-that-understands-cause-and-effect/ 2022-01-28T16:02:34+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/causaLens.jpg https://bostonlifesciencestimes.com/2022/01/merck-and-ridgebacks-molnupiravir-an-investigational-oral-antiviral-covid-19-medicine-demonstrated-activity-against-omicron-variant-in-in-vitro-studies/ 2022-01-28T16:42:37+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/Merck-e1637590913813.png https://bostonlifesciencestimes.com/2022/01/468-capital-raises-400-million-fund-ii/ 2022-01-31T15:26:56+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/usd.jpg https://bostonlifesciencestimes.com/2022/01/u-s-fda-approves-new-label-update-for-car-t-cell-therapy-yescarta-showing-prophylactic-steriod-use-improves-management-of-cytokine-release-syndrome/ 2022-01-31T15:29:18+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/06/Kite-a-Gilead-Company.jpg https://bostonlifesciencestimes.com/2022/01/komodo-health-to-provide-powerful-insights-platform-to-rare-disease-patient-advocacy-organizations/ 2022-01-31T15:32:52+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Komodo-Health.jpg https://bostonlifesciencestimes.com/2022/01/comera-life-sciences-to-become-publicly-traded-via-business-combination-with-otr-acquisition-corp/ 2022-01-31T15:34:26+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Comera-Life-Sciences-1.jpg https://bostonlifesciencestimes.com/2022/01/three-in-four-ceos-fear-losing-their-jobs-says-alixpartners-survey/ 2022-01-31T15:36:13+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/AlixPartners.png https://bostonlifesciencestimes.com/2022/01/juvenescence-ltd-portfolio-company-hails-successful-limb-regeneration-in-adult-frogs/ 2022-01-31T15:39:17+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Greg-Bailey-MD.jpg https://bostonlifesciencestimes.com/2022/01/gandeeva-raises-40m-in-series-a-funding-to-develop-novel-therapies-based-on-precision-imaging-of-protein-drug-interactions/ 2022-01-31T15:43:04+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Gandeeva-Therapeutics.jpg https://bostonlifesciencestimes.com/2022/01/chemence-medical-receives-fda-clearance-for-new-exofin-precision-pen/ 2022-01-31T15:49:56+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Chemence-Medical.jpg https://bostonlifesciencestimes.com/2022/01/fda-approves-prophylactic-treatment-with-vonvendi/ 2022-01-31T15:55:48+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/Takeda.jpg https://bostonlifesciencestimes.com/2022/01/vocera-awarded-a-place-on-nhs-shared-business-services-framework/ 2022-01-31T16:08:58+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Vocera.png https://bostonlifesciencestimes.com/2022/02/seagen-appoints-lee-heeson-as-executive-vice-president-commercial-international/ 2022-02-01T15:35:34+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Lee-Heeson.jpg https://bostonlifesciencestimes.com/2022/02/ontario-bioscience-innovation-organization-welcomes-dr-maura-campbell-as-incoming-ceo/ 2022-02-01T15:40:36+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Ontario-Bioscience.png https://bostonlifesciencestimes.com/2022/02/cyclica-recruits-big-pharma-veteran-michael-palovich-as-chief-science-officer-to-advance-robust-drug-discovery-pipeline/ 2022-02-01T15:43:50+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Cyclica.jpg https://bostonlifesciencestimes.com/2022/02/model-n-announces-new-saas-solution-for-pharmaceutical-and-biotech-companies-to-address-state-price-transparency-mandates/ 2022-02-01T15:52:20+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Model-N.jpg https://bostonlifesciencestimes.com/2022/02/wilson-sonsini-set-to-open-boulder-office-and-expand-its-life-sciences-and-technology-presence-in-the-intermountain-region/ 2022-02-01T15:59:46+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Wilson-Sonsini-scaled.jpg https://bostonlifesciencestimes.com/2022/02/karl-storz-endoscopy-america-announces-appointment-of-new-managing-director/ 2022-02-01T16:34:05+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Sonal-Matai.jpg https://bostonlifesciencestimes.com/2022/02/desktop-health-launches-einstein-and-flexcera-smile-ultra-resin-fda-510k-cleared-class-2-medical-device-for-permanent-printable-dental-restorations/ 2022-02-01T16:41:06+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/The-Einstein.jpg https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/same-day-dental-prosthetics.jpg https://bostonlifesciencestimes.com/2022/02/merz-aesthetics-launches-radiesse-as-first-and-only-aesthetic-injectable-to-improve-moderate-to-severe-loss-of-jawline-contour/ 2022-02-01T16:47:56+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Dr.-Samantha-Kerr.png https://bostonlifesciencestimes.com/2022/02/aldeyra-therapeutics-announces-publication-of-phase-2-clinical-trial-of-reproxalap-in-allergen-chamber-model/ 2022-02-01T17:00:39+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/odd-C.-Brady-M.D.-Ph.D..jpg https://bostonlifesciencestimes.com/2022/02/league-raises-95-million-usd-in-series-c-to-build-worlds-leading-health-os-platform/ 2022-02-01T17:02:29+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/The-League-platform.jpg https://bostonlifesciencestimes.com/2022/02/research-finds-covid-pandemic-worsened-health-equity-gap/ 2022-02-01T17:04:37+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Teva-Pharmaceuticals.png https://bostonlifesciencestimes.com/2022/02/eagle-pharmaceuticals-announces-commercial-availability-of-pemfexy/ 2022-02-01T17:07:49+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Eagle-Pharmaceuticals.jpg https://bostonlifesciencestimes.com/2022/02/following-lsne-acquisition-pci-pharma-services-continues-to-expand-sterile-fill-finish-expertise-with-state-of-the-art-equipment/ 2022-02-02T15:28:08+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/PCI-Pharma.jpg https://bostonlifesciencestimes.com/2022/02/medable-acquires-mobile-applications-from-leo-pharma-expands-global-engineering-team-and-european-presence/ 2022-02-02T15:30:07+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/medable.jpg https://bostonlifesciencestimes.com/2022/02/pfizer-and-biontech-initiate-rolling-submission-for-emergency-use-authorization-of-their-covid-19-vaccine-in-children-6-months-through-4-years-of-age-following-request-from-u-s-fda/ 2022-02-02T15:31:42+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Pfizer.jpg https://bostonlifesciencestimes.com/2022/02/levels-names-former-startup-founders-and-physicians-to-lead-rd-and-clinical-strategy/ 2022-02-02T15:34:04+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Taylor-Sittler-MD.jpg https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Lauren-Kelley-Chew-MD.jpg https://bostonlifesciencestimes.com/2022/02/stevanato-group-appoints-riccardo-butta-as-president-americas/ 2022-02-02T15:35:58+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Riccardo-Butta.jpg https://bostonlifesciencestimes.com/2022/02/n-lorem-foundation-partners-with-argonaut-to-manufacture-aso-medicines-for-patients-with-nano-rare-diseases/ 2022-02-02T15:39:48+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/T.-Crooke-M.D.-Ph.D.jpg https://bostonlifesciencestimes.com/2022/02/innovafeed-readies-for-major-u-s-expansion/ 2022-02-02T15:41:36+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/InnovaFeed.jpg https://bostonlifesciencestimes.com/2022/02/northsea-therapeutics-initiates-phase-1-trial-of-sefa-6179-targeting-the-orphan-indication-intestinal-failure-associated-liver-disease/ 2022-02-02T15:45:15+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/NorthSea-Therapeutics.jpg https://bostonlifesciencestimes.com/2022/02/texas-medical-technology-partners-with-omnysense-to-cut-down-hospital-readmissions/ 2022-02-02T15:47:24+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Omri-Shafran.webp https://bostonlifesciencestimes.com/2022/02/u-s-life-sciences-industry-digitizing-to-meet-pandemic-related-demands/ 2022-02-02T15:48:48+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Information-Services-Grou.png https://bostonlifesciencestimes.com/2022/02/resonant-link-raises-9-3-million-investment-for-wireless-charging-technology-powering-the-future-of-mobility/ 2022-02-02T15:53:08+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Resonant-Link.jpg https://bostonlifesciencestimes.com/2022/02/san-antonio-leaders-attempt-to-silence-physicians-group-over-citys-gift-of-federal-funds-to-texas-biomed/ 2022-02-02T15:56:55+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Physicians-Committee-for-Responsible-Medicine.png https://bostonlifesciencestimes.com/2022/02/emulate-announces-promotion-of-dr-lorna-ewart-to-chief-scientific-officer/ 2022-02-03T15:17:06+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Dr.-Lorna-Ewart.jpg https://bostonlifesciencestimes.com/2022/02/urogen-announces-start-of-pivotal-single-arm-phase-3-trial-for-ugn-102-an-investigational-non-surgical-treatment-for-low-grade-intermediate-risk-non-muscle-invasive-bladder-cancer/ 2022-02-03T15:24:39+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Screenshot-2022-02-03-at-10-23-59-Leadership-Team-UroGen-Pharma.png https://bostonlifesciencestimes.com/2022/02/kriya-announces-the-appointment-of-maan-muhsin-m-d-as-president-and-chief-medical-officer-of-its-oncology-therapeutic-area-division/ 2022-02-03T15:31:21+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Screenshot-2022-02-03-at-10-30-05-TEAM-%E2%80%93-Kriyatx.png https://bostonlifesciencestimes.com/2022/02/eubiologics-phase-iii-clinical-trial-ind-approval-of-eucorvac-19-covid-19-vaccine-candidate-in-south-korea/ 2022-02-03T15:53:36+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/EuCorVac-19.jpg https://bostonlifesciencestimes.com/2022/02/regio-biosciences-enters-into-license-agreement-with-astrazeneca-for-phase-2a-asset-in-peripheral-artery-disease-pad/ 2022-02-03T15:56:45+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Chris-Jeffers.jpg https://bostonlifesciencestimes.com/2022/02/koya-medical-secures-26m-in-series-b-funding-to-advance-portfolio-of-active-compression-therapies-for-lymphedema-and-venous-disorders/ 2022-02-03T16:04:11+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Screenshot-2022-02-03-at-11-03-23-About-Us-Koya-Medical.png https://bostonlifesciencestimes.com/2022/02/rion-aesthetics-wins-octane-launchpad-sbdc-judges-award-at-aesthetics-tech-summit/ 2022-02-03T16:14:36+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Alisa-Lask.jpg https://bostonlifesciencestimes.com/2022/02/exthera-medical-fresenius-medical-care-sign-distribution-agreement-for-seraph-100-blood-purification-device-in-mexico/ 2022-02-03T16:19:04+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Robert-Ward.png https://bostonlifesciencestimes.com/2022/02/school-counseling-in-demand-as-teen-anxiety-and-depression-doubles/ 2022-02-03T16:24:43+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/School-Counseling.jpg https://bostonlifesciencestimes.com/2022/02/spartannash-distributing-n95-masks-to-help-curb-the-spread-of-covid-19/ 2022-02-03T16:27:24+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/SpartanNash.jpg https://bostonlifesciencestimes.com/2022/02/bruker-expands-nanoflow-consumables-portfolio-for-4d-proteomics/ 2022-02-04T15:17:58+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/PepSep-nanoLC-column.jpg https://bostonlifesciencestimes.com/2022/02/university-of-phoenix-college-of-doctoral-studies-releases-whitepaper-summarizing-career-perceptions-during-the-pandemic-by-income-level/ 2022-02-04T15:20:12+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/University-of-Phoenix.jpg https://bostonlifesciencestimes.com/2022/02/labcorp-launches-labcorp-ondemand-digital-health-platform/ 2022-02-04T15:23:44+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/01/Labcorp1.jpg https://bostonlifesciencestimes.com/2022/02/otr-acquisition-corp-announces-confidential-submission-of-s-4-registration-statement-related-to-proposed-business-combination/ 2022-02-04T15:29:08+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/OTR-Acquisition-Corp.jpg https://bostonlifesciencestimes.com/2022/02/ra-medical-systems-inc-announces-pricing-of-12-0-million-underwritten-public-offering/ 2022-02-04T15:32:47+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Ra-Medical-Systems.webp https://bostonlifesciencestimes.com/2022/02/wag-labs-inc-to-become-listed-through-350-million-business-combination-with-chw-acquisition-corporation/ 2022-02-04T18:24:56+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Garrett-Smallwood.png https://bostonlifesciencestimes.com/2022/02/stridebio-announces-mark-velleca-m-d-ph-d-as-chief-executive-officer/ 2022-02-04T18:26:17+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Mark-Velleca-M.D.-Ph.D..jpg https://bostonlifesciencestimes.com/2022/02/healthcare-costs-are-149-higher-among-individuals-with-unrecognized-symptoms-of-depression-new-happify-health-analysis-finds/ 2022-02-07T16:03:34+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Screenshot-2022-02-07-at-11-02-55-People-with-purpose-%E2%80%94-Happify-Health.png https://bostonlifesciencestimes.com/2022/02/curie-therapeutics-expands-radiopharmaceutical-expertise-with-appointment-of-bernard-lambert-ph-d-as-chief-technology-officer/ 2022-02-07T16:09:08+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Screenshot-2022-02-07-at-11-08-34-Our-People-%E2%80%93-Curie-Therapeutics.png https://bostonlifesciencestimes.com/2022/02/koneksa-raises-45m-series-c-financing-to-accelerate-expansion-of-digital-biomarker-platform/ 2022-02-07T16:18:53+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Chris-Benko.jpg https://bostonlifesciencestimes.com/2022/02/bruker-launches-new-timstof-based-maldi-pharmapulse-solution-for-label-free-hts-in-drug-discovery/ 2022-02-07T16:26:30+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/timsTOF-MALDI-PharmaPulse.jpg https://bostonlifesciencestimes.com/2022/02/canbridge-reports-positive-top-line-can106-phase-1-data/ 2022-02-07T16:31:48+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/James-Xue-Ph.D..jpg https://bostonlifesciencestimes.com/2022/02/thermo-fisher-scientific-partners-with-medidata-acorn-ai-to-optimize-clinical-research-site-selection-and-speed-patient-enrollment-in-clinical-trials/ 2022-02-07T16:37:01+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Thermo-Fisher-1.jpg https://bostonlifesciencestimes.com/2022/02/thermo-fisher-scientific-launches-rapid-environmental-pcr-testing-solution-that-detects-in-air-sars-cov-2-pathogens/ 2022-02-07T16:39:22+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/The-Renvo-Rapid-PCR-Test.jpg https://bostonlifesciencestimes.com/2022/02/labcorp-opens-new-laboratory-in-south-bend-expanding-services-and-access-in-the-midwest/ 2022-02-07T16:44:04+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Labcorp.jpg https://bostonlifesciencestimes.com/2022/02/croivalve-raises-an-e8m-series-a-round-to-support-a-feasibility-clinical-study/ 2022-02-07T17:00:41+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Lucy-OKeeffe.jpg https://bostonlifesciencestimes.com/2022/02/global-investors-to-bring-as-much-as-us52b-in-capital-to-fund-canadian-healthcare-innovations/ 2022-02-07T17:03:37+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Ontario-Bioscience.png https://bostonlifesciencestimes.com/2022/02/sternums-solution-beats-botenago-malware-targeting-millions-of-devices-in-a-live-trial/ 2022-02-07T17:10:15+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Sternum.jpg https://bostonlifesciencestimes.com/2022/02/mandy-moore-partners-with-lumenis-to-raise-awareness-of-dry-eye-disease-and-optilight-treatment/ 2022-02-08T15:27:28+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Mandy-Moore.jpg https://bostonlifesciencestimes.com/2022/02/nobel-laureate-jennifer-doudna-ph-d-announced-as-chief-science-advisor-to-sixth-street/ 2022-02-08T15:30:40+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Jennifer-Doudna-Ph.D..jpg https://bostonlifesciencestimes.com/2022/02/n-lorem-foundation-partners-with-cytiva-to-bring-individualized-aso-medicines-to-patients-with-nano-rare-diseases/ 2022-02-08T15:38:21+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/n-Lorem.png https://bostonlifesciencestimes.com/2022/02/doll-play-prompts-children-to-talk-about-others-thoughts-and-emotions/ 2022-02-08T15:42:15+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Doll-Play.jpg https://bostonlifesciencestimes.com/2022/02/innovative-investigators-and-early-stage-biotechnology-companies-were-selected-for-the-texas-based-accelerator-for-cancer-therapeutics/ 2022-02-08T15:56:49+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Emily-Reiser-Ph.D..jpg https://bostonlifesciencestimes.com/2022/02/new-genetic-analyzer-brings-advanced-capabilities-to-sanger-sequencing-and-fragment-analysis/ 2022-02-08T16:09:30+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/SeqStudio-Flex-Series-Genetic-Analyze.jpg https://bostonlifesciencestimes.com/2022/02/gilead-to-present-latest-antiviral-research-and-development-data-at-croi-2022-addressing-urgent-global-needs/ 2022-02-08T16:14:41+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/06/Gilead-Sciences.png https://bostonlifesciencestimes.com/2022/02/new-benchmark-report-from-nist-baylor-college-of-medicine-and-dnanexus-helps-provide-accurate-identification-of-variants-in-challenging-medically-relevant-genes/ 2022-02-08T16:16:45+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/National-Institute-of-Standards-and-Technology.png https://bostonlifesciencestimes.com/2022/02/lumeon-appoints-greg-miller-as-chief-growth-officer/ 2022-02-08T16:19:22+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Lumeon.jpg https://bostonlifesciencestimes.com/2022/02/temple-university-hospital-adopts-masimo-centroid/ 2022-02-08T16:21:21+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Masimo-Centroid.jpg https://bostonlifesciencestimes.com/2022/02/bioskryb-genomics-and-als-automated-lab-solutions-gmbh-sign-u-s-distribution-agreement-to-power-unprecedented-single-cell-spatial-genomics/ 2022-02-08T16:23:49+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Jay-West-Ph.D..jpg https://bostonlifesciencestimes.com/2022/02/rockley-photonics-announces-bioptx-biomarker-sensing-platform-for-professional-healthcare/ 2022-02-08T16:28:00+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Bioptx-Biosensing-Wristband.jpg https://bostonlifesciencestimes.com/2022/02/governments-turn-to-binx-health-to-expand-testing-efforts-for-covid-19/ 2022-02-08T16:30:22+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Covid-Image-Better.png https://bostonlifesciencestimes.com/2022/02/ora-expands-scientific-leadership-with-new-chief-medical-officer-gustavo-de-moraes-md-phd-mph/ 2022-02-08T16:31:49+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Gustavo-De-Moraes-MD-PHD-MPH.jpg https://bostonlifesciencestimes.com/2022/02/merck-and-ridgeback-announce-that-3-1-million-courses-of-molnupiravir-an-investigational-oral-antiviral-covid-19-medicine-have-been-supplied-to-the-u-s-government-for-use-in-the-united-states/ 2022-02-08T16:33:35+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/molnupiravir.jpg https://bostonlifesciencestimes.com/2022/02/tevogen-bio-accelerates-growth-with-new-corporate-hub-to-accommodate-its-expanding-operations/ 2022-02-08T16:36:20+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Tevogen-Bio.jpg https://bostonlifesciencestimes.com/2022/02/oxford-finance-closes-400-million-senior-note-offering/ 2022-02-08T16:37:57+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Oxford-Finance.png https://bostonlifesciencestimes.com/2022/02/wavely-diagnostics-raises-more-than-2mm-in-seed-funding-to-bring-at-home-pediatric-digital-diagnostics-platform-to-parents/ 2022-02-08T16:43:06+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Screenshot-2022-02-08-at-11-42-29-About-Us-%E2%80%94-Wavely-Diagnostics.png https://bostonlifesciencestimes.com/2022/02/transaction-data-systems-appoints-robert-ven-to-cto/ 2022-02-09T18:21:53+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Robert-Ven.jpg https://bostonlifesciencestimes.com/2022/02/sunovion-and-otsuka-initiate-phase-3-clinical-development-of-non-racemic-amisulpride-for-the-treatment-of-people-with-bipolar-depression/ 2022-02-09T18:24:49+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Armin-Szegedi-M.D.-Ph.D.png https://bostonlifesciencestimes.com/2022/02/cyclica-launches-perturba-therapeutics-a-spin-out-from-the-university-of-toronto-creating-the-next-generation-oncology-biotech/ 2022-02-09T18:26:48+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Screenshot-2022-02-09-at-10-24-40-Roots-in-AI-protein-biophysics-and-machine-learning-%E2%80%94-Cyclica.png https://bostonlifesciencestimes.com/2022/02/silence-therapeutics-announces-positive-topline-data-in-sln360-phase-1-single-ascending-dose-study-in-healthy-adults-with-high-lipoproteina/ 2022-02-09T18:36:19+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Giles-Campion-M.D..png https://bostonlifesciencestimes.com/2022/02/eurofins-to-acquire-genetic-testing-service-jsc-and-enter-the-clinical-genetic-testing-market-in-vietnam/ 2022-02-09T18:39:21+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/Eurofins.png https://bostonlifesciencestimes.com/2022/02/dalrada-corporation-enters-into-a-3mm-convertible-debt-funding/ 2022-02-09T18:44:11+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Dalrada-Corporation.jpg https://bostonlifesciencestimes.com/2022/02/idt-unveils-new-solution-to-accelerate-homology-directed-repair-genome-editing-research/ 2022-02-09T18:48:44+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Integrated-DNA-Technologies.png https://bostonlifesciencestimes.com/2022/02/btr-raises-15-million-in-series-a-round-to-transform-the-validation-process-for-life-sciences-companies/ 2022-02-09T18:51:03+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/usd.jpg https://bostonlifesciencestimes.com/2022/02/mevion-selected-to-equip-new-proton-therapy-and-research-center-in-san-antonio/ 2022-02-09T18:54:38+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Tina-Yu.jpg https://bostonlifesciencestimes.com/2022/02/neurovascular-company-perfuze-raises-e22-5m-25m-series-a-for-new-stroke-treatment/ 2022-02-09T18:56:33+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Perfuze.jpg https://bostonlifesciencestimes.com/2022/02/seismic-therapeutic-launches-with-101-million-series-a-financing-to-usher-in-a-new-era-of-immunology-drug-development-integrating-machine-learning/ 2022-02-09T18:58:56+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Jo-Viney-PhD.jpg https://bostonlifesciencestimes.com/2022/02/phase-3-clinical-trial-confirms-sanotizes-breakthrough-treatment-is-99-effective-against-covid-19-receives-regulatory-approval-in-india/ 2022-02-09T19:06:26+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/SaNOtize.png https://bostonlifesciencestimes.com/2022/02/move-with-milliporesigma-hosts-recruiting-event-at-leominster-doubletree-hilton-on-february-22-for-all-manufacturing-positions/ 2022-02-10T15:23:29+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/MilliporeSigma.png https://bostonlifesciencestimes.com/2022/02/virpax-reports-favorable-preclinical-safety-data-for-envelta-for-the-treatment-of-acute-and-chronic-pain/ 2022-02-10T15:26:11+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Anthony-P-Mack.jpg https://bostonlifesciencestimes.com/2022/02/curevo-vaccine-announces-60-million-series-a-financing-to-support-clinical-development-of-next-generation-subunit-vaccines/ 2022-02-10T15:33:09+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/George-Simeon.jpg https://bostonlifesciencestimes.com/2022/02/urogen-announces-data-that-shows-in-office-nephrostomy-tube-administration-of-jelmyto-is-efficient-for-doctors-and-well-tolerated-by-patients/ 2022-02-10T15:36:29+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Dr.-Mark-Schoenberg.jpg https://bostonlifesciencestimes.com/2022/02/labcorp-enters-comprehensive-long-term-laboratory-relationship-with-ascension/ 2022-02-10T15:42:21+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Adam-Schechter-scaled.jpg https://bostonlifesciencestimes.com/2022/02/basf-venture-capital-and-orbia-ventures-invest-in-israeli-biotech-company-fortephest/ 2022-02-10T15:48:15+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/FortePhest.jpg https://bostonlifesciencestimes.com/2022/02/ixaka-expands-management-team-with-multiple-appointments/ 2022-02-10T15:51:21+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Nick-Robbins-Cherry.jpg https://bostonlifesciencestimes.com/2022/02/ra-medical-systems-granted-u-s-patent-for-a-support-catheter-for-use-supporting-a-liquid-core-ablation-catheter/ 2022-02-10T16:05:11+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Will-McGuire.jpg https://bostonlifesciencestimes.com/2022/02/helios-technologies-subsidiary-receives-systems-components-award/ 2022-02-10T16:09:19+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/The-Faster-ABC.jpg https://bostonlifesciencestimes.com/2022/02/altesa-biosciences-inc-launches-operations-to-develop-commercialize-drugs-for-respiratory-viruses-and-global-viral-threats/ 2022-02-10T16:11:34+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Dr.-Brett-Giroir.jpg https://bostonlifesciencestimes.com/2022/02/how-high-schools-can-maintain-career-tech-classes-despite-teacher-shortages/ 2022-02-10T16:13:50+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Learn4Life-Career-Tech-Ed-students.jpg https://bostonlifesciencestimes.com/2022/02/transgene-appoints-steven-bloom-as-chief-business-officer/ 2022-02-10T16:19:29+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Transgene.jpg https://bostonlifesciencestimes.com/2022/02/veklury-remdesivir-retains-antiviral-activity-against-omicron-delta-and-other-emergent-sars-cov-2-variants-in-multiple-in-vitro-studies/ 2022-02-11T15:13:44+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Veklury%C2%AE-Remdesivir.jpg https://bostonlifesciencestimes.com/2022/02/exactech-presents-award-winning-clinical-research-at-2022-orthopaedic-research-society-annual-meeting/ 2022-02-11T15:20:11+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Exactech.jpg https://bostonlifesciencestimes.com/2022/02/senseonics-announces-fda-approval-of-the-eversense-e3-continuous-glucose-monitoring-system-for-use-for-up-to-6-months/ 2022-02-11T15:22:29+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Tim-Goodnow-PhD.png https://bostonlifesciencestimes.com/2022/02/smoore-chinese-industry-leaders-are-committed-to-exploring-harm-reduction-of-vaping/ 2022-02-11T15:25:19+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/FEELM.jpg https://bostonlifesciencestimes.com/2022/02/iveric-bio-announces-foveal-anatomy-post-hoc-analysis-from-gather1-clinical-trial-of-zimura-in-patients-with-geographic-atrophy/ 2022-02-11T15:37:15+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/IVERIC-bio.jpg https://bostonlifesciencestimes.com/2022/02/endra-life-sciences-strengthens-taeus-system-global-intellectual-property-portfolio-with-issuance-of-6th-and-7th-european-patents/ 2022-02-11T15:54:45+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/ENDRA-Life-Sciences.webp https://bostonlifesciencestimes.com/2022/02/investors-in-nrx-pharmaceuticals-inc-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-nrxp-nrxpw/ 2022-02-14T15:29:47+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Robbins-Geller-Rudman-Dowd-LLP.png https://bostonlifesciencestimes.com/2022/02/new-review-article-in-escs-cardiovascular-research-examines-cholesteryl-ester-transfer-protein-cetp-inhibitions-role-in-reducing-cardiovascular-disease-risk/ 2022-02-14T15:32:29+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/NewAmsterdam-Pharma.jpg https://bostonlifesciencestimes.com/2022/02/optikos-president-ceo-stephen-d-fantone-elected-to-the-national-academy-of-engineering/ 2022-02-14T15:42:34+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Stephen-D.-Fantone.jpg https://bostonlifesciencestimes.com/2022/02/pharmacyte-biotech-updates-status-of-investigational-new-drug-application-to-fda/ 2022-02-14T15:51:49+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/PharmaCyte-Biotech.jpg https://bostonlifesciencestimes.com/2022/02/stablix-names-tony-kingsley-ceo/ 2022-02-14T15:58:52+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Stablix.jpg https://bostonlifesciencestimes.com/2022/02/primmune-therapeutics-presents-interim-analysis-of-clinical-data-from-phase-1-study-evaluating-prtx007-at-the-conference-on-retroviruses-and-opportunistic-infections/ 2022-02-14T16:09:37+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Primmune-Therapeutics.jpg https://bostonlifesciencestimes.com/2022/02/first-of-its-kind-coalition-sees-health-industry-professional-bodies-and-experts-come-together-to-holistically-tackle-hidden-pandemic-of-antibiotic-resistant-infections/ 2022-02-14T16:12:44+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Infection-Management-Coalition.jpg https://bostonlifesciencestimes.com/2022/02/stratasys-donates-cutting-edge-3d-printers-to-visible-heart-laboratories-at-university-of-minnesota-medical-school/ 2022-02-14T16:14:36+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/University-of-Minnesota-Visible-Heart-Laboratories.jpg https://bostonlifesciencestimes.com/2022/02/independent-research-with-myomos-myopro-shows-clinically-significant-gains-in-motor-function-in-individuals-with-chronic-moderate-to-severe-arm-weakness/ 2022-02-14T16:17:31+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Myomo-Inc.png https://bostonlifesciencestimes.com/2022/02/chargebacks911-appoints-ex-accertify-and-american-express-industry-heavyweight-robert-hoover-as-vp-business-development/ 2022-02-15T15:45:52+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Robert-Hoover.jpg https://bostonlifesciencestimes.com/2022/02/carevive-appoints-aaron-galaznik-m-d-as-chief-scientific-officer/ 2022-02-15T15:47:40+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Aaron-Galaznik-M.D..jpg https://bostonlifesciencestimes.com/2022/02/news-outlets-highlight-virpax-pharmaceuticals-and-its-potential-solutions-for-the-opioid-crisis-and-covid-19/ 2022-02-15T15:51:12+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Anthony-Mack.jpg https://bostonlifesciencestimes.com/2022/02/aquinnah-pharmaceuticals-announces-collaboration-with-roche-to-advance-new-therapies-for-als-and-other-neurodegenerative-diseases/ 2022-02-15T15:55:35+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Glenn-Larsen-Ph.D..jpg https://bostonlifesciencestimes.com/2022/02/c-lecta-announces-that-it-has-reached-agreement-to-be-acquired-by-kerry-group/ 2022-02-15T15:57:16+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Management-c-LEcta.jpg https://bostonlifesciencestimes.com/2022/02/akanda-corp-names-dr-sunny-nayee-as-u-k-medical-director-to-support-partnership-with-cellen-life-sciences/ 2022-02-15T15:59:24+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Dr.-Sunny-Nayee.jpg https://bostonlifesciencestimes.com/2022/02/intest-invests-in-new-facilities-to-enhance-innovation-expand-customer-relationships-and-streamline-operations/ 2022-02-15T16:03:34+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/inTEST-Invests-scaled-e1644941003368.webp https://bostonlifesciencestimes.com/2022/02/seagen-and-astellas-announce-initial-results-of-padcev-enfortumab-vedotin-ejfv-in-patients-with-muscle-invasive-bladder-cancer/ 2022-02-15T16:05:35+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Seagen.jpg https://bostonlifesciencestimes.com/2022/02/european-medicines-agency-approves-pfizers-20-valent-pneumococcal-conjugate-vaccine-against-invasive-pneumococcal-disease-and-pneumonia-in-adults/ 2022-02-15T16:08:23+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Pfizer-Inc.jpg https://bostonlifesciencestimes.com/2022/02/unseasonably-warm-fall-followed-by-excessive-snowfall-in-winter-creates-perfect-storm-for-increased-vector-pest-pressure/ 2022-02-15T16:10:01+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/National-Pest-Management-Association.png https://bostonlifesciencestimes.com/2022/02/longmore-institute-on-disability-at-san-francisco-state-to-distribute-100000-in-anthem-blue-cross-scholarships-to-students-with-disabilities/ 2022-02-15T16:16:03+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Anthem-Blue-Cross.png https://bostonlifesciencestimes.com/2022/02/german-federal-court-of-justice-upholds-aops-license-rights-in-ropeginterferon-and-pecs-liability-for-damages/ 2022-02-15T16:22:34+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Dr.-Rudolf-Widmann.jpg https://bostonlifesciencestimes.com/2022/02/pharmajet-partner-technovalia-announces-interim-results-of-needle-free-covid-19-vaccine-trial/ 2022-02-15T16:37:38+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Chris-Cappello.jpg https://bostonlifesciencestimes.com/2022/02/legend-biotech-announces-fda-clinical-hold-of-its-phase-1-clinical-trial-for-lb1901/ 2022-02-15T16:43:10+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Legend-Biotech.jpg https://bostonlifesciencestimes.com/2022/02/ambu-donates-650-lifesaving-resuscitators-to-international-charity-mercy-ships-as-it-celebrates-the-65th-birthday-of-the-ambu-bagtm/ 2022-02-15T16:46:24+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Ambu.jpg https://bostonlifesciencestimes.com/2022/02/unitron-group-b-v-chooses-factorylogix-mes-for-medical-device-manufacturing/ 2022-02-15T16:50:19+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Unitron-Group-B.V..png https://bostonlifesciencestimes.com/2022/02/rapid-medical-receives-fda-breakthrough-device-designation-for-vasospasm-treatment/ 2022-02-15T17:13:52+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Rapid-Medical.gif https://bostonlifesciencestimes.com/2022/02/napoli-shkolnik-pllc-wraps-up-2021-with-historic-jury-verdicts-in-opioid-litigations-landmark-settlement-for-flint-residents-johnson-johnson-class-action-and-more/ 2022-02-16T15:49:46+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Marie-Napoli.jpg https://bostonlifesciencestimes.com/2022/02/farmacon-global-partners-with-validcare-for-performance-based-clinical-research-solutions/ 2022-02-16T16:02:43+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Farmacon-Global.jpg https://bostonlifesciencestimes.com/2022/02/saguaro-closes-1-1m-start-up-funding-to-offer-new-drug-discovery-technologies-that-help-fight-human-disease/ 2022-02-16T16:06:18+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Saguaro-Technologies-Inc.jpg https://bostonlifesciencestimes.com/2022/02/privia-health-leverages-amalgam-rxs-ehr-integrated-solutions-to-personalize-care/ 2022-02-16T16:19:16+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Privia-Health.jpg https://bostonlifesciencestimes.com/2022/02/star-therapeutics-emerges-from-stealth-mode-raising-100m-in-financing-since-inception-to-be-an-innovation-engine-for-rare-disease-therapies/ 2022-02-16T16:36:29+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Star-Therapeutics.jpg https://bostonlifesciencestimes.com/2022/02/the-center-for-global-health-innovation-announces-award-of-9-8-million-grant-to-address-vaccine-hesitancy-in-7-states/ 2022-02-16T17:00:27+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Center-for-Global-Health-Innovation.png https://bostonlifesciencestimes.com/2022/02/epitel-secures-12-5-million-series-a-financing-for-wearable-wireless-eeg-monitoring-system/ 2022-02-16T17:13:16+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Epitel.jpg https://bostonlifesciencestimes.com/2022/02/dnanudge-launch-90-minute-rt-pcr-covid-19-test-in-australia/ 2022-02-16T17:25:51+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/DnaNudge.jpg https://bostonlifesciencestimes.com/2022/02/perkinelmers-sirion-biotech-teams-with-centre-for-genomic-regulation-to-develop-new-generation-aav-vectors-for-type-1-and-type-2-diabetes-gene-therapy/ 2022-02-16T17:30:26+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/01/1200px-PerkinElmer_logo.svg_.png https://bostonlifesciencestimes.com/2022/02/my-mhealth-appoints-biotech-veteran-and-digital-therapeutics-pioneer-joel-sangerman-as-chief-commercial-officer/ 2022-02-16T17:47:22+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Joel-Sangerman.jpg https://bostonlifesciencestimes.com/2022/02/imbeds-microlyte-matrix-added-to-vas-idiq-contract/ 2022-02-16T17:49:13+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Microlyte-Matrix.jpg https://bostonlifesciencestimes.com/2022/02/leo-pharma-a-s-appoints-brian-hilberdink-new-president-of-leo-pharma-inc-united-states/ 2022-02-17T16:35:41+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/LEO-Pharma.jpg https://bostonlifesciencestimes.com/2022/02/beigene-announces-approval-for-brukinsa-zanubrutinib-by-swissmedic-for-treatment-of-adult-patients-with-waldenstroms-macroglobulinemia/ 2022-02-17T16:37:30+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/BeiGene.png https://bostonlifesciencestimes.com/2022/02/classiq-announces-33m-in-new-funding-accelerating-its-journey-to-become-the-leading-quantum-software-development-platform/ 2022-02-17T16:45:16+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Nir-Minerbi.png https://bostonlifesciencestimes.com/2022/02/lunaphore-and-massachusetts-general-hospital-pathology-department-to-develop-spatial-biology-based-cancer-diagnostics/ 2022-02-17T16:46:30+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/COMET-6-plex.jpg https://bostonlifesciencestimes.com/2022/02/agilent-acquires-artificial-intelligence-technology-to-enhance-lab-productivity/ 2022-02-17T16:49:18+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Jacob-Thaysen.jpg https://bostonlifesciencestimes.com/2022/02/emids-launches-extensive-rebranding-initiative/ 2022-02-17T16:54:37+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Saurabh-Sinha.jpg https://bostonlifesciencestimes.com/2022/02/bioduro-sundia-appoints-kent-payne-ceo/ 2022-02-17T17:05:54+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Kent-M.-Payne-PhD.png https://bostonlifesciencestimes.com/2022/02/applied-dna-and-evvivax-announce-publication-of-positive-preclinical-data-for-lineardna-platform-approach-to-cancer-immunotherapy/ 2022-02-17T18:21:02+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/EvviVax-e1645122051109.png https://bostonlifesciencestimes.com/2022/02/shouti-introduces-basecamp-bio-as-a-wholly-owned-subsidiary-to-expand-pipeline-and-partnerships/ 2022-02-17T18:25:13+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/ShouTi.jpg https://bostonlifesciencestimes.com/2022/02/immunicom-appoints-dr-annette-marleau-as-chief-technology-officer/ 2022-02-17T18:30:36+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Amir-Jafri.png https://bostonlifesciencestimes.com/2022/02/harpak-ulma-expands-medical-device-market-initiative/ 2022-02-17T18:34:50+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Nick-Kirichkow.jpg https://bostonlifesciencestimes.com/2022/02/uk-health-tech-startup-tympahealth-successfully-closes-a-seed-round-of-8m-and-announces-appointment-of-arjun-desai-karin-ajmani-to-board-of-directors/ 2022-02-17T18:39:10+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Tympa-Health-Technologies.png https://bostonlifesciencestimes.com/2022/02/genomic-visions-technology-is-acquired-by-department-of-cell-biology-microbiology-molecular-biology-at-the-university-of-south-florida-to-study-mechanisms-of-dna-replication-and-replicatio/ 2022-02-17T18:48:26+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Dominique-Remy-Renou.jpg https://bostonlifesciencestimes.com/2022/02/aizons-ceo-john-vitalie-named-one-of-the-top-25-biotech-ceos-of-2022/ 2022-02-18T17:47:08+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/John-Vitalie.jpg https://bostonlifesciencestimes.com/2022/02/novo-integrated-sciences-ionovo-for-kids-pure-iodine-oral-spray-granted-natural-product-number-npn-by-health-canada/ 2022-02-18T17:50:31+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Novo-Integrated-Sciences.png https://bostonlifesciencestimes.com/2022/02/ribon-therapeutics-a-clinical-stage-biotechnology-company-targeting-stress-support-pathways-in-cancer-and-inflammation-announces-ceo-transition-for-its-next-phase-of-growth/ 2022-02-18T17:52:58+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Prakash-Raman-Ph.D.jpg https://bostonlifesciencestimes.com/2022/02/dalrada-clean-energy-board-adds-technology-advisor-charles-tang/ 2022-02-18T18:00:15+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Charles-Tang.jpg https://bostonlifesciencestimes.com/2022/02/beigene-announces-u-s-fda-acceptance-of-supplemental-new-drug-application-for-brukinsa-in-chronic-lymphocytic-leukemia/ 2022-02-22T15:13:22+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/BRUKINSA.jpg https://bostonlifesciencestimes.com/2022/02/kaneka-eurogentec-announces-the-successful-production-of-25g-of-mrna-in-one-batch/ 2022-02-22T15:15:20+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/IVT-RNA-processing.jpg https://bostonlifesciencestimes.com/2022/02/mccord-to-spice-up-lab-and-production-space-for-boston-based-food-technology-company-motif-foodworks/ 2022-02-22T15:18:40+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Motif-FoodWorks.jpg https://bostonlifesciencestimes.com/2022/02/david-meyers-joins-h2scan-as-chief-operating-officer/ 2022-02-22T15:21:05+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/H2scan.jpg https://bostonlifesciencestimes.com/2022/02/mitsubishi-corporation-life-sciences-granted-new-us-patent-for-composition-containing-glutathione-as-an-active-ingredient-for-improvement-or-prevention-of-non-alcoholic-fatty-liver/ 2022-02-22T15:22:42+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Mitsubishi-Corporation-Life-Sciences-Limited.jpg https://bostonlifesciencestimes.com/2022/02/arima-genomics-announces-new-structural-variant-detection-products/ 2022-02-22T15:25:37+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Arima-Genomics.jpg https://bostonlifesciencestimes.com/2022/02/eyebio-raises-65m-in-series-a-funding-to-develop-new-generation-of-eye-disease-therapies/ 2022-02-22T15:28:51+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/EyeBio.jpg https://bostonlifesciencestimes.com/2022/02/boundless-bio-appoints-klaus-wagner-m-d-ph-d-as-chief-medical-officer/ 2022-02-22T15:30:52+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Klaus-Wagner-M.D.-Ph.D..jpg https://bostonlifesciencestimes.com/2022/02/cumulus-oncology-secures-4-1m-5-6m-investment-led-by-eos-advisory/ 2022-02-22T15:49:07+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Dr-Diane-Seimetz.jpg https://bostonlifesciencestimes.com/2022/02/university-hospitals-ventures-to-expand-collaboration-with-lazurite-and-invest-in-the-company/ 2022-02-22T15:53:54+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Lazurite-1.jpg https://bostonlifesciencestimes.com/2022/02/virtamed-and-memic-announce-partnership-for-development-of-new-robotics-virtual-reality-training-simulator/ 2022-02-22T16:00:02+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Hominis.jpg https://bostonlifesciencestimes.com/2022/02/signifier-medical-technologies-is-granted-hcpcs-codes-for-exciteosa-to-help-patients-access-innovative-technology/ 2022-02-22T16:12:00+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/eXciteOSA.jpg https://bostonlifesciencestimes.com/2022/02/orthofix-expands-synthetic-bone-growth-offerings-with-full-market-launch-of-opus-ba-a-bioactive-solution-for-spine-procedures/ 2022-02-22T16:15:25+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Orthofix-Medical-Inc.jpg https://bostonlifesciencestimes.com/2022/02/cdc-partners-with-palantir-to-bolster-the-fight-against-covid-19/ 2022-02-22T16:29:48+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/cbc.png https://bostonlifesciencestimes.com/2022/02/ivanhoe-cambridge-partners-with-lendlease-to-invest-in-life-science-developments/ 2022-02-22T19:07:31+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/60-Guest-Street-in-Boston-Landing.webp https://bostonlifesciencestimes.com/2022/02/lilly-announces-the-institute-for-genetic-medicine-and-700-million-investment-in-boston-seaport-site/ 2022-02-23T18:40:39+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Andrew-C.-Adams.webp https://bostonlifesciencestimes.com/2022/02/interrad-medical-and-eloquest-healthcare-partner-to-expand-u-s-sales-of-securacath/ 2022-02-23T18:43:55+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Interrad-Medical.jpg https://bostonlifesciencestimes.com/2022/02/genomics-company-revolugen-announces-the-appointment-of-dr-annalisa-jenkins-as-chair/ 2022-02-23T18:47:07+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/RevoluGen.jpg https://bostonlifesciencestimes.com/2022/02/psious-rebrands-as-amelia-virtual-care-names-afsana-akhter-as-ceo-to-accelerate-growth-amid-rapid-adoption-of-vr-in-mental-health/ 2022-02-23T19:04:22+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Afsana-Akhter.jpg https://bostonlifesciencestimes.com/2022/02/rohit-gandhi-joins-oxford-finances-senior-lending-platform/ 2022-02-23T19:06:16+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Rohit-Gandhi.jpg https://bostonlifesciencestimes.com/2022/02/moderna-and-thermo-fisher-scientific-announce-long-term-strategic-collaboration/ 2022-02-23T19:07:26+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Thermo-Fisher-1.jpg https://bostonlifesciencestimes.com/2022/02/sequence-based-ai-driven-drug-discovery-company-deargen-raises-us17-million-in-seriesb-financing-round-to-accelerate-in-house-pipeline/ 2022-02-24T15:33:13+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Kilsoo-Kang.png https://bostonlifesciencestimes.com/2022/02/medicago-and-gsk-announce-the-approval-by-health-canada-of-covifenz-an-adjuvanted-plant-based-covid-19-vaccine/ 2022-02-24T15:35:44+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Medicago.jpg https://bostonlifesciencestimes.com/2022/02/scipher-medicine-closes-110-million-financing/ 2022-02-24T15:37:52+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Scipher-Medicine.png https://bostonlifesciencestimes.com/2022/02/genmab-and-seagen-present-first-data-on-tisotumab-vedotin-tivdak-in-patients-with-head-and-neck-squamous-cell-carcinoma/ 2022-02-24T15:42:07+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/David-S.-Hong-M.D.jpg https://bostonlifesciencestimes.com/2022/02/dassault-systemes-introduces-life-cycle-assessment-solution-on-the-3dexperience-platform-to-transform-the-sustainable-innovation-process/ 2022-02-24T15:45:45+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Dassault-Systemes.jpg https://bostonlifesciencestimes.com/2022/02/gliapharm-sa-and-the-wyss-center-enter-collaboration-to-develop-new-therapies-for-alzheimers-disease/ 2022-02-24T15:50:13+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Wyss-Center.jpg https://bostonlifesciencestimes.com/2022/02/pavmed-appoints-shaun-oneil-as-chief-operating-officer/ 2022-02-24T15:53:04+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Shaun-ONeil.jpg https://bostonlifesciencestimes.com/2022/02/contralines-male-contraceptive-technology-wins-best-innovation-at-reproductive-health-innovation-summit/ 2022-02-24T15:59:50+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Contraline.jpg https://bostonlifesciencestimes.com/2022/02/zht-partners-with-maxlinear-for-next-generation-5g-small-cell-solutions/ 2022-02-24T16:05:54+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/MaxLinear-MxL1600-RF-Transceivers.jpg https://bostonlifesciencestimes.com/2022/02/agilent-and-university-of-vermont-announce-the-agilent-laboratory-for-chemical-analysis/ 2022-02-24T16:22:07+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Mike-McMullen.jpg https://bostonlifesciencestimes.com/2022/02/oxford-biodynamics-announces-us-launch-of-its-checkpoint-inhibitor-response-test-episwitch-cirt-for-oncology/ 2022-02-25T15:47:56+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Oxford-BioDynamics.jpg https://bostonlifesciencestimes.com/2022/02/oncocross-begins-clinical-trial-for-ai-developed-drug-for-sarcopenia/ 2022-02-25T15:50:17+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Dr.-Yi-Rang-Kim.jpg https://bostonlifesciencestimes.com/2022/02/capri-egm-acquires-rd-build-to-suit-for-national-resilience-a-biomanufacturing-company-contracted-by-the-dod-harvard-and-moderna/ 2022-02-25T15:52:15+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Resilience.jpg https://bostonlifesciencestimes.com/2022/02/altpep-appoints-nancy-hill-to-newly-created-position-of-chief-product-officer/ 2022-02-25T16:01:42+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Nancy-Hill.jpg https://bostonlifesciencestimes.com/2022/02/inhibrx-selects-genialis-responderid-for-clinical-optimization-study-of-inbrx-109/ 2022-02-28T16:05:51+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Rafael-Rosengarten-Ph.D..jpg https://bostonlifesciencestimes.com/2022/02/bruker-releases-ccs-enabled-timscore-and-tims-dia-nn-4d-proteomics-software/ 2022-02-28T16:09:29+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/3D-box-plot.jpg https://bostonlifesciencestimes.com/2022/02/edenbridge-pharmaceuticals-announces-the-launch-of-dartisla-odt/ 2022-02-28T16:17:11+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Edenbridge-Pharmaceuticals.png https://bostonlifesciencestimes.com/2022/02/adalvo-partners-with-sk-pharma-to-create-arphio-a-new-business-entity-dedicated-solely-to-orphan-and-rare-disease-medicines/ 2022-02-28T18:08:59+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Adalvo.jpg https://bostonlifesciencestimes.com/2022/02/serotiny-and-tessera-therapeutics-enter-into-collaboration-to-engineer-and-optimize-programmable-gene-writer-proteins/ 2022-02-28T18:21:51+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Screenshot-2022-02-28-at-13-20-56-Serotiny.png https://bostonlifesciencestimes.com/2022/02/dr-evidence-expands-capabilities-of-ai-powered-medical-search-engine/ 2022-02-28T18:25:45+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Dr.Evidence.jpg https://bostonlifesciencestimes.com/2022/02/elpiscience-announces-first-patient-dosed-in-phase-1-2-clinical-study-of-es104-for-treatment-of-colorectal-cancer/ 2022-02-28T18:27:18+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Elpiscience.jpg https://bostonlifesciencestimes.com/2022/02/alnylam-debuts-new-documentary-two-of-me-living-with-porphyria-to-help-shorten-time-to-diagnosis-for-acute-hepatic-porphyria/ 2022-02-28T18:29:28+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Two-of-Me-Living-with-Porphyria.jpg https://bostonlifesciencestimes.com/2022/02/rsip-vision-presents-new-tool-for-total-shoulder-arthroplasty-tsa-planning-through-mri-scan/ 2022-02-28T18:32:51+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/RSIP-Vision.jpg https://bostonlifesciencestimes.com/2022/02/butterfly-network-introduces-butterfly-blueprint-and-worlds-first-fda-cleared-ai-guidance-interpretation-software-to-support-the-practical-application-of-ultrasound-information/ 2022-02-28T18:35:21+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Blueprint.jpg https://bostonlifesciencestimes.com/2022/02/novocure-founder-yoram-palti-wins-2022-israel-prize-in-entrepreneurship-and-technological-innovation/ 2022-02-28T18:37:01+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Professor-Yoram-Palti.jpg https://bostonlifesciencestimes.com/2022/03/vaxess-bolsters-commitment-to-vaccine-patch-leadership-with-purpose-built-cambridge-lab-and-fortified-management-team-with-the-addition-of-a-veteran-cfo-and-head-of-device-development/ 2022-03-01T15:12:40+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Vaxess.jpg https://bostonlifesciencestimes.com/2022/03/mablink-bioscience-announces-appointment-of-its-chief-development-officer/ 2022-03-01T15:15:05+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Frederique-Brune-PharmD.jpg https://bostonlifesciencestimes.com/2022/03/newamsterdam-pharma-doses-first-patient-in-prevail-the-cardiovascular-outcomes-trial-of-obicetrapib-in-adults-with-atherosclerotic-cardiovascular-disease/ 2022-03-01T15:18:36+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Screenshot-2022-03-01-at-10-16-51-About-Us-%E2%80%94-New-Amsterdam-Pharma.png https://bostonlifesciencestimes.com/2022/03/janux-therapeutics-appoints-byron-robinson-ph-d-j-d-as-chief-strategy-officer/ 2022-03-01T15:24:17+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Byron-Robinson-Ph.D.-J.D..jpg https://bostonlifesciencestimes.com/2022/03/urogen-submits-investigational-new-drug-application-supporting-planned-phase-1-clinical-study-of-ugn-301-intravesical-solution-in-recurrent-non-muscle-invasive-bladder-cancer/ 2022-03-01T15:27:17+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Janux-Therapeutics.png https://bostonlifesciencestimes.com/2022/03/oxford-properties-group-and-ensemble-mosaic-partner-to-create-3-million-square-foot-life-sciences-hub-at-the-navy-yard-in-philadelphia/ 2022-03-01T15:29:40+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Life-Science-space.jpg https://bostonlifesciencestimes.com/2022/03/accenture-and-microsoft-to-assist-mount-sinai-health-system-on-five-year-transformation-journey-to-cloud/ 2022-03-01T15:32:17+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Accenture.jpg https://bostonlifesciencestimes.com/2022/03/maryland-tech-councils-life-sciences-division-announces-2022-bio-innovation-conference/ 2022-03-01T15:42:48+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Maryland-Tech-Council.png https://bostonlifesciencestimes.com/2022/03/alameda-county-turns-to-the-innovaccer-health-cloud-to-connect-vulnerable-populations-with-vital-community-services/ 2022-03-01T15:44:47+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Innovaccer-Health-Cloud.jpg https://bostonlifesciencestimes.com/2022/03/stevanato-group-announces-agreement-with-barda-for-the-expansion-of-vial-production-to-create-industrial-base-capabilities-for-national-defense/ 2022-03-01T15:47:38+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Vial.jpg https://bostonlifesciencestimes.com/2022/03/north-bay-startup-larasah-launches-results-focused-solution-for-burnout/ 2022-03-01T15:50:49+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/LARASAH.jpg https://bostonlifesciencestimes.com/2022/03/abec-continues-proactive-investment-in-single-use-manufacturing-capacity/ 2022-03-01T15:59:06+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/ABEC.jpg https://bostonlifesciencestimes.com/2022/03/berry-consultants-acquires-addplan-clinical-trial-simulation-software-from-icon/ 2022-03-01T16:03:30+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Berry-Consultants.jpg https://bostonlifesciencestimes.com/2022/03/sjp-properties-and-scotto-properties-announce-new-headquarters-for-valley-national-bank-in-morristown-n-j/ 2022-03-01T16:05:10+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/SJPs-planned-development.jpg https://bostonlifesciencestimes.com/2022/03/aceto-acquires-biotron-laboratories-and-talus-mineral-company-collectively-biotron-leading-manufacturers-of-specialty-ingredients-for-the-nutritional-supplements-industry/ 2022-03-02T15:31:53+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/The-Biotron-facilities-in-Ogden-Utah.jpg https://bostonlifesciencestimes.com/2022/03/patriots-mac-jones-matt-light-gov-charlie-baker-and-600-granite-teammates-shave-their-heads-to-benefit-boston-childrens-hospital/ 2022-03-02T15:47:16+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Granite-Telecommunication.jpg https://bostonlifesciencestimes.com/2022/03/innocoll-announces-positive-topline-results-for-xaracoll-bupivacaine-hydrochloride-implant-in-a-phase-3-study-to-support-expanded-use/ 2022-03-02T15:52:44+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Innocoll.png https://bostonlifesciencestimes.com/2022/03/biomed-realty-leases-96000-square-feet-at-the-companys-flagship-granta-park-campus-in-cambridge/ 2022-03-02T16:00:05+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/BioMed-Realty.jpg https://bostonlifesciencestimes.com/2022/03/purify-investigators-announce-first-patient-enrolled-in-a-us-randomized-controlled-ide-trial-evaluating-seraph-100-for-the-treatment-of-septic-shock/ 2022-03-02T16:13:44+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Robert-Ward.png https://bostonlifesciencestimes.com/2022/03/tevogen-bio-appoints-prominent-industry-leader-susan-podlogar-to-the-companys-corporate-advisory-board/ 2022-03-02T16:20:45+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Susan-Podlogar.jpg https://bostonlifesciencestimes.com/2022/03/caduceus-capital-partners-invests-in-uptimehealth/ 2022-03-02T16:26:55+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/UptimeHealth.png https://bostonlifesciencestimes.com/2022/03/heartbeam-partners-with-phoebe-putney-health-system-for-first-pilot-study-of-emergency-department-myocardial-infarction-software/ 2022-03-02T16:34:21+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/HeartBeam.webp https://bostonlifesciencestimes.com/2022/03/phenovista-biosciences-announces-michelle-mack-as-vp-of-business-development/ 2022-03-03T15:33:47+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Dr.-Michelle-Mack.jpg https://bostonlifesciencestimes.com/2022/03/hdmz-announces-key-executive-leadership-changes-to-position-the-agency-for-continued-growth/ 2022-03-03T15:39:00+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Dillon-Allie.jpg https://bostonlifesciencestimes.com/2022/03/canceriq-raises-14m-series-b-funding-to-improve-access-to-innovations-in-cancer-early-detection-and-prevention/ 2022-03-03T16:05:27+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Feyi-Olopade-Ayodele-and-Olufunmilayo-Olopade-MD.jpg https://bostonlifesciencestimes.com/2022/03/cana-launches-cana-one-the-worlds-first-molecular-beverage-printer-giving-everyone-the-ability-to-print-thousands-of-beverages-from-their-kitchen-with-zero-trash-from-plastic-alu/ 2022-03-03T16:13:07+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Cana-One-Molecular-Beverage-Printer.jpg https://bostonlifesciencestimes.com/2022/03/arrepath-announces-20-million-seed-financing-to-advance-its-machine-learning-based-platform-for-discovery-of-novel-anti-infectives-addressing-antimicrobial-resistance/ 2022-03-03T16:23:56+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Dr.-Lloyd-Payne.jpg https://bostonlifesciencestimes.com/2022/03/adrestia-appoints-robert-johnson-as-chief-executive-officer/ 2022-03-03T16:31:00+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Robert-Johnson.jpg https://bostonlifesciencestimes.com/2022/03/immunicom-announces-dr-julie-tubbs-and-marilyn-panahi-to-join-senior-leadership-team/ 2022-03-03T16:40:27+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Dr.-Julie-Tubbs.jpg https://bostonlifesciencestimes.com/2022/03/lazurite-to-showcase-its-arthrofree-wireless-camera-system-at-multiple-upcoming-conferences/ 2022-03-03T19:21:16+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Lazurite-2.jpg https://bostonlifesciencestimes.com/2022/03/gather-labs-opens-its-doors-in-beverly-hills-providing-full-lab-and-covid-19-testing-services-on-site-with-no-hassle-or-waiting/ 2022-03-03T19:25:02+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Gather-Labs.jpg https://bostonlifesciencestimes.com/2022/03/atrium-hospitality-and-american-red-cross-extend-successful-national-partnership-to-address-nations-blood-supply-crisis/ 2022-03-03T19:27:00+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Alpharetta.jpg https://bostonlifesciencestimes.com/2022/03/maxlinear-and-sumitomo-electric-device-innovations-announce-availability-of-foton-400g-dr4-reference-platform-based-on-keystone-5nm-dsp/ 2022-03-03T19:31:26+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/MaxLinear.jpg https://bostonlifesciencestimes.com/2022/03/pandemic-response-lab-launches-respiratory-panel-test-for-sars-cov-2-flu-a-flu-b-and-respiratory-syncytial-virus-in-rockville-maryland-lab/ 2022-03-03T19:33:03+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Pandemic-Response-Lab.jpg https://bostonlifesciencestimes.com/2022/03/gi-innovation-recruits-chief-executive-officer-byung-geon-rhee-former-ceo-of-gc-pharma-scm-lifescience-corp/ 2022-03-04T15:45:12+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Byung-Geon-Rhee.jpg https://bostonlifesciencestimes.com/2022/03/scitara-continues-to-break-barriers-and-advance-the-modern-lab-with-the-newest-release-of-digital-lab-exchange-dlx/ 2022-03-04T15:49:11+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Scitara.jpg https://bostonlifesciencestimes.com/2022/03/bayer-strengthens-companys-government-and-industry-affairs-group-in-key-u-s-market-with-two-appointments/ 2022-03-04T16:00:07+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Michael-Parrish.jpg https://bostonlifesciencestimes.com/2022/03/rev-ambulance-group-company-delivers-all-electric-zero-emission-ambulance-to-docgo/ 2022-03-04T16:32:20+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/REV-Group.jpg https://bostonlifesciencestimes.com/2022/03/berkley-life-sciences-introduces-ls-prime-advantage-admitted-product-liability-insurance-coverage/ 2022-03-07T14:54:30+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Emily-Urban.jpg https://bostonlifesciencestimes.com/2022/03/goodrx-agrees-to-acquire-vitacare-a-tech-enabled-pharmacy-services-platform/ 2022-03-07T15:00:00+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/goodrx.png https://bostonlifesciencestimes.com/2022/03/microbiotica-raises-50m-67m-to-advance-pipeline-of-microbiome-based-therapeutics/ 2022-03-07T15:10:14+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Mike-Romanos.jpg https://bostonlifesciencestimes.com/2022/03/ontario-announces-public-coverage-for-the-dexcom-g6-continuous-glucose-monitoring-system-under-the-assistive-devices-program/ 2022-03-07T15:41:42+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Dexcom-G6-CGM-System.jpg https://bostonlifesciencestimes.com/2022/03/medorion-announces-first-health-behavior-management-software-for-u-s-based-health-plans/ 2022-03-07T15:55:54+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/MedOrion.jpg https://bostonlifesciencestimes.com/2022/03/mawi-dna-technologies-nabs-ce-certification-for-sample-collection-product-portfolio/ 2022-03-07T16:13:37+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Mawi-DNA.jpg https://bostonlifesciencestimes.com/2022/03/minnesota-rubber-and-plastics-acquires-primasil-silicones-ltd/ 2022-03-07T16:20:02+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Minnesota-Rubber-and-Plastics.png https://bostonlifesciencestimes.com/2022/03/genbody-americas-diagnostic-kit-manufacturing-plant-opens-and-begins-production-in-southern-california/ 2022-03-07T16:27:58+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/GenBody.jpg https://bostonlifesciencestimes.com/2022/03/spring-is-prime-termite-season-are-you-prepared/ 2022-03-07T17:02:22+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/National-Pest-Management-Association.png https://bostonlifesciencestimes.com/2022/03/echosens-launches-fibroscan-go-affordable-state-of-the-art-non-invasive-solution-for-identifying-patients-with-advanced-chronic-liver-disease/ 2022-03-07T17:05:57+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Echosens.png https://bostonlifesciencestimes.com/2022/03/dnanexus-secures-200-million-funding-led-by-blackstone-growth-to-advance-its-biomedical-data-driven-technology-platform-for-precision-medicine/ 2022-03-08T15:42:26+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Screenshot-2022-03-08-at-10-39-20-DNAnexus%C2%AE-Team-is-scientists-engineers-cloud-experts-compliance%E2%80%A6.png https://bostonlifesciencestimes.com/2022/03/new-innovative-gc-and-gc-ms-product-portfolio-enables-greater-uptime-and-efficiency/ 2022-03-08T15:48:11+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/instrument.jpg https://bostonlifesciencestimes.com/2022/03/inscopix-expands-applications-with-blood-flow-imaging-to-study-relationship-between-brain-activity-and-vascular-dynamics/ 2022-03-08T15:50:58+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Kunal-Ghosh-Ph.D.jpg https://bostonlifesciencestimes.com/2022/03/urogen-secures-100-million-non-dilutive-term-loan-financing-with-pharmakon-advisors-allowing-funding-to-cash-flow-breakeven/ 2022-03-08T16:02:37+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Screenshot-2022-03-08-at-11-00-00-Leadership-Team-UroGen-Pharma.png https://bostonlifesciencestimes.com/2022/03/curie-therapeutics-appoints-karen-smith-m-d-ph-d-as-independent-board-director/ 2022-03-08T16:06:58+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Screenshot-2022-03-08-at-11-06-21-Our-People-%E2%80%93-Curie-Therapeutics.png https://bostonlifesciencestimes.com/2022/03/rocket-pharmaceuticals-appoints-jessie-yeung-as-vice-president-of-investor-relations-and-corporate-finance/ 2022-03-08T16:11:52+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Rocket-Pharmaceuticals.jpg https://bostonlifesciencestimes.com/2022/03/maryland-tech-council-expands-statewide-impact-with-two-regional-tech-councils/ 2022-03-08T16:26:45+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Maryland-Tech-Council.png https://bostonlifesciencestimes.com/2022/03/university-health-network-transforms-core-connected-healthcare-system-with-red-hat-integration/ 2022-03-08T16:29:40+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Red-Hat.jpg https://bostonlifesciencestimes.com/2022/03/endra-life-sciences-strengthens-taeus-system-intellectual-property-with-issuance-of-24th-u-s-patent/ 2022-03-08T16:31:48+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/ENDRA-Life-Sciences.webp https://bostonlifesciencestimes.com/2022/03/ananda-scientific-and-nyu-grossman-school-of-medicine-announce-first-patient-enrolled-in-the-clinical-trial-for-opioid-sparing-in-participants-with-radiculopathic-pain/ 2022-03-08T16:36:34+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/NYU-Grossman-School.jpg https://bostonlifesciencestimes.com/2022/03/new-non-hazardous-viral-inactivation-medium-supports-safe-collection-and-transport-of-sars-cov-2/ 2022-03-08T16:42:31+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/InhibiSURE.jpg https://bostonlifesciencestimes.com/2022/03/boston-cell-standards-launches-consortium-for-analytic-standardization-in-immunohistochemistry/ 2022-03-08T16:45:20+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Boston-Cell-Standards.png https://bostonlifesciencestimes.com/2022/03/cionics-neural-sleeve-granted-fda-clearance/ 2022-03-08T16:49:50+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Cionics-Neural-Sleeve.jpg https://bostonlifesciencestimes.com/2022/03/coviddetect-by-drivercheck-partners-with-canadian-cancer-society-to-donate-covid-19-rapid-antigen-testing-kits-to-those-who-need-it-most/ 2022-03-08T16:57:12+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/COVIDdetect.jpg https://bostonlifesciencestimes.com/2022/03/kenota-strengthens-board-of-directors-with-two-new-appointments/ 2022-03-09T16:31:08+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Dennis-Flannelly.jpg https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Ruth-Abdulmassih.jpg https://bostonlifesciencestimes.com/2022/03/twist-bioscience-and-kriya-sign-agreement-to-discover-novel-antibodies-for-applications-in-oncology-using-gene-therapy/ 2022-03-09T16:35:02+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Twist-Bioscience.jpg https://bostonlifesciencestimes.com/2022/03/the-rmr-group-launches-mixed-use-redevelopment-near-seattles-elliott-bay/ 2022-03-09T16:37:08+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/The-RMR-Group.png https://bostonlifesciencestimes.com/2022/03/scribe-therapeutics-appoints-david-parrot-as-chief-financial-officer-and-george-manning-as-controller/ 2022-03-09T16:40:22+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/David-Parrot.png https://bostonlifesciencestimes.com/2022/03/colossal-secures-60m-series-a-funding-to-advance-genetic-engineering-and-de-extinction-technologies/ 2022-03-09T16:43:11+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Colossal.jpg https://bostonlifesciencestimes.com/2022/03/announcing-new-fourier-80-benchtop-ft-nmr-capabilities-for-pharmaceutical-and-food-analysis-markets/ 2022-03-10T15:37:03+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Fourier-80.jpg https://bostonlifesciencestimes.com/2022/03/strateos-expands-leadership-team-to-meet-increasing-customer-demand-for-its-remote-access-laboratories-and-lab-automation-software/ 2022-03-10T15:41:23+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Jason-Pontin.jpg https://bostonlifesciencestimes.com/2022/03/rightsline-acquires-real-software-systems-expanding-from-hollywood-into-a-global-ip-commerce-powerhouse/ 2022-03-10T15:50:41+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Patrick-Arkeveld.png https://bostonlifesciencestimes.com/2022/03/stevanato-group-to-create-manufacturing-hub-in-china/ 2022-03-10T16:00:59+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Stevanato-Group.jpg https://bostonlifesciencestimes.com/2022/03/heartbeam-partners-with-triple-ring-technologies-to-co-develop-telehealth-solution-device/ 2022-03-10T16:06:24+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/HeartBeam.webp https://bostonlifesciencestimes.com/2022/03/herophilus-appoints-industry-veteran-scott-saywell-as-chief-business-officer/ 2022-03-10T16:11:13+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Scott-Saywell.jpg https://bostonlifesciencestimes.com/2022/03/rockley-photonics-and-medtronic-collaborate-to-deliver-the-next-generation-of-wearable-healthcare-monitoring-devices/ 2022-03-10T16:15:56+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Rockley-Photonics.jpg https://bostonlifesciencestimes.com/2022/03/foamtec-medicals-optimized-polyurethane-foam-swabs-help-reduce-risks-of-false-positive-and-negative-covid-19-results/ 2022-03-10T16:17:44+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Foamtec-Medical.png https://bostonlifesciencestimes.com/2022/03/kmc-systems-to-produce-rapid-blood-ammonia-testing-instrument/ 2022-03-10T16:19:51+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/KMC-Systems.png https://bostonlifesciencestimes.com/2022/03/reflexion-raises-80-million-to-broaden-cancer-treatment-options/ 2022-03-10T16:31:20+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/RefleXion.png https://bostonlifesciencestimes.com/2022/03/covid-may-be-waning-but-for-ohio-students-experiencing-homelessness-the-problems-are-just-beginning/ 2022-03-10T16:46:34+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Kristin-Stewart.png https://bostonlifesciencestimes.com/2022/03/massachusetts-leads-global-life-sciences-industry/ 2022-03-10T20:16:26+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Joe-Boncore.jpg https://bostonlifesciencestimes.com/2022/03/audere-and-south-africa-based-medical-diagnostech-partner-to-bring-africas-first-home-grown-covid-19-antigen-test-to-market-with-digital-companion-app/ 2022-03-11T16:41:48+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Audere.png https://bostonlifesciencestimes.com/2022/03/emmy-award-winning-broadcast-journalist-and-storyteller-steve-atkinson-joins-the-seismic-collaborative-as-vice-president-of-executive-media-engagement/ 2022-03-11T16:49:19+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Steve-Atkinson.jpg https://bostonlifesciencestimes.com/2022/03/happify-health-and-zuellig-pharma-partner-to-commercialize-prescription-digital-therapeutics-in-asia/ 2022-03-14T16:02:51+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Happify-Health.jpg https://bostonlifesciencestimes.com/2022/03/thermo-fisher-scientific-to-expand-clinical-research-labs-capacity-in-virginia/ 2022-03-14T16:08:10+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Thermo-Fisher-1.jpg https://bostonlifesciencestimes.com/2022/03/texas-medical-center-doubles-the-size-of-the-tmc-venture-fund/ 2022-03-14T16:13:20+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Texas-Medical-Center.jpg https://bostonlifesciencestimes.com/2022/03/suffolk-hires-brad-brown-as-president-of-suffolk-texas/ 2022-03-14T16:15:53+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Brad-Brown.jpg https://bostonlifesciencestimes.com/2022/03/nutcracker-therapeutics-raises-167-million-in-series-c-financing-to-advance-its-mrna-therapeutics-and-first-of-its-kind-biochip-based-manufacturing-platform/ 2022-03-14T16:17:48+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Igor-Khandros-Ph.D..jpg https://bostonlifesciencestimes.com/2022/03/applied-dna-executes-loi-with-spindle-biotech-for-research-collaboration-on-simplified-high-yield-mrna-production-system/ 2022-03-14T16:22:28+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Applied-DNA.jpg https://bostonlifesciencestimes.com/2022/03/curie-therapeutics-appoints-georgette-verdin-as-chief-people-officer/ 2022-03-14T16:24:33+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Screenshot-2022-03-14-at-12-23-45-Our-People-%E2%80%93-Curie-Therapeutics.png https://bostonlifesciencestimes.com/2022/03/livermultiscan-has-achieved-nationwide-payer-coverage-for-diagnosis-and-management-of-nafld-and-other-established-chronic-liver-diseases/ 2022-03-14T16:26:20+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/LiverMultiScan.jpg https://bostonlifesciencestimes.com/2022/03/dt-research-delivers-the-most-comprehensive-line-of-healthcare-computing-solutions-purpose-built-for-diverse-medical-environments/ 2022-03-14T16:29:03+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/DT-Research.jpg https://bostonlifesciencestimes.com/2022/03/masimo-debuts-telehealth-for-patient-safetynet-at-himss-2022-global-health-conference/ 2022-03-14T16:30:23+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Masimo.jpg https://bostonlifesciencestimes.com/2022/03/fresenius-kabi-receives-u-s-food-and-drug-administration-510k-clearance-for-wireless-agilia-connect-infusion-system-with-vigilant-software-suite-vigilant-master-med-technology/ 2022-03-14T16:32:37+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Fresenius-Kabi.jpg https://bostonlifesciencestimes.com/2022/03/mustafa-noor-md-facp-joins-olatec-as-chief-medical-officer/ 2022-03-15T14:44:43+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Mustafa-Noor-MD.jpg https://bostonlifesciencestimes.com/2022/03/inversago-pharma-announces-dosing-of-first-participant-with-metabolic-syndrome-in-phase-1b-clinical-trial/ 2022-03-15T14:49:17+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Dr.-Francois-Ravenelle.jpg https://bostonlifesciencestimes.com/2022/03/spectrum-chemical-launches-new-biocertified-products-to-support-global-demand-for-new-vaccines-therapeutics-and-other-biopharmaceuticals/ 2022-03-15T14:51:33+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Spectrum-Chemical.jpg https://bostonlifesciencestimes.com/2022/03/aizon-and-aggity-launch-partnership-to-help-biopharmaceutical-firms-increase-the-speed-and-efficiency-of-drug-manufacturing/ 2022-03-15T15:02:08+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Glenn-Griffin.jpg https://bostonlifesciencestimes.com/2022/03/the-massman-companies-acquires-new-england-machinery-inc/ 2022-03-15T15:11:11+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/The-Massman-Companies.jpg https://bostonlifesciencestimes.com/2022/03/intel-announces-initial-investment-of-more-than-e33-billion-for-semiconductor-rd-and-manufacturing-in-eu/ 2022-03-15T15:23:30+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/rendering.jpg